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Abstract
This thesis describes the development o f a new variety o f lumophores, in particular 
luminescent rhenium(l) complexes o f the type [Re(bisim)(CO>3 L]n+, where bisim 
represents a bisimine derivative, e.g. bipyridine, and L i s a  pyridine derivative (n = 1) or a 
chloride (n = 0), suitable for specific cell imaging and whose modified photophysical 
properties overcome some o f the problems associated with traditional imaging agents 
(small Stokes shift, short lifetimes, etc).
Specifically the successful synthesis and photophysical studies o f a chemical model to 
validate the concept o f a membrane permeable cell-imaging device, fac- 
[Re(bipyXC0 )3(PyCH2 C0 0 (CH 2 )3 0 TBD)]+, are presented. Further investigations towards 
and improved cell imaging agent, considering different issues like water solubility, 
lipophilicity and cell encapsulation rate, are then undertaken. Consequently, a new range of 
water soluble rhenium complexes, yac-[Re(bisimXCO)3 (L)]n' where bisim is a water 
soluble bathophenanthroline and L is a pyridine derivative (n = 2) or a chloride (n = 1), as 
well as a variety o f novel yac-[Re(bisimXCO)3 Cl] complexes, where bisim is a terpyridine 
derivative bearing a se lf destruction device which can be triggered by nitroreductase, are 
also presented. Additionally, the synthesis and structural description o f a trinuclear 
rhenium complex is reported, along with a discussion o f its use in inclusion experiments 
and attempts at analogue formation.
The design and synthesis o f a thiol selective luminescent rhenium complex, fac- 
[Re(bipyXCO)3(PyCH2 Cl)]+, is described, along with the demonstration o f its thiol 
selectivity both in vitro and in vivo as demonstrated by specific mitochondrial localization. 
Finally, studies o f membrane permeability in liposome models, cellular uptake and 
localization in different cells such as Spironucleous vortens, yeast cells and human breast 
cancer cells of a variety o f rhenium complexes above cited are also reported.
These results combine to demonstrate the promising future o f this new class o f imaging 
probes as specific cell imaging agents and therefore, this work represents the initial step in 
the growing area o f the development o f transition metal based imaging agents.
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Chapter 1
1.1 Introduction.
Optimum detection o f individual biomolecules, cell components and other biological 
entities, as well as the proper distribution and targeting o f drugs, is becoming one o f the 
most important issues in medicine. Traditionally, organic dyes such as Malachite green. 
Fluorescein, Rhodamine, etc. have been used to visualize biological tissue or cell 
organelles.1 Recently, however, the demand for more precise information about biological 
processes and the biodistribution o f drugs or biomolecules, in addition to the technological 
advances o f the last decade, have led to the development o f a new range o f biological 
luminescent probes including quantum dots (QDots) and transition metal and lanthanide 
complexes. In particular, transition metal complexes as light-emitting markers have 
exceptional characteristics as lumophores.2 Not only do they offer obvious advantages over 
the traditional dyes, but also over quantum dots and lanthanide complexes as they can be 
used in a new range o f experiments, i.e. anisotropy measurement.
1.1.1 Organic dyes: Simple colour staining and fluorescence techniques.
In the early nineteenth century there was an interest in the development o f organic dyes for 
biological and microscopy applications as some o f these dyes allowed specific staining o f 
biological tissues and showed a preference for particular inner cell organelles.3 These 
pioneering dyes include Malachite green, Sudan black, Coomassire blue and also 
Hematoxylin, which is an organic dye whose affinity for negatively charged molecules 
reveals the distribution o f DNA, RNA and acidic proteins in the cell F igure 1.1. However, 
achieving an adequate level o f sensitivity that enabled selective staining in order to reveal 
the localisation o f specific proteins or macromolecules within the cell, as well as to 
overcome interference from other coloured materials, was difficult.
2
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Malachite green
Coomassire blue
Hematoxylin
Sudan black
Figure 1.1. The chemical structures of Malachite green. Sudan black. Hematoxylin and 
Coomassire blue.
An alternative method that overcomes these drawbacks was pioneered with the use of 
fluorescent dyes, revolutionising the biological imaging field. Two fluorescent dyes 
commonly used for biological applications are fluorescein, which emits an intense green 
fluorescence when excited with blue light, and rhodamine, which emits a deep red when 
excited with green-yellow light (see Figure 1.2.). The coupling of an antibody3 to either of 
the fluorescent dyes allows visualization of, for example, the biodistribution of an 
antibody 's target or monitoring changes in concentration and location of the target inside 
living cells.
* Which often binds extremely strongly to a specific target foreign molecule or cell, thereby inactivating it or 
marking it for destruction.
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Fluorescein Tetramethylrhodamine
Figure 1.2. Chemical structure of fluorescein and rhodamine derivatives.
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1.2 T ra n s p o r t  A cross T h e  C ell M e m b ra n e .
Monitoring or “tagging” an intracellular analyte or organelle without affecting its 
morphology or function, requires the design of non toxic, highly luminescent contrast 
agents including the ability to tune the solubility and cell permeability of these reagents. In 
order to do this effectively, an understanding of the different mechanisms of transporting 
an exogenous species inside the cell and thus the constitution of the cell and cell membrane 
is necessary. Figure 1.3 depicts a schematic of a typical animal cell.
Within the cytoplasm, the major organelles and cellular structures include (1) nucleolus (2) 
nucleus (3) ribosome (4) vesicle (5) rough endoplasmic reticulum (6) Golgi apparatus (7) 
cytoskeleton (8) smooth endoplasmic reticulum (9) mitochondria (10) vacuole (11) cytosol 
(12) lysosome and (13) centriole.
Figure 1. 3. Schematic drawing of a typical animal cell. (Reproduced with permission of, 
and Copyright ©, 2000, 2001, 2002 Free Software Foundation)
The cell membrane is a lipid bilayer mainly constituted of phospholipids, amphiphilic 
entities with a hydrocarbon tail and a polar head, and, to a smaller extent, cholesterol and 
membrane proteins, known as transmembrane proteins. The cell membranes are dynamic 
fluid structures which are crucial for many membrane functions, such as transport 
processes and enzymatic activity. See Figure 1.4.
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Lateral diffusion
Polar heads
Flip-flop
Rotation Flexion
Figure 1.4. The types of movement possible for phospholipid molecules in a lipid bilayer.
Transmembrane proteins are responsible for transferring solutes such as water, nutrients 
and waste into and out of the cell. They can be divided in two major classes; carrier 
proteins which have moving parts to shift specific molecules across the membrane and 
channel proteins which form narrow hydrophobic pores. Figure 1.5. Active transport 
requires a source of metabolic energy, such as ATP hydrolysis or an ion gradient and is 
generally mediated by carrier proteins. These proteins bind to the specific solute to be 
transported and undergo a series of conformational changes that allow transfer of the solute 
across the membrane. Passive transport, or facilitated diffusion, is due to a positive 
electrochemical or concentration gradient and does not involve any metabolic energy. 
Some examples of passive transport are simple diffusion (water, oxygen, carbon dioxide, 
ethanol and urea) which is mediated by both carrier proteins and protein channels. 
Transport through protein channels occurs at a much faster rate than transport mediated by 
carrier proteins.
■Carrier protein
Transmembrane protein 
Figure 1.5 Schematic drawings showing two-dimensional view of a cell membrane.
In addition, short peptide sequences are known to cross the plasma membrane, e.g. Tat- 
peptide,4 or polyarginines. These peptide sequences are used to transport diverse substrates 
such as polymers,5 nanoparticles,6 DNA7 and liposomes8 across the cell membrane. The
6
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cell entrance mechanism can be via endocytosisb or a direct process involving translocation 
of the lipidic bilayer (see Figure 1.6). Those peptides using a direct mechanism of uptake 
would be expected to display transport that is sensitive to changes in membrane properties, 
such as fluidity and membrane potential.
Phagocytosis
Pinocytosis
Endocytosis
Direct translocation
Figure 1.6. Schematic representation of entrance mechanism of cell membrane.
Later investigations reveal that the route of entry of a cell via a penetrating peptide (CPP) 
can be dependent on the identity of the attached cargo9 {e.g. drug, fluorophore, 
nanoparticle, protein etc.) and on the cell type.10 CPPs have been proven to be effective at 
increasing the efficacy of several therapeutics by improving cellular uptake and also their 
use as molecular vehicles offers several advantages such as lower toxicity and more 
controlled administration.11 An example of the application of CPPs for imaging was 
recently reported by Tsien and co-workers.12 Their work used a fluorescein-peptide 
hairpin0 that takes advantage of the increased number of extracellular proteases 
surrounding tumour tissues. These proteases allow the internalization of the cargo, i.e. the 
imaging agent, upon proteolytic cleavage of the anionic domain, i.e. the impermeable 
domain. Thus the imaging marker is taken up specifically by the cancer cells. (See Figure 
1.7).
b Endocytosis, includes phagocytosis and pinocytosis, where the difference is that in the first one there is a 
enlargement o f the cell membrane (pseudopods) that surround the external agent, whereas in the second type 
vesicles of fluid are formed in the cell membrane (no pseudopods).
c It is the simplest protein motif involving two beta strands that aligns with itself to form a needle like 
structure
7
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Cargo: Therapheutic 
Imaging agent
CPP
Impermeable
Peptide
Cancer specific 
cleavage sequence
Specific
Protease
Outside-Cell Inner-Cancer Cell
Figure 1.7. CPP-delivered therapeutics using protease-triggered cellular uptake.
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1.3 In tro d u c tio n  T o  L u m in escen ce .
Since the first observation of fluorescence from a quinine solution in sunlight reported by 
Sir John Frederick William Herschel in 1845,13 many other scientists became involved in 
the study of this bizarre phenomenon that was only observed in a small number of 
compounds. More than 50 years of further investigations provided Professor Alexander 
Jablonski with enough information to illustrate the process between absorption and 
emission of light. Jablonski diagrams. Figure 1.8, represent a starting point for discussing 
the process of luminescence.
Luminescence can be divided into fluorescence and phosphorescence, distinguished by the 
excited state from which the emission of light comes: from the singlet excited state for 
fluorescence and the triplet excited state for phosphorescence. In both cases, once the 
molecule is irradiated there is an electronic transition from the ground state (So) to the 
excited states (Si) and (S2); the time that it takes is extremely brief, in the order of 
femtoseconds. The molecule can then release the energy through different pathways -  
radiation-less (vibrational relaxation, internal conversion and intersystem crossing) and 
emission of light (fluorescence and phosphorescence). The emission of light typically takes 
place from the lowest vibrational level of Si or Ti to any of the ground state vibrational 
levels after removal of excess of energy by vibrational relaxation, internal conversion 
or/and intersystem crossing.
Vibrational relaxation
Absorption
10*,5sec
Internal conversion
10,2sec
Intersystem
crossing
10'8sec 
Fluorescence
Rotational g g = :  V ibrational!
levels —  levels 1
.T X  Radiation less process 
 ► Radiation process
Phosphorescence
KP-KrSec
Figure 1.8. Jablonski diagram.
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An interesting consequence of the energy pathways involved is that the emitted light has a 
longer wavelength than that absorbed, first observed in 1852 by Sir George Gabriel 
Stokes14 at the University of Cambridge after performing an incredibly simple experiment, 
Figure 1.9. The experiment did not need any electronic equipment, only the intelligence of 
a scientist like Sir Stokes. The source of ultraviolet light was provided by the sun and was 
then filtered by a stained glass window which only transmitted light below 400 nm. This 
light was absorbed by the quinine solution and was then filtered again using yellow glass, 
in fact a glass of wine, which only transmits light above 400 nm. Quinine emission is near 
450 nm and therefore easily visible.
Observer
Yellow-glass 
of wine
Blue glass emission filter
church window transmits > 400nm
transmits <400nm
Figure 1.9. Experimental schematic for the detection of the Stokes shift.
As a result of this experiment, the Stokes shift, an intrinsic property of a luminescent 
substance, became an important concept in luminescent processes. It is defined as the 
difference, in wavelength or frequency units, between the maxima of the absorption and 
emission spectra. In addition, the emission spectrum is generally a mirror image of the 
absorption spectrum of the So —► Si transition, since the different excitation wavelength 
does not affect the emission maxima. Moreover, there is no alteration of the nuclear 
geometry in the electronic transition, and consequently, no alteration of its vibrational 
energy levels. These two statements are respectively known as Kasha's rule,d elaborated in 
1926 and the Franck-Condon principle,6 in 1927. Figure 1.10.
d Exceptions to this rule arise when there are large energy gaps between excited states, e.g. azulene. 
e Named after James Franck and Edward Ulher Condon, a German physicist and an American nuclear 
physicist respectively.
10
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N uclear C oordinates
-►2
Fluorescence A bsorption
6 + -  0<-00
o-o
Energy
Figure 1.10. A Franck Condon principle energy diagram and its absorption and 
fluorescence spectra.
The measure of the efficiency with which absorbed light produces a certain effect is called 
the quantum yield (O) (in the case of luminescence, ratio of the number of photons emitted 
to the number of photons absorbed). It is directly related to the luminescence intensity, 
whereby the substances with the largest quantum yields, close to unity, such as 
rhodamines, display the brightest emission. Other essential features in a fluorophore1 are 
the molar absorption coefficient (e) and lifetime (t ). The molar absorption coefficient is an 
intrinsic characteristic of the fluorophore that indicates how strong the absorption is at a 
given wavelength.8 The lifetime of a species is inversely proportional to the radioactive 
decay rate and can be defined as the average time that the molecule remains excited before 
yielding a photon and hence, it is the time available to interact with, or diffuse in its 
environment. These interactions affect the intensity of the emission spectra.
The particular case of a loss of luminescence is known as luminescence quenching which 
can occur by various mechanisms. The most common quenching process is due to the 
collision of the excited state of the fluorophore with certain other molecules, known as 
quenchers, releasing the excess energy in this way. A wide range of molecules can act as 
collisional quenchers, for example; oxygen, halogens, amines. The mechanism of 
quenching varies between the fluorophore-quencher pairs (e.g. electron transfer, spin-orbit
f Although the term fluorophore strictly includes only those molecules that display only fluorescence not
phosphorescence, it is used in this work as a generic term for lumophore, as is common in fluorescence
microscopy related work.
8 Lambert-Beer law: A = eel, where A is the absorbance, c sample concentration and / path length.
11
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coupling, intersystem crossing, etc). Other quenching processes are known as static 
quenching, when a fluorophore forms a non-luminescent compound by interaction with a 
quencher, and trivial quenching processes, i.e. non molecular mechanisms where there is 
an attenuation of the incident light by the fluorophore itself or other absorbing molecules 
(inner-filter effect).
12
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1.4 Fluorophores.
The search for suitable fluorophores is one of the major issues in fluorescence 
spectroscopy and thus in biological imaging. Fluorophores can be divided broadly into two 
main classes, intrinsic and extrinsic, where the intrinsic fluorophores are those belonging to 
biological media and whose fluorescence occurs naturally (e.g. aromatic amino acids, 
NADPH, flavins, etc). Extrinsic fluorophores are those added to the studied sample in 
order to change its spectral properties. Nowadays there is a wide range of commercially 
available extrinsic fluorophores15 that can be used to tag or label bio-molecules. Organic 
chromophores are incredibly abundant in contrast to lanthanide or transition metal 
compounds. Examples of commercial fluorophores used in protein labelling via a coupling 
reaction with amines or sulfhydryl in proteins are illustrated below. Figure 1.11.
HO.HO
COOHCOOH
so2ci
NHCOCH2l n cs
DNS-C1 5AAF FITC
COOH
NBD-C1TR1TC Acrylodan
Figure 1.11. Commercial organic fluorophores
To illustrate the photophysical properties of these extrinsic fluorophores, dansyl chloride 
(DNS-C1), originally described by Weber,16 will be discussed. It has excitation and 
emission maxima at 350 and 520 nm respectively and a lifetime of 10 ns. Unfortunately, 
not all the organic fluorophores display such a big Stokes shift, 170 nm, and long lifetime 
as this compound. Thus, this is the reason why there is currently an increase in interest in 
exploring the area of lanthanides and transition metal complexes as new extrinsic 
fluorophores.
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Fluorophores with small Stokes shifts are likely to self-quench if, for example, they are 
being used to label proteins where various fluorophores are attached close to each other in 
the same protein. Therefore, energy transfer between these fluorophores can occur (Fdrster 
resonance energy transfer (FRET) may also be referred to as fluorescence resonance 
energy transfer), due to the small distance between the imaging probes, which have a high 
probability of being within the Fdrster distance.1
Photostability is another important characteristic that the extrinsic fluorophores should 
have to be used in biological imaging, and regrettably almost all existing organic 
fluorophores are photobleached1 upon continuous illumination.
Long-wavelength probes are also an interesting area of investigation as the sensitivity of 
fluorescence detection is generally limited by autofluorescence* of biological samples. 
Therefore, as the excitation wavelength becomes longer, the autofluorescence of biological 
samples decreases, making differentiation of the signal from the background easier; this 
topic is discussed in more detail in the next section. In addition to this, tissue penetration 
increases with longer excitation wavelengths.17
14.1 Long lifetime probes: Quantum dots, lanthanide and transition metal 
complexes.
Although biological imaging techniques based on organic dyes are highly sensitive, they 
are not completely adequate to overcome the difficulty of separating the fluorescence of 
the stain from that of the sample as, generally, biological material is highly complex and 
usually includes numerous fluorescent groups. In addition, almost all of the organic dyes 
display lifetimes from 1 to 10 ns, which limits the dynamic information content of 
fluorescence, for example anisotropy measurements,11 (see Section 1.4.5). Semi conductor 
nanoparticles (quantum dots) and lanthanide and transition metal complexes are taking 
advantage of the limitations of organic dyes and are becoming the subject of many recent 
studies in the field. These compounds show emission via phosphorescent processes,
k Dooor-to-acceptor separation distance.
* The photochemical destruction of a fluorophore. 
i Fluorescent of the intrinsic biological components (see Chapter 5).
k Measurement of protein denaturalization, protein association, internal viscosity of membranes, effect of 
tipid composition in the phase-transition temperature, etc.
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providing emission bands well separated from the emission of organic moieties. Moreover, 
their photophysical properties (emission wavelength, excited state lifetime, quantum yield, 
etc.) can be tuned by changing the coordinated ligands (especially in transition metal 
complexes) or the chemical composition in the case of QDots. However, there are 
problems to overcome as many of the relevant metal ions are toxic. Therefore, not only is it 
desirable to synthesise kinetically stable complexes, but also to improve features such as 
solubility or cell permeability, especially when they are designed for biological purposes. 
The synthesis of the right ligand system is the key to achieving this objective.
1.4.2 Quantum dots (QDots).
QDots have shown their suitability as fluorescent biological labels since the first studies in 
1988.18 Their composition consists of a core, usually CdSe or CdS, and a shell, usually 
ZnS, to coat the core from the outside and hence confer the chemical and photostability 
needed. In addition, a polymer or a silica layer surrounding the shell modulates the 
solubility properties and a final coating with biocompatible molecules ensure its specific 
binding to biomolecules and hence its localization, see Figure 1.12.
Bioaffinity molecules 
Core (CdSe)
Figure 1.12. Schematic drawing of typical QDots.
Some spectral properties of QDots that make them useful for biological fluorescent probes 
are listed below:
i. Homogeneous sized QDots display emission spectra twofold narrower than 
conventional fluorophores.
ii. QDots do not exhibit a long-wavelength emission tail.
iii. Large extinction coefficients.
iv. High photostability.
v. Emission wavelength depends on the size and chemical composition.|y
15
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Examples of QDots being used as specific labels in live cells can be found in various 
reports, principally by Jaisawal20 and Wargnier.21
1.43 Lanthanides.
The first interest in lanthanide complexes in biology was due to their similarity to calcium 
ions. Although they have a higher charge (Ln3+ vs. Ca2+), their ionic radii confer a high 
affinity for Ca2+ sites in biological molecules, acting as either Ca2+ inhibitors or probes.22 
Currently, their luminescent properties have drawn attention to their potential for use in 
medical imaging as emitted light is the most convenient and sensitive medium to detect 
and image, and even single-molecule detection is often within reach.
Lanthanides, or 4 f  elements, are the series from lanthanum to lutetium, and have a trivalent 
charge in aqueous solution. The rare earth designation generally includes scandium and 
yttrium. Their characteristic decrease in atomic size and radius with increasing atomic 
number is known as the lanthanide contraction. In addition, the shielding of the 4 / orbitals 
results in special spectroscopic properties such as lanthanide emissions resulting from 
transitions involving these 4f  orbitals, which are forbidden by the Laporte rules.1 Therefore, 
the absorption coefficients are very low, less than 10 M^cm'1 and the emission rates are 
very slow, resulting in long lifetimes. Lanthanides behave like atoms and display line-like 
spectra, making their emission profile easily recognizable.23 Because of their weak 
absorption, lanthanides are not usually directly excited, instead, a chromophore, generally 
an organic compound incorporated into a chelating ligand, is irradiated with UV light and 
then the lanthanide becomes excited via an energy transfer process, see Figure 1.13.
1 Named after Otto Laporte, 1925. The electronic transitions conserving either symmetry or asymmetry with 
respect to an inversion center (eg., g (gerade ) —► g, or u (ungerade) —► u) are forbidden i.e. transitions within 
a given set of/? or d orbitals.
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Figure 1.13. Jablonski diagram for terbium excitation.
However, there are also non-radiative paths that release energy and which must be 
minimized in order to increase the quantum yield of the process. Vibrational deactivation is 
(me of the most efficient deactivation processes. It is temperature dependent and has a 
major impact when a donor atom involved in the vibration is directly attached to the metal 
ion. For instance, there is severe quenching of the luminescence of lanthanides via O-H 
interactions of the aqueous solution (e.g. biological media) with the metal centre and so the 
metal must be protected from the aqueous environment by encapsulation using a 
muhidentate ligand. It is also important to have efficient sensitization of the lanthanide by 
matching the energy gap between the lowest triplet state of the ligand and the emissive 
state. Another deactivation process is energy back transfer, which is also avoided with a 
suitable energy level gap. Therefore the design of luminescent lanthanide complexes for 
biological imaging requires a broad knowledge of their intrinsic properties. (Figure 1.14)
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A F
Sensitizer
P
ket
S|: singlet state 
Ti: triplet state 
A: absorbance 
F: fluorescence 
P: phosphorescence 
kc,: energy transfer 
kisc: intersystem crossing 
kback: transfer back 
km: non radiactive
Figure 1.14. Radiative and non-radiative processes.
The coordination number of lanthanide complexes varies from 6 to 12, the preferred being 
8 and 9. The major challenge for a chemist is ligand design in order to control the 
coordination sphere through the conformational restrictions of the ligand. Moreover, the 
ligand design must provide a strong metal-ligand interaction in order to have a high 
thermodynamic stability and kinetic inertness. In biological media, i.e. aqueous solutions, 
the stability of lanthanide complexes increases upon substitution of the bonded water 
molecules for a polydentate ligand due to the chelate effect. As the preorganization of the 
ligand increases this also raises its thermodynamic stability in the case of macrocyclic 
ligands due to the macrocyclic effect. Therefore, by encapsulating the metal in a complex 
scaffold, not only does the stability of the complex improve, but also the vibrational 
deactivation processes are avoided as water molecules from the environment are not able 
to reach the metal centre. Many different ligands have been used for this purpose; some 
examples are shown in Figure 1.5.
Macrocyclic ligands EDTA type ligands
Figure 1.15. Types of suitable ligands for lanthanides.2'
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1.4.4 Lanthanide com p lexes as b io log ica l lu m in escen t probes.
As discussed in Sections 1.2.1 and 1.2.3, lanthanides have appropriate photophysical 
characteristics for use as luminescent probes and hence, as diagnostic tools. Not only do 
they have well defined, intense and long-lived emission lines, but they also show large 
Stokes shift upon ligand excitation. These characteristics are useful to separate the 
lanthanide emission from the organic background-emission-autofluorescence. Among the 
lanthanides some emit in the visible region i.e. Eu and Tb, and others in the near infrared
i.e. Yb, Nd, Dy, Pr, and Er, see Figure 1.16. For biological purposes, as tissue penetration 
by light increases with wavelength, near IR-emitting probes are ideal, although their 
lifetimes are shorter, in the order of microseconds (ps), than those that emit in the visible 
range, in the order of milliseconds (ms).
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Figure 1.16. Partial energy diagrams for lanthanide aquo ions.26 Main luminescent levels 
are drawn in red while the fundamental level is indicated in blue.
In addition, lanthanide complexes allow time resolved spectroscopy and microscopy, the 
basis of which is to apply a delay time, 1-100 ps, between the pulse and the detection, 
eliminating possible interferences due to light scattering and autofluorescence and 
therefore enhancing the signal/noise ratio. Figure 1.17.
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Figure 1.17. Principle of time resolved techniques.
All the different examples of lanthanide complexes for biological imaging applications 
found in the literature follow the same general structure. The lanthanide ion is isolated 
from the media by a chelator, i.e. a scaffold, whose function is not only to increase the 
quantum yield of the unit by displacing the water molecules, but also to provide a means to 
bind the lanthanide to a biomolecule and/or to a sensitizer. A list of examples of lanthanide 
complexes already commercially available and also in development is shown in Figure 
1.18 and 1.19
Chromophore
cc R II N -(C H 2)nCHN—n = 5, 2,1 Maleimide, Thiol Reactive
Scaffold
DTPA-csl24R 
commercially available
Isothiocyanate 
R SCN ^  > - (C H 2)3C O O -  A m in e  R eac tjve
Figure 1.18. Chemical structure of DTPA-csl24R.~7
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Ln = Tb used in cell 
Mouse skin fibroblasts 
(NIH-3T3 cells).
Scaffold 
Ln: Eu, Gd, Tb
Figure 1.19. Lanthanide complex whose antenna is an organic chromophore designed by 
Parker et aJ
There are now also examples of transition metals acting as chromophores in these systems. 
They offer the advantage over organic molecules of larger absorption maxima and more 
effective lanthanide sensitization, mainly because the difference between energy levels 
involved in the energy transfer process is small enough to facilitate quick and effective 
lanthanide sensitization. See Figure 1.20 and 1.21.
Scaffold 
Ln: Gd, Tb
Figure 1 JO. Lanthanide complex whose antenna is a transition metal complex designed by 
Faulkner et al.™
Ln = Gd and Yb 
photophysical properties 
suitable to also be used in MRI
Chromophore
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Scaffold
Chromophore Chromophore
Figare 1.21. lan than ide complex whose antennae are transition metal complexes designed 
by De Cola et al. 30
1 AS Transition metal complexes.
Transition metal complexes, particularly those with metal electronic configurations defined 
by a d6 system, have been the subject of much attention mostly because of their unique 
photophysical and photochemical properties.31,32,33 Complexes of Re(I), Ru(II), Os(II) and 
Ir(IH) have been widely studied over the last three decades as possible candidates for 
biological probes for imaging or therapeutic purposes. Generally, d6 metal complexes 
display an octahedral geometry; the presence of the ligands around the metal split the d- 
orbitals into three lower and two higher levels. The energy difference between them 
depends on the crystal field strength which is dictated by the nature of the ligands. See 
Figure 1.22.
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Figure 1.22. Metal and ligand orbitals.
The spectrochemical series of ligands. Figure 1.23, shows common ligands in order of 
increasing crystal field splitting. A, and hence, in increasing n acceptor and strong o donor 
ligand character.
The electronic transitions in a metal complex are classified depending on the molecular 
orbitals between which the transitions occur. Therefore, for an octahedral complex, the 
electronic transitions are as follows: see Figure 1.23.
i. IL, intraligand bands: transitions between energy levels of the ligands, which are 
relatively unaffected by the metal centre.
ii. LF, ligand-field bands: transitions between energy levels of the metal d-orbitals. 
They are the lowest intensity transitions, usually in the visible region.
iii. LMCT, Ligand-to-metal-charge-transfer: transitions in which the electronic charge is 
transferred from the ligands to the coordinated metal.
iv. MLCT, metal-to-ligand-charge-transfer: electronic transition in which the electronic 
charge is transferred from the coordinated metal to the ligands.
I '< Br < Cl* < F * < H20  < NH3 < CO, H < SnCl3
Low A  
71 donor
High A  —►
n acceptor/ a  donor —►
Figure 1.22. Spectrochemical series of ligands.34
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v. CTTS, charge-transfer-to-solvent: electronic charge moves to the solvent from the 
metal or ligand orbitals.
MLCT
CTTS
A
IL
77
Solvent
Orbitals
71
n
o
Metal
Orbitals
Molecular Orbitals Ligand
Orbitals
Figure l i3 .  Molecular orbital diagram for an octahedral coordination complex and the 
different electronic transitions.35
In d6 metal complexes, especially when the metal is Re(I), Ru(II), Os(II) and Ir(III), the 
emission arises from an MLCT transition. The luminescence from these metal complexes 
is formally phosphorescence and generally short lived compared to that of lanthanides 
(microseconds), due to the efficient spin-orbit coupling"1 with a heavy atom which allows 
radiationless deactivation, Figure U 4 .
MLCT
hvAv_>
So
< 300 fs 
Intersystem Crossing
MLCT
hvi
Figure 1.24. Jablonski diagram for a d6 metal complex.
For a metal complex to be luminescent several criteria must be fulfilled. The crystal field 
must be strong enough to raise the d-d state above the MLCT state in order to have an 
emissive MLCT complex. In addition, the separation between the excited state, MLCT, 
and the ground state should be reasonably large to avoid radiationless decay, as smaller 
energy gaps result in a more rapid deactivation. Furthermore, the relative levels of MLCT 
and d-d states determine the sensitivity of the transition metal complex decay time to the
Interaction between the intrinsic angular momenta associated with the particle spin and the orbital motion.
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temperature. Hence, if the d-d levels are close to the MLCT level, then the d-d levels are 
thermally accessible, decreasing the life time of the probe, as the d-d level can become 
populated. Figure 1.25
37i-a*
MLCT
3d-d
Thermal 
, Deactivations i i
\ T  Pathway
Egap: 2eV Egap; 1.6eV
[Fe(L-L)3]2+ [Ru(L-L)3]2+
Non-Luminescent Luminescent 
----------------------------------------------------------
Increasing crystal field strength
Figure 1.25. Energy states for non-luminescent, luminescent and weakly luminescent 
complexes.36
1.4.6 Transition metal complexes as biological luminescent probes.
The high photostability, large Stokes shifts, long wavelength excitation and long decay
n   Itimes give transition metal complexes significant potential as biophysical probes. Their 
polarized emission0 (unlike lanthanide complexes) makes transition metal complexes 
useful for the measurement of dynamic processes on the microsecond scale. Furthermore, 
their long decay times allow an easy separation of the luminescence of the imaging probe 
from any autofluorescence, using time gating techniques, as in the case of the lanthanide 
probes.
The metal-ligand covalent bonds and their high photostability confer the stability necessary 
in order not to dissociate under physiological conditions, avoiding any toxicity that the free
* Emission from a partially oriented population in the fluorophores which were excited with polarized light as 
fluorophores preferentially absorb photons whose electric vector is aligned parallel to their transition 
moment
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metal can confer to the imaging agent and also preventing photobleaching. Moreover, 
metal complexes overcome the problem of the self-quenching found in organic 
chromophores, e.g. fluorescein, as a result of their large Stokes shift.
Their applications range from being used as lipid probes, measuring domain-to-domain 
motion in proteins,38 or measuring DNA dynamics39 to ion sensing complexes.40 Therefore, 
transition metal complexes seem to have a promising future as luminescent biological 
probes. Some examples are listed below in Figure 1.26.
Example A Example B
Ru. —N
\ / +OC Re— N
/  \OC CO
ReCbcpXCO)3(pyCOOH)-PE-l ipid[RuCbpy)2(dppz)](PF6 ) 2
Figure 1.26. DNA and lipid luminescent probes.
[Ru(bpy)2(dppz)](PF6)2. (Figure 1.26, example A)39 is used to study DNA dynamics as it 
intercalates into the double-helix and displays polarized emission. It is highly luminescent 
after its interaction with DNA. Transition metal complexes represent an important 
breakthrough in these kinds of studies as the organic molecules, e.g. EB,° acridine orange, 
etc,41 used so far for this purpose display decay times of around 30 nanoseconds (ns) 
whereas the expected motion for DNA ranges from ns to ps. Anisotropy decayp can 
typically be measured for up to three times the lifetime of the fluorophore; therefore 
transition metal complexes can be used to measure all the expected DNA motions. 
Specifically, complex A can be used to study DNA dynamics of 300 ns or longer. For that 
reason, these luminescent probes allow extended observation to the microsecond scale, 
offering the opportunity to increase the information content in time-resolved measurement 
of nuclei acids. Complex B,38 on the other hand, is an example of a long lifetime lipid
• Ethktium bromide. 
’ Polarized emission.
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probe which can be used to study rotational motions of entire lipid vesicles or to measure 
diffusions by their effect on resonance energy transfer.
Transition metal complexes sensitive to different ions and pH are another important area of 
investigation within the biological imaging field and also in the detection of toxic 
substances. Figure 1.27 shows an example of each category. Example C42 shows a 
luminescent probe that can be used for measurement of blood pH due to its high sensitivity 
to pH variations between 7.35 and 7.46, pH values of clinical relevance. On the other hand, 
example D40 shows a cyanide sensitive probe whose emission decreases as cyanide 
concentration increases.
Example C Example P
Ru
Ru
[Ru(bpy)2(deabpy)](PF6)2 [Ru(bpy>2(dcbpy)](PF6)2
Figure 127. pH and ion sensitive luminescent probes.
In the last year different research groups such as Lo’s group43 from Hong Kong, Li’s 
group44 from Shanghai and the work described in this thesis,45 have demonstrated the 
viability of using novel d6 MLCT transition metal complexes as fluorophores in cell 
microscopy. Cell uptake, low toxicity and in some cases their demonstrated localization in 
inner organelles represent a great breakthrough in this area. These earliest investigations 
symbolize an initial step towards the development of other metal complexes, whose 
luminescent properties could help to overcome the difficulties found with conventional 
dyes in cell imaging. Examples from other groups organised in chronological order are 
shown in Figures 1.28 to 130. No examples of work from this group will be presented at 
this point as they are discussed in the following chapters of this thesis.
27
Chapter 1
Example E
NH(H2C)3HNH2C
[Ru(Ph2-Phen)2(mbpy-C6-est)](PF6)2
Figure 1.28. Lo's [Ru(Ph2-phen)2(mbpy-C6-est)](PF6)2 complex incubated with HeLa 
cells showing distribution inside the cytoplasm with a lower extent of nuclear uptake.
Example F
O
H N NH
'/(H2C)4OCHN(H2C)2HN
—N
R, :H
[Re(Phr phen XCO)3(py-biotin-TU-Et)]PF6
Figure 1.29. Lo’s [Re(Ph2-phenXCO)3(py-biotin-TU-Et)]PF6 complex incubated with 
HeLa cells showing not homogeneous distribution within the cytoplasm but localized in 
the perinuclear region.
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Example G
PF,
[Ir(dfppy)2(bpy)]PF6
Figure 1.30. Li’s [Ir(dfppy)2(bpy)]PF6 complex incubated with HeLa cells showing 
internalization of the dye in the cell distributed throughout the cytoplasm.
1.5 Conclusions.
A new door is open to the application of transition metal complexes in biological 
recognition and cell imaging as they offer some unique features not available with either 
organic fluorophores or lanthanide complexes. Lifetime values ranging between those of 
lanthanides and organic fluorophores, in addition to polarized emission, large Stokes shifts 
and the possibility of excitation wavelength over 400 nm, make transition metal probes a 
great alternative to overcome some of the problems encountered in the use of organic 
fluorophores and lanthanide complexes.
29
Chapter 1
1.6 References.
1J. C. Politz, Trends Cell Biol., 1999,9,284.
2 S.-S. Sun, A, J. Lees, Coord Chem. Rev., 2002,230,171.
3 B. Alberts, D. Bray, J. Lewis, M. Raff, R. Keith, J. D. Watson, Molecular Biology O f The 
Cell, 3rd ed., Garland, New York, 1994.
4 A. D. Frankel, C. O. Pabo, Cell, 1988,55, 1179.
5 A. Non, K. D. Jensen, M. Tijerina, P. Kopeckova, J. Kopecek, Bioconjugate Chem., 
2003,14,44.
6 M. Zhao, M. F. Kircher, L. Josephson, R. Weissleder, Bioconjugate Chem., 2002, 13, 
840.
7 A. Astriab-Fisher, D. Sergueev, M. Fisher, B. R. Shaw, R. L. Juliano, Pharm. Res., 2002, 
19,744.
* V. P. Torchilin, R. Rammohan, V. Weissig, T. S. Levchenko, Proc. Natl. Acad Sci. U. S. 
A., 2001,98,8786.
9 •) J. R. Maiolo, M. Ferrer, E. A. Ottinger, Biochim. Biophys. Acta, 2005, 1712, 161; b) 
G. Tunnemann, R. M. Martin, S. Haupt, C. Patsch, F. Edenhofer, M. C. Cardoso, FASEB 
J., 2006,20,1775.
10 X. Zhang, L. Wan, S. Pooyan, Y. Su, C. R. Gardner, M. J. Leibowitz, S. Stein and P. J. 
Sinko, Mol. Pharm., 2004,1,145.
11 S. Veldhoen, S. D. Laufer, A. Trampe, T. Restle, Nucleic Acids Res., 2006, 34,6561
12 T. Jiang, E. S. Olson, Q. T. Nguyen, M. Roy, P. A. Jennings, R. Y. Tsien, Proc. Natl. 
Acad Scl U. S. A., 2004,101,17867.
13 Sir J. F. W. Herschel, Phil. Trans. Royal, 1845,143.
14 Sir G. G. Stokes, Phil. Trans. Royal, 1852,463.
15 R. P. Haugland, Handbook O f Fluorescent Probes And Research Chemicals, 6th ed., 
Molecular Probes, Eugene, 1996.
16 G. Weber, Biochem. J., 1951,51,155.
17 P. Lenz, Applied Optics, 1999, 38,3662.
18 M. Bruchez, M. Moronnne, P. Gin, S. Weiss, A. P. Alivisatos, Science, 1988,2013.
19 A. Watson, X. Wu, M. Bruchez, Biotechnol., 2003,34,296.
20 J. K. Jaisawal, H. Mattossi, J. M. Mauro, S. M. Simon, Nature Biotechnol., 2003,21,41.
21 R. Wargnier, A. V. Baranov, V. G. Maslov, V. Stsiapura, M. Artemyev, M. Pluot, A. 
Sukhahanove, I. Nabiev, Nanotechnol. Lett., 2004,4,451.
30
Chapter 1
22 C. H. Evans, Trends Biochem. Sci., 1983,445.
23 F. S. Richardson, Chem. Rev., 1982, 82,541.
24 J.-C. G. Btinzli, C. Piguet, Encyclopedia o f Materials: Science and Technology, Vol. 10 
K. H. J. Buschow, R. W. Cahn, M. C. Flemings, B. Ilschner, E. J. Kramer, S. Mahajan 
(Eds.), Elsevier Science, Oxford, 2001.
25 A. Sigel, H. Sigel (Eds.), Metal Ions in Biological System, 1st edn, Marcel Dekker Inc., 
New York, 2004.
26 J.-C. G. Bttnzli, C. Piguet, Chem. Soc. Rev., 2005, 34,1048.
27 P. R. Selvin, Applied Fluorescence In Chemistry, Biology And Medicine, W. Rettig, B. 
Strechmel, S. Scharder, H. Seifert(Eds.), 1st ed., Springer, New York, 1999.
28 R. A. Poole, G. Bobba, M. J. Cann, J.-C. Frias, D. Parker, R. D. Peacock, Org. Biomol. 
Chem., 2005,3,1013.
29 T. Koullourou, L. S. Natrajan, H. Bhavsar, S. J. A. Pope, Ji. Feng, J. Narvainen, R. 
Shaw, E. Scales, R. Kauppinen, A. M. Kenwright, S. Faulkner, J. Am. Chem. Soc. 2008, 
130,2178.
30 P. Coppo, M. Duati, V. N. Kozhevnikov, J. W. Hofstraat, L. De Cola, Angew. Chem. Int. 
Ed, 2005,44,1806.
31V. Balzani, N. Sabbatini, Chem. Rev., 1986, 86, 319.
32 P. Chen, T. J. Meyer, Chem Rev., 1998,98,1439.
33 S-S. Sun, A. J. Lees, Coord Chem. Rev., 2002,230,171.
34 R. H. Crabtree (Ed.), The Organometallic Chemistry O f The Transition Metals, 3rd ed., 
Wiley, New York, 2001.
35 O. Horv&h, K. L. Stevenson (Eds.), Charge Transfer Photochemistry O f Coordination 
Compounds, Is1 ed., VCH, New York, 1993.
36 J. N. Demas, B. A. DeGraff, Anal. Chem., 1991,63, 829.
37 J. R. Lakowicz, E. Terpetschnig, Z. Murtaza, H. Szmacinski, J. Fluoresc., 1997,240, 54.
38 L. Li, H. Szmzcinski, J. R. Lakowicz, Anal. Biochem., 1997,244, 80.
39 R. E. Holmin, E. D. A. Stemp, J. K. Barton, Inorg. Chem., 1998,37,29.
40 P. Anzenbacher, D. S. Tyson, K. Jursikovd, F. N. Castellano, J. Am. Chem. Soc., 2002, 
124,6332.
41 D. Suh, J. B. Chaires, Bioorg. Med Chem., 1995,3, 723.
42 Z. Murtaza, Q. Chang, G. Rao, H. Lin, J. R. Lakowicz, Anal. Biochem., 1997,247,216.
31
Chapter 1
43 a) K. K.-W. Lo, M.-W. Louie, K.-S. Sze, J. S.-Y. Lau, Inorg. Chem., 2008, 47, 602, b) 
K. K.-W. Lo, T. K.-M. Lee, J. S.-Y. Lau, W.-L. Poon, S.-H. Cheng, Inorg Chem., 2008, 
47,200.
44 M. Yu, Q. Zhao, Li. Shi, F. Li, Z. Zhou, H. Yang, T. Yia, C. Huang, Chem. Commun., 
2008,2115.
45 a) A. J. Amoroso, M. P. Coogan, J. E. Dunne, V. FemAndez-Moreira, J. B. Hess, A. J. 
Hayes, D. Lloyd, C. Millet, S. J. A. Pope, C. Williams, Chem. Commun., 2007,3066; b) A. 
J. Amoroso, R. J. Arthur, M. P. Coogan, J. B. Court, V. Fem&ndez-Moreira, A. J. Hayes, 
D. Lloyd, C. Millet, S. J. A. Pope, New J. Chem., 2008, 32,1097.
32
Chapter 2
Synthetic Studies Directed Towards A 
Luminescent Rhenium(I) Complex For Specific 
Cell Imaging.
2.1 Aims...................................................................................................................34
22  Introduction....................................................................................................... 34
23 Retrosynthetic Analysis................................................................................... 39
2.4 Results And Discussion: Synthesis Attempts Toward The Axial Ligand. 40
2.5 Results And Discussion: Synthetic Studies Directed Towards
Hydroxybutyranote Substituted Complexes.............................................................46
2.6 Crystalline Structures Discussion....................................................................51
2.7 The “Self Destruction” Experiment................................................................ 57
2.8 Photophysical studies....................................................................................... 62
2.9 Conclusions...................................................................................................... 64
2.10 Experimental.................................................................................................... 65
2.11 References........................................................................................................ 72
Chapter 2
2.1 Aim s.
This chapter is focused on the synthesis of luminescent, membrane-permeable rhenium 
complexes that will act as chemical models to validate the concept of a membrane 
permeable cell-imaging device. The device is comprised of three parts - a luminescent 
core, a lipophilic ‘tail’ and a sensor. These compounds are formulated as part of the 
development of a delivery system that will introduce an imaging device through a bilipidic 
membrane into a cell.
2.2 Introduction.
2^.1 Transport across the cell membrane: R. Y. Tsien’s Quin2 system.
A range of membrane-permeable devices for medical imaging and biodiagnostic analysis 
has been developed in the last few years. In many cases, transport of these devices across 
the cell membrane is facilitated by the lipophilicity of the substrate, which provides the 
permeability required to cross the lipidic bilayer.
One method of providing this lipophilicity to a device that, in its active state, is not able to 
pass through the membrane bilayer, was designed by Tsien et al. in order to monitor 
intracellular Ca(II) ion concentrations.1 The device (or system) is based on a simple Ca(ll)- 
selective chelator acetoxymethyl tetraester, that is made temporarily membrane permeable. 
This is achieved by esteritying the four carboxylate groups to make the molecule lipophilic 
affording a acetoxymethyl tetraester. This then allows the system to enter the cell without 
perturbing membrane integrity. Once in the cell, the esters are hydrolysed by 
acetylesterases,* reforming the original Ca(II) chelator (Figure 2.1). The lipophilicity and 
thus, membrane permeability of the whole system can thereby be changed by a simple 
esterification process.
* Enzymes belonging to the hydrolase family that act specifically on carboxylic ester bonds.
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Esterified Ca(II) Chelator 
Figure 2.1. Tsien’s Ca(II) chelator.
Bilipidic
Membrane
Ca(II) Chelator
2.2.2 Premises.
Tsien’s idea is for a compound with a lipophilic “tail” that crosses a cell membrane where 
it undergoes a modification of its chemical structure, ensuring its encapsulation. This 
concept provides the basis for the development of a similar system that will deliver 
lumophores into target cells Scheme 2.2. The general scheme shows the target molecule 
divided in three parts: a luminescent core, the imaging agent, linked to a lipophilic chain, 
for membrane permeability of the whole unit, and a sensor, the nature of which depends on 
the analyte to be monitored.
Lipophilic
chain
OQuencher
Luminescent 
, core
Sensor
membrane permeable
Analyte
□+ 0
Luminescent core 
non-membrane 
permeable
Scheme 2.1. General concept.
In the presence of an analyte (e.g. an intracellular enzyme) which reacts with the sensor, 
not only does the linkage break between the sensor and the lipophilic chain, but also the
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link between the latter and the luminescent core cleaves. At this stage, the luminescent 
core, lacking in enough lipophilicity to re-cross the membrane, remains encapsulated, 
thereby allowing the cell to be imaged specifically. Further, a quencher can be introduced 
into the linker chain, affording a system that can be switched on and off,b simplifying the 
recognition process {i.e. once the lipophilic chain has come off, the luminescence from the 
imaging agent switches on).
2J23 The linker chain - benzyloxybutanoate (BOB) and silylbutanoate (SOB).
The esterification of a compound in order to increase its lipophilicity exemplifies a 
convenient means of temporarily altering the lipophilicity of a substrate in order to deliver 
a diagnostic device (system) to a cell without altering the active part of the device. Other 
mwins of esterification include the use of butyrate-based molecules as ester protecting 
groups. These protecting groups can also be viewed as linker chains connecting the sensor 
to the lumophore and also serve as a means to deliver the lumophore to the target within 
die cell.
In die last decade, a series of studies by Ganem and Gala concerning the application of 
benzyloxybutanoate (BOB) and silyloxybutanoate (SOB) as ester protecting groups have 
been carried out They have shown in their work that not only are both protecting groups 
easily synthesized, but also that their selective removal is possible in the presence of other 
ester groups. Figure 2.2.
0  f t OBn HOJ ^ ^ O S iR ,R 2R3
BOB: benzyloxybutanoic acid SOB: 4-silyloxybutanoic acid
Figure 2.2. The chemical structures of BOB and SOB.
The selective removal of the ester protecting group (the deprotection process) relies on an 
intermediate butyrolactone formation step, i.e. a cyclization reaction, providing a 
convenient method for deprotecting an ester under mild conditions. Using BOB as the 
esterification agent, debenzylation and the addition of a base is needed prior to the 
lactonisadon reaction. In contrast, when SOB is used, the removal of the silyl compound
fc On/off devices that can be flipped from being non emissive to emissive or vice versa by interaction with an 
external agent
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takes place before the lactonisation reaction. The optimum conditions found for the de- 
esterification processes are shown in Scheme 2.2 .
R-BOB
OSi
OBn 1 atm H2. 
EtOAc 
10% Pd/C
, RiR2R3 TBAF 
THF 
rt
SiR,R2R3: SiMe2'Bu
OH Base O
R-SOB
immediate 
reaction o
Scheme 23. Lactonisation reaction.
23.4 The sensor.
The SOB group, silyloxybutanoate, was chosen as the linker chain in our system due to the 
work published by Gala in 2001,3 showing that there is a strong driving force for the chain 
to Mself destruct”, leading to a butyrolactone. In addition, SiMe2tBu group is known to be 
stable in water across a wide pH range (stable between pH 4 and 12), a feature necessary if 
it is to be used in biological media. Furthermore, Si-O systems are very sensitive to 
fluoride ions which can be used as a trigger in the first instance to test the viability of the 
system.
2.23 Specific imaging agent design.
A chemically activated model molecule consisting of a luminescent core, a lipophilic chain 
and a sensor, designed to comply with the premises enunciated in Section 2.2.2, is shown 
in Scheme 23.
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SiMe^Bu
Re(CO)3/ R e{CO)3
Luminescent Lipophilic Sensor 
core chain
Scheme 2.3. Specific models.
The strategy involves binding the well known imaging unit [Re(bisim)(CO)3L]+ 4,5,6 (bisim 
represents a bisimine ligand i.e. a bipyridine, phenanthroline or derivative, and L is a 
pyridine derivative) to a sensor, through a linker chain. This linker chain will “self 
destrucf \  that is, cut itself away from the ligand upon the loss of the sensor. Scheme 2.4. 
No quencher has been considered for the specific model molecule, contrary to the original 
design Scheme 2.1, as the initial objective is to probe the chain self-destruction” 
mechanism.
SOB
OH
analyte ^
L J L LJ  L J
+ + FSiMe2‘Bu
Luminescent Lipophilic Sensor Luminescent 
core chain core membrane
impermeable
Scheme 2.4. The self destruct mechanism.
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2 3  R etrosynthetic A nalysis.
A retrosynthetic route to the target rhenium complexes was designed using the volume of 
literature available since the beginning of the eighties.7,8,9 The route shown in Scheme 2.5 
describes an adaptation of literature methods concerning the synthesis of complexes of the 
type [Re(bipyXCO>3L]+ where L is a pyridine derivative which is chosen in preference to a 
range of other axial ligands present in the literature, like phosphine derivatives, etc., due to 
its chemical versatility.
NCCH3
Re(CO)3
Cl
I
/ Re(CO )3
C m D Re(CO)5Cl
L: axial ligand, pyridine derivative 
Scheme 23. Rhenium complex retrosynthesis.
The first approach to the synthesis of the axial ligand, L, was based upon consecutive 
reactions of a butyrolactone fragment, Scheme 2.6. This would give a derivative bearing a 
good leaving group suitable to accomplish an addition/elimination reaction with the 3- 
hydroxymethylpyridine, PyCFhOH. An alternative retrosynthetic analysis (Scheme 2.7) 
involves a coupling reaction between an acid and an alcohol, using carbodiimides such as 
EDC1 or DCC and DMAP in catalytic amounts. This is a well-known method of 
esterification. 10,11
j  OTBDi
3-Hydroxy-
methyl-pyridine
OTDB
GL: Good Leaving group 
e.g. acyl chloride,
p-toluene sulphonyl
OTDB
TBD: !BuMe2Si
Scheme 2.6. Initial retrosynthetic analysis of the pyridine derivative.
OTBD
HO
OTDB TBD: W tfejS i
Scheme 2.7. Final retrosynthetic analysis of the pyridine derivative.
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2.4 R esults And D iscussion: Synthesis A ttem pts Toward The Axial 
Ligand.
2.4.1 Synthesis of the axial ligand, L, via an acyl chloride adduct
The first step towards the final target molecule 3-(4- 
tertbutyldimethylsilyloxybutanoatomethyl)pyridine was the ring opening of butyrolactone, 
Scheme 2.8. Step (i) in the procedure, using sodium hydroxide in DMF, was published by 
Marvel in 1929.12 The product was obtained as its sodium salt in good yield (88 %).
Scheme 2.8. Synthesis of compounds 2.1 and 2.2.
Step (ii) was the protection of the terminal alcohol using terf-butyldimethylsilyl chloride, 
TBDC1. Pyridine was used as a solvent in order to overcome the problem of the low 
solubility of compound 2.1 in solvents such as DMF and at the same time to act as a base 
and neutralize the HC1 formed during the reaction. However, the salt 2.1 is only sparingly 
soluble in this solvent and the reaction mixture remained heterogeneous even after 12 
hours stirring at room temperature. After 72 hours, an aqueous work up was done to isolate 
the product. If some pyridine remained, further extractions with copper sulphate were 
performed to purify the product. The reaction was monitored by following the shift of the 
CH2(4) protons from 3.45 ppm in the alcohol to 3.56 ppm, which is a typical value for 
aliphatic protons contiguous to a protected alcohol.13 Also, the strong band observed in the 
1R spectrum at 1714 cm' 1 indicative of a carbonyl stretching band of a carboxylic acid 
(typical range 1700-1725 cm' 1) 14 suggested, in stage (ii), that the alcohol protection had 
been successfully accomplished. These spectroscopic data agree with those given in the 
literature for compound 2 .2 .15
The reason why such a long reaction time is required in order to synthesise compound 2.2 
is that the silylation occurs initially at the carboxyl group rather than the hydroxyl group. 
This is followed by silyl migration to the hydroxyl group under these reaction conditions as 
depicted in Scheme 2.8. This transformation was studied by Renton in 2002.15
i: NaOH, DMF, 88 % 
ii: TBDC1, Py, 28 %
4JDTDB
40
Chapter 2
NaO
2.1
TBDCT
Not isolated
OTDB
Scheme 2.9. TBD migration.
The next step in the synthesis (see Scheme 2.6) was the transformation of the carboxylic 
acid, 22, into a carbonyl compound bearing a good leaving group. This required the 
transformation of 2J2 into its potassium salt, 23 , in order to improve the nucleophilicity of 
the oxygen atom so that its reaction with oxalyl chloride would yield the acyl chloride 
compound, 2.4. Scheme 2.10.
O O O
JL  .OTDB i JL  .OTDB ii   Cl
2J2 23
OTDB
i: *BuOK, MeOH, 75 % 
ii: (COClfe, CHC13
Scheme 2.10. Leaving group improvement.
The transformation of the carboxylic acid, 2.2, into its potassium salt, 23, was achieved 
with !BuOK in methanol and it was monitored by !H-NMR, in which there was a clear shift 
to higher field of the protons closer to the carbonyl group (from 2.30 to 2.10 ppm). The 
attempt to synthesise the acyl chloride 2.4 was then carried out. The potassium salt 23, 
was stirred at room temperature with oxalyl chloride in chloroform for 12 hours under a 
nitrogen atmosphere. Initially, the reaction mixture effervesced as CO and CO2 were 
released as by-products of the transformation. The reaction mechanism is shown below in 
Scheme 2.11.
OTDB
OTDB
^  -  ,OTBD|
Gci
N.B. multiple mechanistic 
steps combined for 
simple
c o 2 + CO
Scheme 2.11. Reaction mechanism.
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Unfortunately, although the acyl chloride adduct, 2.4, was obtained (as shown by a change 
in the CH2<3) hydrogen chemical shift from 2.10 ppm to 2.94 ppm) the butyrolactone was 
also produced in a 1:1.4 ratio (acyl chloride adduct:butyrolactone). This is because of 
alcohol deprotection followed by a cyclisation reaction, Scheme 2.12. It was likely that 
some HC1 formation took place during the reaction leading to the unprotected alcohol.
Scheme 2.12. Cyclisation reaction.
Attempts to purify compound 2.4 by fractional distillation were unsuccessful and the 
product decomposed to a mixture of species impossible to identify. As a result, another 
attempt to synthesise the final target was performed, via a one-pot reaction. Oxalyl 
chloride and compound 23  were stirred at room temperature until the effervescence 
finished. Then, without any isolation or purification, 3 -hydroxymethylpyridine and 
triethylamine were added to the reaction mixture, Scheme 2.13. The latter was added not 
only to keep the reaction basic and prevent alcohol deprotection, but also to facilitate the 
addition/elimination reaction with the acyl chloride by forming the salt EtjNHCl. Scheme
OTBD
Scheme 2.14. Proposed addition-elimination reaction mechanism.
The final product, 2.5, was obtained as colourless oil. IR experiments clearly showed the
O
Cl
O
O* Cyclisation O
2.14
O O
J k /^ O T B D
23
OTBD
OTBD
i: (COCl)2, CHC13, after 25 min., PyCH2OH, Et3N, 10 %
Sheme 2.13. One pot reaction via an acyl choride adduct.
O
OTBD
presence of 23  as the CO band observed at 1714 cm'1 is shifted to 1769 cm"1 which is the
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normal frequency for an ester.16 Moreover, !H-NMR spectroscopy also showed a clear 
shift to lower field (from 4.6 to 5.0 ppm) of the methylene protons of the oxy-methyl 
pyridine upon esterification, indicating a reduction in shielding. On the other hand, the 
methylene protons belonging to the butanoyl fragment are barely shifted, only those closest 
to the carbonyl group show a significant change in chemical shift from 2.30 to 2.42 ppm, 
again indicating a decrease in shielding. Although full characterisation confirmed the 
structure of the target molecule, a new route for its synthesis was required due to the low 
yield (less than 10%).
2.4.2 Synthesis of the axial ligand, L, via a mixed anhydride.
Next, attention turned to the use of the /rtoluene-sulfonyl group as an alternative leaving 
group in an attempt to form the mixed anhydride of the acid 2.2. The reaction was 
performed in dry DCM, stirring the potassium salt, which is partially soluble in this 
solvent, in the presence of /^toluene sulfonyl chloride under a nitrogen atmosphere at room 
temperature for 2 hours. The product, 2.6, a moisture sensitive white solid, was obtained in 
35 % yield. Scheme 2.15.
O
OTBD i / /  \  H i: TsCl, DCM, 35 %
\  /  i i
23
Scheme 2.15. Synthesis of compound 2.6.
Unfortunately, several attempts at further characterisation of 2.6 were hindered by its ease 
of hydrolysis, and so only ’H-NMR spectroscopic studies were carried out. Once again, a 
slight shift to lower field is visible for the methylene unit adjacent to the carbonyl group 
(2.10 ppm to 2.46 ppm), comparable to the shift observed for compound 2.5. This mixed 
anhydride was immediately stirred with 3-hydroxymethyl pyridine in the presence of a 
base in dry chloroform. However, the result was a mixture of decomposition products 
indicating the un-viability of obtaining the desired product in this way. Nevertheless, a 
one-pot reaction was tried again, as the final product, 2.5, is known to be more stable and 
so easier to handle than the mixed anhydride, Scheme 2.16.
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OTBD
OTBDs-o
i
i: TsCl, DCM, after 4 hours, PyCH2OH, Et3N
2.5
OTBD
Scheme 2.16. One pot reaction via a mixed anhydride adduct.
The potassium salt and p-toluene sulfonyl chloride were stirred for 4 hours in dry DCM 
under a nitrogen atmosphere to generate the mixed anhydride 2.6 in situ. 3- 
hydroxymethylpyridine (PyCH2OH) was then added and the reactants stirred for a further 
12 hours. After an aqueous work up, *H-NMR spectroscopy showed a mixture of 
compounds including the desired product 2.5 together with unreacted p-TsCl and unknown 
species containing the butanoyl fragment. The product was unable to be purified and this 
synthetic route to synthesise 2.5 was abandoned.
2.43 Synthesis of the axial ligand, L, via a coupling reaction.
A third route to the target molecule 23  was described in the retrosynthetic analysis 
discussed in Section 2 3 3 . This route utilizes the direct coupling reaction between an acid 
and an alcohol using a carbodiimide derivative such as EDCI as a coupling agent, Scheme 
2.17. As discussed in Section 2 3 3 . several examples of this coupling reaction are 
described in the literature.10,11,17 Specifically, research groups headed by Roush18 and 
Zhang19 describe the coupling reaction between the acid 23 and an alcohol (3- 
hydroxymethyl pyridine). The accepted mechanism of the reaction is presented in Scheme 
2.18.20
/
O EDCI o  EDCI: ^  N= . = N— HCI
“  ' '
DMAP:
R, R': Generic hydrocarbon chain
Scheme 2.17. Generic acid-alcohol coupling reaction scheme.
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Step 1: X—N===N—Y + HO K
HCI
Y -N
X-NH
>
v-
Step 2: r- c
O
R, R'. Generic hydrocarbon chain 
X, Y: indicated in Scheme 2.16.
Scheme 2.18. Accepted mechanism for an acid-alcohol coupling reaction.
'H-NMR spectroscopy confirmed the formation of the target compound 2.5, with the 
characteristic shift of the hydroxymethylpyridine CH2 proton from 4.60 ppm to 5.1 ppm 
upon esterification as discussed in Section 2.4.1. An aqueous work up and 
chromatographic purification afforded a clean product in 46 % yield. Scheme 2.19.
i: EDCI, DMAP, DCM, 46 %
Scheme 2.19. Successful synthesis of the desired target, 2.5.
The advantage of not having to pre-synthesise an activated acid derivative represented a 
successful outcome in the synthesis of the pyridine derivative that would act as the axial
O
HO
O
2.2
OTBD
OTBD
EDCI, DMAP 
see Scheme 2.18.
ligand in the rhenium complex. The generality of this route to a range of ligands used 
throughout this thesis will be discussed in subsequent chapters.
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2.5 R esults And Discussion: Synthetic Studies Directed Towards 
H ydroxybutanoate Substituted Com plexes.
2.5.1 Synthesis of imaging target via an activated tetrafluoroborate rhenium 
sa lt
Following the synthesis proposed in Scheme 2.5, Section 23 (vide supra), the second part 
of this discussion focuses on rhenium coordination chemistry. Taking the synthesis 
presented in the first instance by Caspar et al. in 19837 as a guideline, the complex 
Re(bipyXCO)3Cl 2.7 was successfully synthesized by the reaction of Re(CO)5Cl in toluene 
with one equivalent of bipyridine (bipy). The desired product 2.7 was obtained in excellent 
yield, 98 %, after 1 h. As IR data observed from the synthesised Re(bipy)(CO)3Cl were
•j
similar to those previously reported by Caspar no further characterization was carried out.
Re(CO)5Cl
2.7
i: bipy, toluene, 98 %
Scheme 230. Synthesis of complex 2.7.
Halide abstraction was the next step in the synthesis in order to access more easily the 
hydroxybutanoate substituted complex via an activated complex. Silver tetrafluoroborate 
was used to abstract the chloride because of the high affinity of silver for chloride. The 
reaction was carried out by heating both reagents in acetonitrile at reflux in the dark 
(because of the photosensitivity of silver salts), and under an inert atmosphere, Scheme 
231. A coordinating solvent is needed to achieve the final product in order to fill the 
coordination sphere about the metal centre. However, the choice of solvent is critical as a 
too strongly bound solvent (i.e. pyridine or DMSO) would not dissociate readily in the 
following derivatisation step.
Cl
RefCOh
0-0
2.7
NCCH3
Re(CO)3
r —N N = \
2.8
i: AgBF4, CH3CN, 88 %
(b f4>-
Scheme 231. Halide abstraction with AgBF4.
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IR showed the expected change for the transformation of a neutral complex into a cationic 
species: u(CO) moved from 2020, 1895 and 1880 cm' 1 to 2035 and 1918 cm-1 (the latter is
chloroform corroborated this result, showing a distinctive shift of the coordinated CH3CN 
resonance to 2.10 ppm (the resonance for non-coordinated CH3CN occurs at 2.00 ppm).
proposed synthesis shown in Section 23, Scheme 2.5. Optimisation of the substitution 
procedure was carried out using simpler pyridine derivative before using the target 
molecule 23  due to the limited supply of this compound.
[Re(bipyXCO)3(CH3CN)][BF4], 2.8, was heated at reflux with 10 equivalents of 3- 
hydroxymethylpyridine in dry THF under a nitrogen atmosphere. Precipitation by addition 
of diethyl ether to the reaction mixture afforded [Re(bipyXC0 >3(PyCH2 0 H)][BF4], 2.8 in a 
62 % yield. Yellow crystals suitable for X-ray diffraction analysis were grown from a 
THF/Et20  solution. Discussion of the crystal structure of 2.9 is in Section 2.6.
demonstrated by a shift in the resonance for the 3-pyridyl-methylene group CH2(7) from
4.6 ppm in the free ligand to 4.3 ppm upon coordination. This difference cannot just be due 
to the loss of electron density from the ligand upon coordination as this would cause a shift 
to higher frequency as electron density is donated into the metal centre. It is likely that an
observed for the bipyridine moiety have also changed, with chemical shifts that are
8.85 to 9.18 ppm; CH(3): from 8.49 to 8.30 ppm; CH(5) from 7.57 to 7.70 ppm). The IR 
d(CO) bands also shift to lower frequencies upon coordination of 3-
a broad band) as Re has less electron density to back donate into the carbonyl n orbital, 
thereby increasing the CO bond strength.21 !H-NMR spectroscopic studies in deuterated
The substitution of acetonitrile for the desired axial ligand, 2.5 is the last step in the
NCCH3
Re(CO)3
+
Re(CO)3 i: PyCH2OH, THF, 62 %
6
Scheme 232. Acetonitrile substitution reaction.
H-NMR spectroscopy on a CD3CN solution of 2.9 indicated a successful reaction as
interaction with the bipyridine it system is responsible for this displacement. The signals
characteristic of a complex with a pyridine derivative in an axial position (CH(6): from
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hydroxymethylpyridine. This is due to the better 7-acceptor properties of the ligand in 
comparison to acetonitrile, in concordance with axial ligand electronic effects over the 
carbonyls. (The better 7-acceptor properties of the axial ligand, the higher vibration 
frequencies of the carbonyls as the retrodonation from the metal to the antibonding orbitals 
of the CO decreases).
Once the synthetic route to the target molecule analogue was optimised, the same reaction 
conditions were employed in an attempt to form [Re(bipyXCO)3L][BF4] where L is 3-(4- 
tert-butyldimethylsilyloxybutanoatomethyl)pyridine 2.5. However, the isolated product 
was not the expected complex but of its desilylated derivative, Scheme 2.23.
O n
i: 2.5, THF, 20%
Re(CO>3 OTBD
.. N XN =
' - A  //
Expected complex
1 . ^
Re(CO )3 OH
2.10
Obtained complex
Scheme 2.23. Synthesis of the desilylated rhenium complex 2.10.
Mass spectrometry studies confirmed the desilylated structure, no fragments containing 
SiMe^Bu were found, m/z (ESI) 622.1 [MH]+, 536.1 [M-C0 (CH2)30 ]+, 427.0 [M-BF4- 
PyCH2OCO(CH2)OH]+. A possible explanation for the desilylation reaction is that the 
counter anion, BF4\  acts as fluoride ion donor which reacts with the silyl group, breaking 
the Si-O bond, Scheme 2.4.
2.5.2 Synthesis of imaging target via an activated nitrate rhenium salt.
In order to overcome the desilylation problem a different anion with no reactive fluoride 
was required. The first approach was to use silver nitrate (AgN03), instead of silver 
tetrafluoroborate (AgBF4) for the halide abstraction as the nitrate is a non-coordinating 
anion which does not contain any fluoride. The same reaction conditions as in Scheme 
2.21 were used; in this case however, the product, complex 2 .11, was very difficult to 
handle due to its low solubility in a wide range of solvents (chloroform, THF, acetonitrile).
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Re(CO)3
NCCH3
/ Re(CO )3
7/ N N=>
 ^ //
+
i: AgNQ3, CH3CN
(n o 3)-
2.7 2.11
Scheme 2.24. Halide abstraction with AgN03.
Examples of this reaction found in the literature solve this solubility problem by 
precipitating the product as a PF$ salt by addition of aqueous ammonium 
hexafluorophospate (NH4PF6) to the reaction mixture.22 However, it was very likely that 
the same desilylation reaction would occur if PF6 was used as the counter ion. Therefore a 
second abstraction reaction using silver trifluoromethylsulfonate (AgCF3S03) was 
attempted.6
2.53 Synthesis of imaging target via an activated trifluoromethanesulphonate 
rhenium sa lt
Even though silver trifluoromethylsulfonate contains fluorine atoms, they are more 
strongly bound to carbon via a covalent bond than those in BF4 Presumably, this would 
prevent any fluoride donation in subsequent reactions. Following the same conditions as 
described for the halide abstraction, [Re(bipyXCO)3CH3CN] [CF3S03] complex 2.12 was 
synthesised in 74% yield.
Cl
/ Re(CO )3
O O
ncch3
Re(CO)3 i: AgCF3S03, CH3CN, 74 %
(CF3S03)’
2.7 2.12
Scheme 2.25. Halide abstraction with AgCF3SC>3 .
After the reaction of 2.12 and 1.1 equivalents of 2.5 in dry THF, the acetonitrile ligand was 
successfully substituted and the final target (complex 2.13) thus synthesised. Confirmation 
was given by !H-NMR spectra in CD3CN which showing the characteristic shift from 5.1 
to 5.0 ppm of the resonance for the 3-pyridylmethylene group CH2(7), indicating that 
coordination had occurred, Scheme 2.25. The aromatic protons on bipy are also shifted due 
to the presence of the new axial ligand. These shifts are in concordance with the data
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reported for complex 2.9: CH(6) from 8.88 to 9.08 ppm, CH(3) from 8.61 to 8.79 ppm and 
CH(5) from 7.59 to 7.80-7.71 ppm. Yellow crystals were obtained after addition of 
petroleum ether to the reaction mixture, which were too small for standard X-ray 
diffraction and so were analysed using synchrotron X-ray studies (vide infra).
i OTBD
2.12 2.13
i: 2.5, THF, 45 %
Scheme 226. Synthesis of the designed target 2.13.
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2.6 C ry s ta llin e  S tru c tu re s  D iscussion .
Solid state structures of complexes 2.9C and 2.13d were determined by standard X-ray 
crystallography and Synchrotron X-ray23 respectively. The structures are presented as 
ORTEP drawings in Figure 2.3 and Figure 2.4. Details of collection and refinement data 
and selected bond lengths and angles for 2.9 and 2.13 are given in Table 2.1, Table 2.2, 
Table 2.3, Table 2.4 respectively.
N(22)
0 (3 )
co) cm - T
e(l)N(11)
N(10)
C(2)
0 (2)
Figure 2 3 . ORTEP representations of the structure of 2.9 with thermal ellipsoids drawn at 
the 50 % level.
c Crystal structure measured and solved by Dr Elena Davis at Cardiff University. 
d Crystal structure measured and solved by Dr. Madeleine Helliwel at Daresbury Laboratory.
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Red)
Ct24)
Figure 2.4. ORTEP representations of the structure of 2.13 with thermal ellipsoids drawn 
at the 50 % level.
Both complexes feature a distorted octahedral coordination geometry around the Re(I) 
centre. The Re-to-bipyridine nitrogen bonds are ca. 2.172 A in length which is typical for 
Re(I) complexes.24 Furthermore, the two pyridine rings of the bipyridine ligand in complex 
2.13 are almost coplanar (0.14° torsion angle between the two rings). This may promote 
better delocalization of the 7r-electronic system and confer better ^--acceptor properties on 
this ligand than in the case of complex 2.9 where the bipyridine ligand displays an inter 
ring angle of about 14.73°.
Examination of the packing in complex 2.9 shows a different environment and interactions 
of each pyridyl unit within the bipyridine. Figure 2.5. Pyridyl A displays a short 
interaction with a fluorine atom from one of the counterions surrounding the molecule, as 
well as a non-symmetrical n stacking interaction with a bipyridine of an adjacent molecule. 
Not only are the same interactions observed for Pyridyl B but also interactions with two 
axial carbonyls belonging to two other molecules within the unit cell. Moreover, Pyridyl B
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is within bonding distance with a hydroxyl group and a fluorine atom of a second 
counterion. Therefore, the torsion angle between the two pyridyl rings in complex 2.9 can 
be rationalized as a packing effect. These data agree with the solution-state data whereby 
no significant differences are observed as the photophysical properties remain almost the 
same as for the analogous complex, 2.13 (i.e. less conjugation in bipyridine would lead to a 
higher energy absorption and emission, see Section 2.8).
Pyridyl A
Rel
C( 16) .386 \F (4).•irC
0 (2) /Re(l)
id y l B
0 ( 2'
Pyridyl A interaction. 
Pyridyl B interaction.
Figure 2.5. Packing of complex 2.9 and short interactions of the two pyridyl units.
The distance between the metal and the carbon atom of the carbonyl units trans to the 
chelated ligand, which define the equatorial plane, in species 2.9 and 2.13 range between 
1.912(6) and 1.929(8) A respectively, and agree with the corresponding values found in the 
literature for complexes of the same type i.e [Re(CO)3(a-diimide)]+.23 The Re-COax 
distance (the carbonyl in the cis position to both of the bipyridine nitrogen atoms is 
referred to as the axial CO ligand) is affected by the nature of the ligand trans to it. In both 
cases the trans ligand is a pyridine derivative, 3-hydroxymethylpyridine and 3-(4- 
tertbutyldimethylsilyloxybutanoatomethyl)pyridine. The N-Re distances are 2.221(4) A 
and 2.184(5) A respectively. The shorter bond length in complex 2.13 (2.184(5) A) 
suggests better ^-acceptor versus <r-donor properties for 2.5 over that of 3-
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hydroxymethylpyridine. This is also reflected in the Re-COax and C-Oax bond lengths 
being 1.929(8) and 1.137(11) A respectively. These distances are slightly longer and 
shorter in that order than the analogous bonds in complex 2.9 (Re-COax: 1.912(6) and C- 
Om: 1.150(7) A).
The long chain attached to the pyridine derivative in complex 2.13 distorts the N-Re-COax 
angle from perfect octahedral geometry to 176.4(2)°. Less distortion is observed in 
complex 2.9 where the N-Re-COax angle is 178.27(18)°, indicating that the lack of a bulky 
substituent on the axial pyridine allows a more symmetrical geometry about the metal 
centre, see Figure 2.6.
T
F(21)
0 (8 )
H(14)
I< > < * >  h o i V V ^
n j R e ( l )
0 ( 10)
0 (9 )
H(25B)
Complex 2.9 Complex 2.13
Figure 2.6. Short intermolecular interactions of the complexes 2.9 (left picture) and 2.13 
(right picture).
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Empirical
Formula
C19H15BF4N3C>4Re a (A) 10.2550
Molecular
weight
622.35 b(A) 12.5820
Crystal
system
monoclinic c(A) 15.6370
Space group P 2 j/c a O 90
Volume (A3) 2012.69 P(°) 94.006
Z 4 Y(°) 90
Table 2.1. Complex 2.9, collection and refinement data.
Re-C(l) 1.920(6) C(2)-Re(l)-N(10) 92.2(2)
Re-C(2) 1.912(6) C(l)-Re(I)-N(10) 98.3(2)
Re-C(3) 1.922(6) C(3)-Re(l)-N(10) 173.3(2)
Re-N(10) 2.172(4) C(2)-Re(l)-N(l 1) 96.1(2)
Re-N(ll) 2.176(4) C(l)-Re(l)-N(l 1) 172.6(2)
Re-N(12) 2.221(4) C(3)-Re(l)-N(l 1) 98.3(2)
CdH KI) 1.144(7) N(10)-Re(l)-N(ll) 75.06(16)
C(2)-0(2) 1.150(7) C(2)-Re(l)-N(22) 178.27(18)
C(3)-0(3) 1.150(7) C(l)-Re(l)-N(22) 93.3(2)
C(2)-Re(l)-C(l) 87.4(2) C(3)-Re(l)-N(22) 92.2(2)
C(2)-Re(l)-C(3) 89.4(2) N(10)-Re(l)-N(22) 86.16(15)
C(l)-Re(l)-C(3) 88.3(2) N(11)-Re(l)-N(22) 83.04(16)
Table 2J2 . Complex 2.9, selected bond lengths (A) and angles (°).
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Empirical
Formula
CsoHasFsNaOgReSSi a (A) 11.1847(8)
Molecular
weight
884.96 b(A) 13.3116(10)
Crystal system monoclinic c(A) 24.0160(18)
Space group P2i/c o O 90
Volume (A3) 3558.7(5) PC) 95.5780(10)
Z 4 Y(°) 90
Table 23. Complex 2.13, collection and refinement data.
Re(l)-C(24) 1.907(8) C(24)-Re(l)-N(l) 92.8(3)
Re(l)-C(22) 1.927(7) C(22)-Re(l)-N(l) 97.3(3)
Re(l)-C(23) 1.942(8) C(23)-Re(l)-N(l) 174.2(2)
Re(l)-N(l) 2.171(5) C(24)-Re(l)-N(2) 92.4(2)
Re(l)-N(2) 2.169(5) C(22)-Re(l)-N(2) 172.1(3)
Re(l)-N(3) 2.201(5) C(23)-Re(l)-N(2) 99.4(2)
0(7)-C(22) 1.138(9) N(l)-Re(l)-N(2) 74.94(18)
0(8)-C(23) 1.112(10) C(24)-Re(l)-N(3) 176.2(2)
0(9)-C(24) 1.163(10) C(22)-Re(l)-N(3) 94.2(3)
C(24)-Re(l)-C(22) 89.4(3) C(23)-Re(l)-N(3) 93.0(3)
C(24)-Re(l)-C(23) 88.4(4) N(l)-Re(l)-N(3) 85.39(19)
C(22)-Re(l )-C(23) 88.4(3) N(2)-Re(l )-N(3) 83.80(17)
Table 2.4. Complex 2.13, selected bond lengths (A) and angles (°).
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2.7 The “S elf Destruction" Experim ent.
After the successful synthesis of the desired target 2.13, the concept of the linker self- 
destruction mechanism proposed in Scheme 2.4, Section 2.2.5 was studied. This 
experiment was designed to test if, after deprotection of the alcohol, the reaction proceeds 
to lactone formation, indicating that the cyclisation reaction (linker self-destruction) has 
taken place successfully. This study could also point towards an explanation as to why, in 
the synthesis of complex 2.10, no cyclisation process was observed, Scheme 2.23.
Following the same conditions found in the literature for the desesteriftcation reaction 
when SOB is used as esterification agent, tetrabutylammoniumfluoride, TBAF, was used 
as a fluoride source, and THF as solvent.3 The reaction was carried out on a 'H-NMR 
spectroscopic scale and was monitored by this technique. Typical experimental conditions
Scheme 2.21. Proposed chain self-destruction mechanism.
*H-NMR spectra in THF-ds are shown in Figure 2.6. After the addition of TBAF, the 
peaks from the protons A, B and C of the butyryl chain attached to the 3- 
hydroxymethylpyridine disappear and three new peaks (A’, B’ and C’) from the 
butyrolactone appear indicating that not only has the desilylation taken place, but also the 
chain self-destruction that leads to the butyrolactone formation has been a success.
used 4.5 mM of 2.13 and 38 mM of TBAF.
SOB
I +
,Re(CO) 3
I +
RefCOfe O + FSiMe2tBu
2.13 2.9
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DBTO.
3.50 1.002.50 2.004.00 3.00 1.504.50
4.50  4.00  3.50 3.00 2.50 2.00 1.50 1.00
Figure 2.7. !H-NMR spectra (aliphatic region) of the pre and post-cyclisation species of 
the chain self-destruction experiment.
The reaction was also explored in different solvents in order to optimize the process and 
assess its suitability for use under physiological conditions. A summary of the results 
obtained are listed in Table 2.5.
THF CDCb MeOD
Deprotection Reaction Immediate Slow Slow
(<5 min) (>12 h) (>12 h)
Desilylated product Not observable Not observable Observable 
(15 days)
Cyclisation Reaction Immediate 
(<5 min)
Immediate 
(<5 min)
Slow
Table 2.5. Summary.
The deprotection reaction and desilylated product are shown in Scheme 2.28, and the 
cyclisation reaction is shown in Scheme 2.29.
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OTBD
Deprotection reaction
2.13
Desilylated product
Scheme 2.28. Deprotection reaction and desilylated product.
N
1 +
/ReJCOh 
/ /  ^  N
Re(CO) 3 Cyclisation reaction
Scheme 2.29. Cyclisation reaction.
To understand these results some physical properties related to the solvent and the 
tetrabutylammonium salt, TBAF, should be considered. Depending on the polarity of the 
solvent, the ion pair, TBAF, is going to be more or less dissociated, facilitating the attack 
of fluoride at the silyl group. A compromise is needed in order not to exceed a particular 
polarity as not only is it responsible for the ion pair dissociation but also solvation of 
fluoride. Therefore, TBAF in a very polar solvent will be highly solvated which can slow 
down the desilylation reaction. According to these principles, a solvent like MeOH makes 
the deprotection reaction slower. Moreover, as MeOH is a protic solvent it slows down the 
cyclisation reaction, due to the protonation of the alkoxide, leaving only a small 
equilibrium concentration of alkoxide, which is the rapidly cyclising species in aprotic 
solvents.
Among the different conditions used, THF was found to be the most convenient solvent for 
the self-destruction reaction. Probably its high polarity, 4.1 P \ and dipole moment, 1.63 
Debye, facilitates dissociation of TBAF to give the free fluoride ion and its consequent 
attack at the silyl group. Moreover, the fact that THF is a non-protic solvent makes the 
final cyclisation easier as there are no proton sources that can protonate the alkoxide. In
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fact, when a protic solvent like MeOH is used instead of THF, the desilylated product is 
observed for up to 15 days until the final cyclisation is concluded, see Scheme 2.29.
Bu
OH
MeOH
MeOH
2.13 2.9
observable for 12 h desilylated product
observable for 15 days
OH
+ MeO'
Scheme 230. Chain self-destruction experiment in MeOH.
Further studies were performed in CDCI3  where, once again, its polarity and dipole 
moment, 4.1 Debyes and 1.04 P’ respectively, can be used to explain the reaction rate 
differences from the other two solvents, MeOH and THF. In this case the deprotection 
reaction is slower than when THF is used as a solvent, probably because its low dipole 
moment does not allow easy TBAF ionisation. In comparison to MeOH, the cyclisation 
reaction is faster as chloroform is a non-protic solvent which will not interfere with the 
cyclisation process, Scheme 231.
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N
I +
/Re(CO)3
B u ^ r
c h c i3 y Re<CO)3 O
CHCI3  N ► 1 +
/Re^CO )3
OH
2.9
observable for 12 h desilylated product
not observable
Scheme 231. Chain self-destruction experiment in CHCI3 .
A possible explanation for the lack of cyclisation observed in Scheme 2.23 (Synthesis of 
the desilylated rhenium complex, 2.10) could be because no TBAF was used during the 
reaction. Hence, the basicity of the system is insufficient for the cyclisation reaction to take 
place (F  is quite basic in water and TBAF always contains some water as anhydrous 
TBAF is not stable).25 It is worth remembering that Ganem2 showed that, on ester 
deprotection using BOB as a protecting group, a non-nucleophilic base is needed to cyclise 
the butyrate fragment, Scheme 232. The assumed desilylation conditions for complex 2.10 
{i.e. F  from BF4 ) are likely, via hydrolysis, to lead to an acidic environment through boric 
acid formation.
O
EtOAc 
10% Pd/C
unless the medium is 
R: generic hydrocarbon chain basic enough
Scheme 232. Cyclisation conditions of R-BOB.
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2.8 Photophysical Studies.
Photophysical studies of complexes 2.9 and 2.13 were carried out in order to assess their 
viability as biological probes. The electronic absorption spectra of both complexes were 
measured at room temperature and in acetonitrile solution; their spectral data are 
summarized in Table 2.6. With reference to previous studies of related rhenium (I) 
polypyridine complexes,26 the intense absorption bands at ca. 246-318 nm have been 
assigned to spin-allowed intraligand (!IL) (71 —> 71*) (N-N and pyridine ligand) transitions. 
Additionally, the absorptions at ca. 340-342 nm has been assigned to spin-allowed metal- 
to-ligand charge-transfer ( lMLCT) (d7c(Re) —► 7i*(N-N)), transitions. An example of a UV 
spectrum of 2.9 is shown in Figure 2.6.
Complex 'iL , Xabs/nm (£/dm3m or1cm l) 'M LCT, Xabs/nm, (E/dm3m or,cm '1)
2.9, 248 (4590), 264 (4605), 306 (2862). 
318(2240)
342 (980)
2.13, 246 (2917), 257 (2808), 306 (1962), 
317(1423)
340 (642)
a CH 3C N  as solvent.
Table 2.6. Absorption band assignments.
2.9 UV spectrum
10000
MLCT
200 250 300 350 400 450 500
Waveleng th  X (nm)
Figure 2.6. UV spectrum example of complex 2.9.
The excitation and emission spectra were also recorded. These types of complex show an 
emission originating from the lowest energy 3MLCT, (d7t(Re) —► 71 (N-N)) excited state, 
i.e. phosphorescence. The luminescent properties of both complexes, 2.9 and 2.13, do not
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differ from those that have previously been observed for 3MLCT based emission from 
related rhenium bis(imide) complexes.27 Both complexes presented broad excitation 
maxima at around 390 nm and also broad emission maxima, specifically 555 nm in the 
case of complex 2.13 and 556 nm for complex 2.9, see emission and excitation spectra in 
Figure 2.7. In addition, the value of the lifetimes for both species do not differ 
significantly, 117 ns in the case of complex 2.9 and 127 ns for complex 2.13, see Table 
2.7. An example of the typical excitation and emission spectra can be seen in Figure 2.7.
Complex Excitationm, x (>7nm) Emissionm,i  (>Vnm) Lifetimes (x/ns)
2.9, 392 556 117
2.13, 385 555 127
a CH 3C N  as solvent.
Table 2.7. Excitation and emission maxima for 2.9 and 2.13.
1.6E+06 
1.4E+06 
1.2E+06 
£* 1.0E+06 
c  8.0E+05 
I  6.0E+05 
4.0E+05 
2.0E+05 
0.0E+00
200 300 400 500 600 700 800
Wavelength  M n m )
Figure 2.7. Excitation and emission spectra of complex 2.9.
Although they have a large Stokes’ shift, around 177 nm, in comparison to those belonging 
to organic molecules or biomolecules, thus allowing an easy separation from scattered light 
and, what is more important when the measurement is done in a biological media, an easy 
separation form the autofluorescence,28 this result is not satisfactory for the initial purpose, 
see Scheme 2.33. The slight difference in the emission maxima values and also in the 
intensity of the bands between the initial imaging agent, 2.13, and the self destructed 
complex, 2.9, is probably due to the small electronic effect that changes in the pyridine 
susbtituent induce at the metal centre. This makes it difficult to calculate the exact
Excitation
Emission
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concentration of analyte that has reacted with the initial complex and therefore the 
concentration of the analyte in the studied medium.
O
F
Analyte
Luminescence
initial complex: 
LA
Re(CO)3
Luminescence 
final complex: 
LB
O + FSiMe2'Bu
Scheme 2.33. Sensing experiment.
2.9 Conclusions
The synthesis of a new family of luminescent ^ ac-bipyridine tricarbonyl pyridyl rhenium 
cations [Re(bipyXCO>3L] and the synthesis of 3-(4- 
tertbutyldimethylsilyloxybutanoatomethyl)pyridine 2.5 has been achieved. The potential 
application of these species as biological imaging agents was studied by mimicking the 
process with fluoride as an analyte instead of a biomolecule, and using SOB, an alcohol 
protecting group known to be labile in the presence of fluoride ions, as sensor. Although 
the sensing experiment was successful in that desilylation leads to self-destruction, there 
are some problems to overcome, mainly the rate of the sensing process and the insolubility 
of the complexes in physiological conditions (i.e. aqueous systems).
The promising photophysical properties of 2.9 and 2.13 need to be tuned in order to 
enlarge the difference between the maxima of the emission peaks f  the iomitial target, 
2.13, and the product 2.9, in order to facilitate determination of the analyte concentration. 
Introduction of water solubilising groups such as sulphonates in the chelate ligand or the 
axial pyridine derivative could be the answer to the solubility issues. Modification to the 
axial ligand is crucial in order to increase the rate of cyclisation by, for example, 
improving the leaving group. All these changes would alter the electronic properties of the 
imaging agent and therefore their luminescent properties, thereby allowing easier 
differentiation of the pre- and post-cyclisation species.
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2.10 Experim ental
General considerations*: All starting materials, reagents and solvents were purchased 
from commercial suppliers and used as supplied unless otherwise stated. *H-NMR and 13C- 
NMR spectra were recorded at 400 and 100 MHz respectively on a Bruker DPX and 
referenced to residual solvent peaks unless otherwise reported. IR spectra were recorded on 
a Perkin Elmer 1600 FT IR as thin films or nujol mulls and are reported in wavenumbers. 
Mass spectra were recorded on a VG Fisons Platform II or at the EPSRC national mass 
spectrometry service in Swansea (HRMS). Elemental analyses were performed by 
Warwick Analytical Services (University of Warwick). All photophysical data were 
obtained on a JobinYvon-Horiba Fluorolog spectrometer fitted with a JY TBX picosecond 
photodetection module and a Hamamatsu R5509-73 detector (cooled to -80 °C using a 
C9940 housing). The pulsed laser source was a Continuum Minilite Nd:YAG configured 
for 355 nm output. Lifetimes were obtained using the JY-Horiba FluorHub single photon 
counting module. Estimated errors are Ten, ± 10% and excitation and emission maxima are 
limited in accuracy to the monochromator slit width of 5 nm.
Sodium 4-hydroxybutylacetate (2.1).12
To a solution of y-butyrolactone (11.2 g, 0.13 mol) in methanol (10 
ml) was added sodium hydroxide (5.2 g, 0.13 mol). The solution 
was heated at reflux for 2 hours. Finally the methanol was removed 
on a rotary evaporator and the product was recovered as a white solid. (14.4 g, 88 % yield). 
5H (D2O) 3.45 (2H, t, 7=  6.6 Hz, C//2(4)), 2.08 (2H, t, J = 7.6 Hz, C//2(2)), 1.65 (2H, m, 
C//2( 3)).
4-terbutyldimethylsilyloxybutanoic acid (2.2).15
To a solution of sodium 4-hydroxybutylacetate (2.5 g, 19.8 mmol) 
in pyridine (25 ml) was added /er/-butyldimethylsilyl chloride (3.0 
g, 19.8 mmol). The reaction was stirred at room temperature for 72 
hours. After this, ammonium chloride solution (saturated, 25 ml) was added and the 
mixture was neutralized with hydrochloric acid 0.5 M. Then it was extracted with ether (3 
x 25ml) and finally the organic phase was extracted with copper sulphate solution (20 ml)
e NB. These general considerations are applicable to all the experimental sections throughout this thesis.
O
hoA ^ otbd
N a O ^ ? ^ OH
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and dried with magnesium sulphate. Distillation gave the product as colourless oil. (1.2 g, 
28 % yield). 8H (CDC13) 3.56 (2H, t, J=  3.3 Hz, C//2(4)), 2.30 (2H, t, J =  6.5 Hz, CH2(2)\ 
1.81 (2H, m, C//2(3)), 0.89 (9H, m, (SiC(C//3)3)), 0.01 (6H, m, (Si(C//3>2)). Vmax (Nujol) 
1714 (CO).
Potassium 4-terf-butyldimethybilyloxybutanoate (23). 
4-/er/-butyldimethylsilyloxybutanoic acid (1.8 g, 1.2 mol) and 
potassium tert-butoxide (0.9 g, 1.2 mol) were stirred in solution in 
methanol (20 ml) under a nitrogen atmosphere at reflux for 3 hour.
After removing the solvent on a rotary evaporator, 10 ml of toluene was added and 
subsequently evaporated. This process was repeated 4 times. Finally the product, 23, was 
obtained as a yellow solid. (1.6 g, 76 % yield). 8H 0 ^ 0 ) 3.58 (2H, t, J=  6.6 Hz, C//2(4)),
2.10 (2H, t, J=  7.2 Hz, C/72(2)), 1.68 (2H, m, CZ/^3)), 0.80 (9H, m, SiC(C//3)3), 0.01 (6H, 
m, Si(C//3)2). 5C (CDC13) 184 (C(l)), 64 (C(2)), 34 (C(4)), 28 (C(3)), 25 (SiC(CH3)3), 18 
((SiO). Vmax (CHC13) 1564 (CO).
Attempts towards the synthesis of 3-(4-tert-
butyldimethylsilyloxybutanoatomethyl)pyriduie (2.5).
A. Via an acyl chloride adduct (successful reaction but low yield).
To a solution of potassium 4-tert- 
butyldimethylsilyloxybutanoate, 23, (1.0 g, 4.0 mmol) in 
chloroform (10 ml) was added dropwise oxalyl chloride 
(0.36 ml, 4.0 mmol). The mixture was stirred at room 
temperature and under a nitrogen atmosphere for XA hour. Then a solution of 3- 
(hydroxymethyl)pyridine (0.38 ml, 4.0 mmol) and triethylamine (0.38 ml, 4.0 mmol) in 
chloroform was added dropwise. After 16 hours stirring, 10 ml of dichloromethane was 
added and it was extracted with an aqueous solution of saturated sodium hydrogen 
carbonate (10 ml) and dried with magnesium sulphate. The product, 2.5 was purified by 
chromatography on silica using petroleum ether and ethyl acetate (7:3), Rf = 0.7, as eluent 
to give the product as a clear oil (0.1 g, 10 % yield). 8H (CDC13) 8.60 (1H, s, C//(2)), 8.54 
(1H, m, CH(6)% 7.68 (1H, m, C//(4)), 7.30 (1H, m, CH(5)), 5.10 (2H, s, CH2(7) ), 3.62 
(2H t, J  = 6.1 Hz, CH2( 12)), 2.42 (2H, t, J  = 7.4 Hz, C//2(10) ), 1.82 (2H, m, CH2(\ 1) ), 
0.85 (9H, s, SiC(C//3)3), 0.0 (6H, s, Si(C//3)2). 5C (CDC13) 172.3 (C(9)), 148.6 (C(6)),
O
kqX ^ o t b d
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148.5 (C(2)), 134.9 (C(4)), 130.6 (C(3)), 122.4 (C(5) ), 62.5 (C(7», 60.8 (C(12», 29.6 
(C(10) ), 26.7 (C (ll) ), 24.8 (SiC(CH3)3), 17.3 (SiC). v,™ (CHCI3) 1740 (CO), m/z EI/CI
310.2 [MH]+, 252.1 [M-*Bu]+. Accurate mass of ion [M+H]+ = 310.1833, measured mass 
ofion[M+H]+ = 310.1833.
B. Via a mixed anhydride (unsuccessful reaction).
To a solution of potassium 4-tert- 
butyldimethylsilyloxybutanoate, 23, (890 mg, 4 
mmol) in DCM (40 ml) was added toluene-4- 
sulfonyl chloride (660 mg, 4.0 mmol). The mixture 
was stirred at room temperature and under a 
nitrogen atmosphere for 1.5 hours. The solvent was 
removed on a high vacuum line to afford a white 
solid which was washed with petroleum ether in 
order to eliminate the impurities (452 mg, 35 % yield). SH (CDCI3) 7.78 (2H, d, J=  8.2 Hz, 
C//(o)), 7.38 (2H, d, J =  8.2 Hz, Ctf(m)), 3.60 (2H, m, C//2(4)), 2.50 (2H, t, J =  7.3 Hz, 
C//2(2)), 2.46 (3H, s, C//3), 1.80 (2H, m, CH2(3)), 0.82 (9H, s, SiC(C//3)3), 0.00 (6H, s, 
S\(CHjyd. Due to its moisture sensitivity, 2.6 was stirred straight away with one equivalent 
of 3-hydroxymethylpyridine (0.09 ml, 0.9 mmol) in presence of triethylamine (0.12 ml, 0.9 
mmol) in dry chloroform (15 ml) for 12 h at room temperature. The mixture was washed 
with an aqueous NaHC03 solution (3 * 10 ml). The organic layer was dried over MgSC>4, 
filtered, and concentrated in vacuo. The brown gel was a mixture of decomposition 
products.
C. Via a coupling reaction (successful reaction in a good yield).
To a mixture of EDCI (440 mg, 2.2 mmol) and DMAP 
(139 mg, 1.1 mmol) in DCM (1.5 ml) was added a 
solution of 4-/erf-butyldimethylsilyloxybutanoic acid,
23, (250 mg, 1.1 mmol) in DCM (0.8 ml) at 0 °C. After 
15 min, a solution of 3-(hydroxymethyl)pyridine (0.11 ml, 1.1 mmol) in DCM (lmL) was 
added to the reaction mixture, and stirring was continued at room temperature for 3 h. The 
mixture was diluted with an aqueous NH4PF6 solution (5 ml), and the aqueous layer was 
extracted with Et20  (4 ^ 5  ml). The combined organic extracts were dried over MgSC>4, 
filtered, and concentrated in vacuo. The residue was purified by chromatography column
- ^ y ! - o A ^ ° TBD
m o  ®
Intermediate compound:
Toluene-4-sulfonil-4-
tertbutyldimethylsilyloxibutanoate
(2.6)
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(hexane-EtOAc, 5:2), Rf = 0.7, to give compound 2.5 (161 mg, 47 %) as a white oil. 5H 
(CDClj) 8.60 (1H, s, CH(2)), 8.54 (1H, m, C//(6)), 7.68 (1H, m, C//(4)>, 7.30 (1H, m, CH 
(5)), 5.10 (s, 2H, C//X7)), 3.62 (2H, t, y  = 6.1 Hz, C/ / 2 (12», 2.42 (2H, t, y  = 7.4 Hz, C/ / 2 
(10), 1.82 (2H, m, CH^U)), 0.85 (9H, s, SiC(C//3)3), 0.0 (6H, s, Si(CH^h)- SC (CD3C1)
172.3 (C(9)), 148.6 (C(6)), 148.5 (C(2)), 134.9 (C(4)), 130.6 (C(3)), 122.4 (C(5) ), 62.5 
(C(7)), 60.8 (C(12)), 29.6 (C(10) ), 26.7 (C(l 1) ), 24.8 (SiC(CH3)j), 17.3 (SiC). m/z EI/CI
310.2 [MH]+, 252.1 [M-'Bu]+. Accurate mass of ion [M+H]+ — 310.1833, measured mass 
ofion[M+H]+= 310.1833.
-Synthesis of the rhenium complexes: Chloride adduct, A, activated complexes, B, 
and final targets, C.
A: /flc-Re(bipyXCO)3Cl (2.7).7
Re(bipyXCO)3Cl was prepared by heating equimolar quantities of 
Re(CO)5Cl (211 mg, 0.6 mmol) and 2,2 -bipyridine (91 mg, 0.6 
mmol) in dry toluene (2 ml) at reflux for 1 hour. The yellow product 
precipitated from solution and was filtered and used without further 
purification (262 mg, 98 % yield). 8H (CDCb) 9.0 (2H, d, J  = 5.6 
Hz, C//(6)), 8.15 (2H, d, J  = 7.10 Hz, C(3)), 8.0 (2H, m, C(4)), 7.50 (2H, m, C(5)). v™ 
(Nujol) 2020,1895,1880 (CO).
B: /ac-|Re(bipyXCO)3CH3CN](BF4) (2.8).7
To a solution of Re(bipyXCO)3Cl (243 mg, 0.5 mmol) in 
acetonitrile (100 ml) was added one equivalent of silver 
tetrafluoroborate (105 mg, 0.5 mmol). It was heated at 
reflux under a nitrogen atmosphere in the dark for 5 
hours. After filtering the solution through Celite, the 
solvent was removed at high vacuum. Then the dark 
yellow solid was dissolved in a smaller amount of acetonitrile and it was filtered again 
through Celite to remove the possible silver chloride remaining. Once again the solvent 
was removed at high vacuum affording a yellow solid (255 mg, 88 % yield). 8H (CDCI3)
8.85 (2H, d, J  = 5.4 Hz, CH(6)), 8.49 (2H, d, J  = 8.3 Hz, C//(3)), 8.19 (2H, m, CH(4)), 
7.57 (2H, m, CH(5)) 2.13 (s, 3H, CH3). w  (Nujol), 2035,1918 (CO).
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B: /ac-IR^bpyMCOhCHjCNKCFjSOj) (2.12).7
To a solution of Re(bpyXCO)3Cl (109 mg, 0.2 mmol) 
in acetonitrile (50 ml) was added one equivalent of 
silver triflate (60 mg, 0.2 mmol). It was heated at 
reflux under a nitrogen atmosphere in the dark for 6.5 
hours. After filtering the solution through Celite, the 
solvent was removed at high vacuum. Then the dark 
yellow solid was dissolved in a smaller amount of acetonitrile and it was filtered again 
through Celite to removed the possible silver chloride remaining. Once again the solvent 
was removed at high vacuum affording a yellow solid (100 mg, 74 % yield). 8H (CDCI3) 
8.88 (2H, d, J  = 5.1 Hz, CH(6)\ 8.61 (2H, d, J  = 8.2 Hz, CH(3)), 8.20 (2H, m, CH(4)), 
7.59 (2H, m, C//(5)), 2.20 (3H, s, CH3). (Nujol) 2040,1932,1910 (CO).
C: /ac-[Re(bipyXC0)3PyCH20H](BF4) (2.9).
Complex Re(bipyXCO)3CH3CN](BF4) (255 mg, 0.4 
mmol) and 3-(hydroxymethyl)pyridine (0.45 ml, 4 
mmol) were heated at reflux in 175 ml of THF under 
a nitrogen atmosphere for 1.5 hour. After the solution 
had cooled, petroleum ether was added dropwise to 
crystallize the product as a yellow solid (178 mg, 62 
% yield), m.p. 200 °C. 6H (CD3CN) 9.18 (2H, d, J  =
5.5 Hz, CH(6) bipy), 8.30 (2H, d, J  = 8.1 Hz, C/f(3) 
bipy), 8.2 (2H, m, C//(4) bipy), 8.12 (1H, s, CH(2) Py), 8.04 (1H, d, J  = 5.5 Hz, CH(6) 
Py), 7.68-7.78 (m, 3H, C//(4) Py, C//(5) bipy), 7.18 (1H, m, CH(5) Py), 4.38 (2H, s, C//2), 
3.33 (1H, s, OH). 8C (CD3CN) 195.4 (CO*, ), 191.3 (COv ), 155.4 (C(3), py), 153.5 (C(6), 
bipy), 150.0 (C(6), py), 149.5 (C(2), py), 140.8 (C(3), bipy), 140.6 (C(2), bipy), 137 (C(5), 
py), 127.8 (C(4), bipy), 125.8 (C(4), py), 124.3 (C(5), bipy), 59.6 (CH2). (Nujol) 
2032s, 1915sb v (CO), m/z (ESI) 536.1 [MH]+ , 427 [M-BF4-PyCH2OH]+. Elemental 
analysis, found C, 36.68; H, 2.30; N, 6.56. ReCi9Hi504N3BF4 requires C, 36.65; H, 2.41; 
N, 6.75. X-ray: Ci9Hi5BF4N30 4 Re, M  = 622.35, yellow block, 0.15 * 0.15 * 0.08 mm, 
monoclinic, space group P 2 j/c, a = 10.2550 A, b = 12.5820 A, c = 15.6370 A, p  = 94.006°, 
V= 2012.69 A3, Z = 4, Dc = 2.054 mg cm-3, F(000) = 1192, 14713 Reflections collected, 
4614 Reflections unique, R(int) = 0.0620; Goodness-of-fit on F2 = 1.030, R1 = 0.0375, 
wR2 -  0.0834.
OH
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C: /ac-[Re(bipyKC0)3PyCH20C0(CH2>30H](BF4) (2.10).
To a solution of
[Re(bipyXCO)3CH3CN](BF4) (219 mg,
0.4 mmol) in THF (100 ml) was added one 
equivalent of 3-(4-tert-
butyldimethylsilyloxybutanoatomethyl)- 
pyridine (134 mg, 0.4 mmol) dissolved in 
40 ml of the same solvent. It was heated at 
reflux under a nitrogen atmosphere for 9 
hours and then stirred at room temperature. Finally it was filtered by gravity and the
solvent was removed at the rotary evaporator. By recrystallisation from ethyl acetate a dark
yellow solid was obtained, m.p. 72 °C. 5H (CD3CN) 9.21 (2H, m CH(6) bipy), 8.38 (2H, 
m, CH(3) bipy), 8.3-8.1(4H, m, C//(4) bipy, CH(2,6) Py), 7.87-7.79 (3H, m, C//(4) Py, 
CH(5) bipy), 7.29 (1H, m, CH(5) Py), 4.92 (2H, s, CH2), 3.48 (2H, m, CH2( 12)), 2.38 (2H, 
t, J =  7.4 Hz, CH2{ 10)), 1.68 (2H, m, CH2(\ 1)). v ^  (CH3CN) 2031, 1920, 1734 (CO), m/z 
(ESI) 622.1 [MH]+, 536.1 [M-C0 (CH2)30]+ 427.0 [M-BF4-PyCH2OCO(CH2)OH]+. 
Theoretical isotope pattern 620.1 (58%), 621.1 (17%), 622.1 (100%), 623.1 (28%), 624.1 
(3%). Actual isotope pattern 620.1 (57%), 621.1 (15%), 622.1 (100%), 623.1 (24%), 624.1 
(5%).
C: /ac-[Re(bipyXC0 )3PyCH2 0 C0 (CH2)3 0 SiMe2tBuK CF3SO3) (2.13).
The reaction was carried out in 
THF (25 ml). The complex 
Re(bipyXC0 )3CH3CN](CF3S03 )
(100 mg, 0.16 mmol) and 
compound 2.5 (55 mg, 0.18 mmol) 
were heated at reflux under a 
nitrogen atmosphere for 10 h. After 
2 days stirring at room 
temperatrure, petroleum ether was added dropwise to crystallize the product as a yellow 
solid (37 mg, 26 %), m.p. 145 °C. 5H (CD3CN) 9.08 (2H, d , J =  5.3 Hz, CH(6) bipy), 8.79 
(2H, d, J=  8.9 Hz, CH{3) bipy), 8.35-8.28 (3H, m, C//(4) bipy), C//(2) Py), 7.97 (1H, d, J  
= 8.9 Hz, CH(6) Py), 7.80-7.71 (3H, m, CH(4) Py, CH(5) bipy), 7.35 (1H, m, CH(5) Py),
(CF 3 SO 3 )
Re(CO)3
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4.90 (2H, s, CH2\  3.60 (2H, t, J  = 6.3 Hz, C//2( 12)), 2.37 (2H, t, J  = 7.4 Hz, C//X10)), 
1.79 (2H, m, CH* 11)), 0.88 (9H, s, SiC(C//3)3), 0.0 (6H, s, Si(C//3)2). 8C (CD3CN) 194.4 
(CO*,), 191.0 (COap ), 172.05 (CO(9)), 154.9 (C(2), bipy), 151.4 (C(6), bipy), 150.7 (C(2), 
py), 149.7 (C(6), py), 140.8 (C(4), bipy), 138.8 (C(4), py), 134.6 (C(3), py), 127.8 (C(3), 
bipy), 126.2 (C(5), py), 125.4 (C(5), bipy), 61.1 (C(7)), 60.8 (C(12)), 29.4 (C(10)), 26.7 
(C (ll)), 24.9 (SiCCCHsW, 17.3 ((SiC)). w  (Nujol): 2035, 1935, 1925, 1722, o (CO), m/z 
(ESI) 736.4 [MH]+, 622.3 [M-CFaSOa-SKCH^QCH^]*, 427.2 [M-CFaSCb-
PyCH2OCO(CH2)20Si(CH3)2C(CH3)3)]+. Theoretical isotope pattern 734.2 (56%), 735.2 
(23%), 736.2 (100%), 737.2 (39%), 738.2 (11%). Actual isotope pattern 734.4 (60%),
735.4 (22%), 736.4 (100%), 737.4 (36%), 738.4 (11%). X-ray: C30H35F3N3O9ReSSi, M  = 
884.96, yellow block, 0.10  x 0.05 x 0.05 mm, monoclinic, space group, a -  11.1847(8) A, 
b = 13.3116(10) A, c = 24.0160(18) A, f i  = 95.5780(10)0, V = 3558.7(5) A3, Z = 4, Dc = 
1.211 mg cm"3, F(000) — 1264, Reflections collected = 45252, 12616 Reflections unique, 
R(int) = 0.0449; Goodness-of-fit on F2 = 1.579, R1 = 0.0719, wR2 = 0.2237.
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Chapter 3
3.1 Aim s.
This chapter focusses on the synthesis of improved luminescent rhenium complexes for 
specific cell imaging. Tuning of luminescent properties and solubility as well as 
improvement in the cyclisadon rates for the self-destruction device are investigated.
3.2 Introduction
3.2.1 Tuning of photophysical and photochemical properties.
The photophysical and photochemical properties of luminescent complexes of d6 transition 
metal such as Re(I), Ru(II) or Ir(III) are influenced by the nature of the ligands and their 
environment Therefore varying of one or more of these factors can tune the luminescent 
properties of complexes.
In particular, complexes of the type y&c-Re(NN)(CO)3L, where NN is an a-diimine ligand 
and L a pyridine derivative, can have their luminescence properties tuned by modifying the 
spectator ligand, L, and/or the chromophoric a-diimine. Modifications in the latter have 
been found to be more effective as they directly affect states implicated in the luminescent 
process (MLCT states). Variations in the pyridine derivative only affect the energy of these 
states by a secondary alteration of electron density on the central metal. Groups headed by
I *s
Thomas J. Meyer and B.A. DeGraff, among other researchers, have studied how different 
electron-donating or electron-withdrawing character of the substituents on the a-diimine 
and/or on the pyridine derivative can tune the luminescent properties. Figure 3.1 and 
Figure 3.2 respectively.
NO
Ex (nm) 350 370 448
Em ^  (nm) 573 642 780
Figure 3.1. Rhenium complexes bearing a bipyridine or a derivatised bipyridine.
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N
1+
Re(CO)3
OH
N
1+
/ Re(CO )3
N
1+
/ Re(CO)3
Ex ^ ( n m )  
Em A,,,ax (nm)
A
402
582
B
366
558
C
340
552
Figure 3.2. Rhenium complexes bearing a pyridine or a derivatised pyridine.
Extended n conjugation in the spectator ligand and in the a-diimine can also result in 
changes in the luminescent properties as this stabilises the 7c*(a-diimine) and x*(L) orbitals,
promoting a red shift in the emission.
3.2.2 4’- Substituted-terpyridine complexes.
4’-Substituted-terpyridine complexes of Ru(II), Os(II) and Ir(III) have been widely 
studied3,4 due to their important applications in biosensors, solar cells and molecular and 
electronic devices, etc. Functionalisation of terpyridine can not only be helpful in tuning 
the luminescent properties, but also in the design of novel probes. Recently, Williams et al. 
synthesised bis-terpyridine iridium complexes bearing pH-sensitive groups (phenol and 
pyridine, Figure 33) where changes in the pH modify the luminescent properties of the 
compounds drastically.
Emission reduces eight-fold
pH = 6 Xabs = 360 nm 
pH =10 O  Kbs==^ nm
Figure 33. Examples of bis-terpyridine iridium complexes reported by Williams et al.5
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3.2.3 Dicarbonyl rhenium complexes.
Only a few examples of dicarbonyl rhenium complexes6,7 were found in the literature, 
Figure 3.4, in comparison to the numerous tricarbonyl analogues. The photophysical 
properties of the dicarbonyl complexes are also suitable for their use as fluorescent probes 
as they have increased emission, lifetimes, quantum yields and the MLCT absorption band 
shifts to longer wavelength than for the analogous tricarbonyl rhenium complexes. On the 
other hand, they may potentially work as macromolecular building blocks with a “linear 
shape” in contrast to the L-shaped geometry of the tricarbonyl rhenium complexes.
Figure 3.4. Example of a dicarbonyl rhenium complex reported by Ishitani.7
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3.3 Premises.
Studies performed in the past 20 years have shown that changes in the luminescent 
properties of complexes can be generated by modifying directly conjugated substituents on 
the a-diimine and/ or the axial ligand. Therefore, a similar approach was considered in this 
work in order to produce detectable changes in emission caused by the self-destruction 
mechanism. This approach can also be used to increase the cyclisation rate (i.e. the linker 
self-destruction mechanism), as the direct conjugation of the self-destruction device to an 
aromatic system affords a better leaving group, which will accelerate the cyclisation 
reaction once the sensor has been removed. Scheme 3.1 and 3.2 show a diagrammatic 
depiction of the improved target. The concept of the linker self destruction reaction was 
described in detail in Chapter 2, Scheme 2.2.
Lipophilic 
chain
Sensor
Analyte
O h
Luminescent
core
Scheme 3.1. Directly conjugated substituents in the axial ligand and its linker self- 
destruction reaction.
Lipophilic
chain
ReReRe
SensorLuminescent
core Analyte
Scheme 3.2. Directly conjugated substituents in the a-diimine and its linker self- 
destruction reaction.
Further derivatisation is also needed in order to render the complexes more water soluble. 
Therefore, sulphonate groups or similarly charged, polar units can be introduced as 
substituents on either the a-diimine or in the axial ligand.
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3.3.1 Luminescent properties and cyclisation rate.
Two molecules based on complex 2.13 have been designed to comply with the requirement 
for both an improved linker self-destruction mechanism and a greater difference in 
luminescent properties between the pre- and post-cyclisation species, as shown in Figure
3.5. The first imaging agent bears the self destruction device directly attached to the axial 
ligand in the para position (with respect to the nitrogen). This will directly affect the 
electronic properties of the N-Re bond, and consequently, the luminescence, by additional 
electron donation into the MLCT excited state. The second model also has the self- 
destruction device directly conjugated with the axial ligand, which in this case, is a 
quinoline -  containing a more extended x-system than the pyridine.
* Directly congujated with the axial ligand.
Placed in a para position.
Figure 3.5. Specific targets for improving the luminescence and cyclisation rate of species
O
self destruction device
1 +
/ Re(CO )3
•Not directly congujated with 
the axial ligand.
•Placed in a meta position.
SOB:
(SOB)
2.13
O
O
1 + 1 +
/ Re(CO)3 Re(CO )3
1* Target 2nd Target
SOB:
2.13.
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A further target complex is shown in Figure 3.6. This complex is based on studies reported 
by several research groups such as those of Sullivan,6 and Koike,7 concerning the 
favourable photochemical features of dicarbonyl diimine rhenium complexes and on the 
reported synthesis of the rhenium biscarbonyl complex, [Re(terpy)(CO)2Cl], made by 
Sebastiano Campagna et al.8
O3S < = 3  Water solubiliy
■=N
OTBDOC---- Re— N
SOB
3rd Target
SOB:
• Directly conjugated
* Placed in para position
Figure 3.6. Specific model of a water soluble dicarbonyl rhenium complex.
This third model also bears the self-destruction device, SOB, directly conjugated with an 
aromatic ring. In this case, it is attached to the a-diimine ligand, and there is an axial water 
soluble pyridine present as well, in order to enhance the solubility of the compound in 
polar solvents.
Finally, in order to progress towards the synthesis of a luminescent rhenium complex with 
biologically relevant applications, two new complexes were designed whose self- 
destruction device has been modified so that it can be triggered by nitro-reductase*. The 
nitro-reductase enzyme is derived from bacteria and is also used as a marker gene in 
genetic engineering. Therefore, detection of nitro-reductase is important both for detecting 
the presence of bacteria and for showing that genetic modification has occurred. Both 
structures are shown in Scheme 33  together with the proposed self-destruction 
mechanism.
“ Nitro reductase is an enzyme that catalyses the reduction of nitro groups in a wide range of substrates to 
produce die corresponding hydroxy lam ine.
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Water solubility
nitro
reductase
OC—Re N
OC
Self-destruction
4* Target
device
Water solubility
OC
Self-destruction
nitro
reductase
5* Target
device
OC—Re N
NH
N=-
O
OC—Re OH
OC N=<
OC—Re
OC N=<
Scheme 3.3. Specific models with nitro groups as the trigger.
3.3.2 Solubility in biological media.
The sixth and final challenge described in this chapter will deal with the problem of low 
solubility in polar solvents. Water solubilising substituents are needed in order to modulate 
the solubility of new complexes towards a practical application in biological systems.
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Figure 3.7 represents a rhenium complex with a water soluble diimine ligand with an 
extended it-system and the already reported ligand, 2.5.
OTBD
"+ SOB
Re(CO)i Self-destruction 
\ N device
— N
^  Water solubility 
6th Target
Figure 3.7. Target water soluble rhenium complex.
33 3  Retrosynthetic analysis.
The synthetic pathway that was followed to synthesise the six proposed imaging agents is 
the same as that followed in the synthesis of complexes 2.9 and 2.13 in Chapter 2 (vide 
supra Scheme 2.5). In addition, based on the excellent results also obtained and discussed 
in the previous chapter concerning the synthesis of the axial ligand, compound 2.5, the 
same retrosynthetic analysis (coupling reaction) is considered when it comes to 
synthesising the five new self-destruction ligands, Scheme 3.4 and Scheme 3.5.
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OH
OTBD
N'
EDCI, DMAP
OEt
OTBD
Py N Py
CO(CH3)2 
EDCI, DMAP
EDCI, DMAP
OTBD
EDCI: N = = N -
/
HCI DMAP: XN
: " ' X J '
X Y
Scheme 3.4. Retrosynthetic analysis of ligands bearing SOB as self-destructing device.
/ s==\  O
V< O ^O H OII/
n
n o 2
i f V °2u
h 1
U
r  -  — -i»
N
+
*N py EDCI, DMAP cckch3)2
O n o 2
EDCI, DMAP P y^^N ^^P y
EDCI, DMAP see Scheme 3.4
Scheme 3.5. Retrosynthetic analysis of ligands bearing a nitro group as the trigger for the 
self-destruction mechanism.
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3.4 R esults And D iscussion.
3.4.1 Attempted synthesis of a Re complex with a para substituted pyridyl 
axial ligand.
Several attempts to synthesise the fiinctionalised 4-hydroxypyridine using the established 
coupling method (EDCI and DMAP, Scheme 3.4) were not successful, giving a mixture of 
starting material and unidentified decomposition products. Possibly, the equilibrium 
between the hydroxyl and ketone forms reduces the nucleophilicity of the hydroxyl group, 
preventing the coupling reaction from taking place, Scheme 3.6.
Scheme 3.6. Pyridone-hydroxypyridine equilibrium.
Coordination of 4-hydroxypyridine to the rhenium core followed by the coupling reaction 
to attach the self-destruction device to the hydroxyl group could overcome this problem.
[Re(C0 )3(bipyX4-H0 -py)](C104), Scheme 3.7. The synthesis entails the direct reaction of 
the Re(CO>3(bipy)Cl with an excess of the axial ligand, 4-hydroxypyridine, in presence of
Scheme 3.7. DeGrafTs procedure for coordination of 4-hydroxypyridine to a rhenium 
centre.
The coupling reaction was then attempted using the same conditions as before but using 
chloroform instead of DCM due to the poor solubility of complex 3.1 in DCM, Scheme 
3.8. After stirring for 3 days, no product formation was observed. This can be rationalised
OH O
The same procedure as reported by DeGraff et al.2 was used to synthesise
the silver perchlorate. *H-NMR spectroscopy confirmed the success of the reaction, with 
the axial ligand proton signals shifting to low field upon coordination.
OH n
Re(CO )3
Cl
I i: 4-HOpy, AgC104, toluene1 +
Re(CO)3
3.1
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by the hydroxyl group having lowered electron density, and thus, lower nucleophilicity. 
The electron density of the hydroxyl group can be donated to the metal centre quite 
efficiently as the donor and acceptor are placed in para to each other.
OTBD
i: 2.5, EDCI, DMAP 
Scheme 3.8. Lack of reactivity of complex 3.1 towards coupling with SOB.
OH C para
3.4.2 Synthesis of a Re complex with a more conjugated axial ligand.
6-SOB-Quinoline, 3.2, was synthesised successfully by the coupling reaction between the 
6-HO-quinoline and 4-ter/-butyldimethylsilyloxybutanoic acid, 2.2, Scheme 3.9. The low 
yield of the reaction can be rationalised by the low solubility of the starting material, 6- 
hydroxyquinoline and its low nucleophilicity (the direct conjugation of the hydroxyl with 
the aromatic system increases the electron delocalisation within the molecule). The 
structure of the white crystalline solid that was isolated from the reaction was confirmed by 
*H-NMR spectroscopy, as the protons belonging to the acid fragment were shifted to low 
field; further characterization by IR and mass spectrometry corroborated the result.
SOB
OTBD i: 2.2, EDCI, DMAP, 
DCM 20 %
Scheme 3.9. Coupling reaction between 6-hydroxyquinoline and 2.2.
Next, the reaction of the quinoline derivative 3.2, with the activated rhenium species 
[Re(C0 )3(bipyXCH3CN)](CF3S03), 2.12, was attempted, Scheme 3.10 {N.B. Synthesis of 
the activated rhenium species has been discussed in Chapter 2). Unfortunately, no 
displacement of acetonitrile by the new ligand was observed under normal reaction 
conditions (THF, reflux, N2), with both starting materials being recovered from the
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reaction mixture. A higher boiling solvent, toluene, was then tried in an attempt to force 
the reaction with a higher temperature but with the same negative result. In this case, 
however, the products recovered from the reaction were the activated rhenium complex 
and unidentified decomposition products derived from the ligand.
OTDB
i: 3.2, THF 
i: 3.2, toluene
Scheme 3.10. Reaction of 3.2 with the activated rhenium species.
Given the difficulty in synthesising the desired target, attention turned to the synthesis of a 
rhenium adduct with two quinoline derivatives instead of the chelate ligand, bipy, as 
rhenium complexes with a similar structure, [Re(CO)3(N)2L], where N is a highly 
conjugated monodentate pyridine, also have good photophysical properties to use as 
fluorescent probes.9
Chloro pentacarbonyl rhenium was heated with either two equivalents of ligand 3.2 in 
toluene, or with 6-hydroxyquinoline, Scheme 3.11. However, neither of these reactions led 
to the desired product; ester hydrolysis was observed in the case of ligand 3.2 and no 
reaction occurred when 6-hydroxyquinoline was used. Therefore, the idea of using a 
quinoline derivative as an anchor for the linker chain and sensor was dropped.
Cl
1a/b
Re(CO)jCI M COh
\  /N=\  // 
A //
R, -OH, -SOB 
.p ia: 3.2, Toluene
ib: 6-OH-Quinoline, Toluene
Scheme 3.11. Attempted synthesis of rhenium quinoline complexes.
3.4.3 Attempted synthesis of Re complexes with tert-pyridine derivatives as 
the a-diimine.
The synthesis of 4’-hydroxyterpyridine was published by Edwin C. Constable and Michael 
D. Ward in 1990.10 It entails a two step synthesis starting with the reaction of ethyl 2-
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pyridine carboxylate, acetone and sodium hydride to afford 1,5-bis(2’-pyridyl)pentane- 
1,3,5-trione. Subsequently, addition of ammonium acetate to an ethanol solution of this 
intermediate gives the desired product, Scheme 3.12. The product was successfully 
obtained following the described procedure, and as its 'H-NMR spectrum correlated with 
the reported data, no further characterization was carried out.
o
N N.
Intermediate 1
i: NaH, DME, 52%
Intermediate 2ii: CH3COONH4 EtOH 46 %
Scheme 3.12. Synthesis of 4’-hydroxyterpyridine by Constable and Ward’s procedure.
Additional ligand fiinctionalisation was carried out using the coupling reagents, EDCI and 
DMAP. Compounds 33, 3.4, and 33 were synthesised following a general procedure 
whereby the corresponding carboxylic acid was added to a mixture of DMAP and EDCI in 
dry DCM at 0 °C. After stirring a solution of the alcohol adduct for 15 min, 
4’hydroxyterpyridine was added in the same solvent to the reaction mixture and stirring 
was continued for the required time at room temperature under a nitrogen atmosphere, 
Scheme 3.13.
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3.4
11
OH
in
3.5
OTBD
i: 2.5, EDCI, DMAP, DCM, 3 h, 20 %
ii: 2-N02C6H4C00H, EDCI, DMAP, DCM, 3 days, 47 %
iii:2-N02C6H4CH2C00H, EDCI, DMAP, DCM, 3 days, 36 %
Scheme 3.13. Synthesis of 33,3.4, and 3.5.
The three reactions were monitored by *H-NMR spectroscopy whereby the shift of the 3' 
protons from 7.00 ppm in the starting material to 8.32, 8.18, and 8.20 ppm in the new 
compounds 33,3.4 , and 33 , respectively, indicated the reaction was complete. Moreover, 
the double integration of each peak in the regions of the lH-NMR spectrum relating to the 
terpyridine fragment, together with the 13C-NMR spectrum, in which only half the number 
of carbons belonging to the terpyridine fragment appeared, showed that the new 
compounds were symmetrical. Further characterisation (IR and mass spectrometry) 
confirmed their structures.
Coordination of these three species and 4-hydroxyterpyridine to chloropentacarbonyl 
rhenium was performed using standard conditions, see Scheme 3.14. However, the product 
obtained from each reaction turned out to be the bidentate terpyridine derivative complex, 
i.e. a facial tricarbonyl rhenium system, which disagrees with the data reported in 1988 by 
Sebastiano Campagna et al.% for a similar complex [Re(CO)2(terpy)Cl]. !H and 13C- NMR 
spectroscopy showed the loss of ligand symmetry upon coordination, suggesting a
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bidentate coordination. Moreover, the appearance of three carbonyl stretching bands, one 
symmetric and two asymmetric, in IR experiments indicated the existence of three 
carbonyls within the complex (if there were only two carbonyls in the complex then only 
two bands would have been visible, Osym and Uasym)- Mass spectrometry, additional 
crystallographic data from complex 3.6 and further reports found in the literature11 
corroborated these results, see Section 3.7.
*a/b/c/d
Re(CO)5Cl
1a/b/c/d
R: -H ia: 4-HO-terpy, toluene, 89 % ^  3^
-CCKCH^OTBD c> ib- 33, toluene, 80 % ^  3 .7
-CCX2-NO2C6H4) □:> ic: 3.4, toluene, 60 % ^  3.8
-C0CH2(2-N02C6H4) id: 33, toluene, 57 % ^  3 .9
Scheme 3.14. Coordination of terpyridine derivatives to Re(CO)sCl.
3.43.1 Reactivity of complex 3.6.
The activation reaction of these terpyridine derivative complexes was then attempted, 
starting with complex 3.6. The yellow solid, 3.6, was dissolved in acetonitrile affording a 
bright yellow solution which changed to pale yellow after addition of an excess of silver 
tetrafluoroborate. After heating at reflux under nitrogen atmosphere in the dark overnight, 
the *H-NMR spectrum showed marked changes, which could not be explained by a simple 
halide abstraction reaction as a less complicated spectrum was observed suggesting the 
formation of a more highly coordinated species, Figure 3.8.
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9.50 9.00 8.50 8.00 7.50 7.00 6.50
. . . . . .  . .  ,  . T ■
9.50 9.00 8.50 8.00 7.50 7.00 6.50
Figure 3.8. The !H-NMR spectra of the starting materia] 3.6 and the final product 3.10.
Slow evaporation of an acetonitrile solution of this complex afforded yellow crystals 
suitable for X-ray diffraction studies, revealing the reason for the highly symmetric 1H- 
NMR spectrum. The solid state structure contains three rhenium units, [Re(CO>3(Oterpy)], 
bonded to each other through the oxygen atom in a triangular geometry. The three non­
coordinated pyridyl units are bound to a single silver atom which is located in the central 
position of the triangle but in a different plane, mimicking a cup shape, Scheme 3.15. The 
crystal structure of this compound will be discussed in detail in Section 3.7.2.
Re N O—
oc
CO
!AgCI
3.10
OC OH
OC CO
i: CF3S03Ag, CH3CN
Scheme 3.15. Unexpected tetrametallic species 3.10.
In order not to use a silver compound to synthesise the activated species, which might 
template the formation of the tetrametallic complex, two different approaches were then 
considered. Complex 3.6 was reacted with sodium tetrafluoroborate in acetonitrile for 16 
hours affording the acetonitrile adduct, 3.11. Complex 3.6 was also reacted with 
trifluoromethylsulfonic acid (triflic acid) affording the triflate adduct, 3.12, after stirring 
for 1 hour at room temperature, Scheme 3.16.
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Re— N
OC c °
*a/b
Re— N
OC CO
n+
ia: NaBF4, CH3CN, 70% ia:X=CH3CN, n = 1:3.11 
ib: CF3S03H, DCM, 90% ib: X= F3CS03 n = 0:3.12
Scheme 3.16. Synthesis of activated complexes using triflic acid and NaBF4.
Substitution of the labile triflate and acetonitrile ligands for pyridine was then attempted by 
heating both reagents at reflux, in a 1:1.5 ratio in THF. The reactions were monitored by 
!H-NMR spectroscopy, which suggested, by the shift of the hydroxy-terpy protons and the 
appearance of a new set of peaks belonging to the coordinated pyridine, completion of the 
reaction in less than one hour. The pyridine excess was the only impurity observed. 
Different attempts to isolate the product from the reaction, e.g. by precipitation and/ or 
washing with different solvents, were completely unsuccessful, ending up with the starting 
rhenium complex. Therefore, this observation suggests that the starting material, complex
3.6, and the pyridine are in a dynamic equilibrium with the desired product. Once the 
excess of ligand is removed the reaction is displaced toward the reactants leading to
complex 3.6 as the only product in the reaction.1
■* o
OC Re
OH
OC CON
% ') '  i • i *
X: CH3CN (n = 1) or CF3S03 (n = 0)
Scheme 3.17. Equilibrium displacement when pyridine is removed from complexes 3.11 
and 3.12.
b Le Ch&elier principle: If a dynamic equilibrium is disturbed by changing the conditions, the position of the 
equilibrium moves to counteract die change.
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These results, plus a report published by Orrel and co-workers,12 suggest that terpyridines 
behave as fluxional bidentate ligands in rhenium complexes. This inspired an investigation 
into the fluxional behaviour of the 4-hydroxy terpyridine complex and to determine 
whether this ligand fluxionality led to increased lability of the axial ligands, possibly via a 
seven-coordinate intermediate, Figure 3.9
PH
CO
CO
Figure 3.9. Proposed seven-coordinate intermediate of 4-hydroxyterpyridine rhenium 
complex with pyridine in the axial position.
The chloro-rhenium complex 3.6, and 5 equivalents of pyridine were dissolved in CD3CN. 
Triethylamine was also added in order to prevent protonation of the pyridine by the phenol 
of 3.6 that could lead to the reaction failure. !H-NMR spectroscopy demonstrated complete 
conversion of the chloro-complex to the pyridine complex (N.B. the reactivity of the 
unactivated chloro-complex is itself unusual and suggests a labilising effect by terpy). 
Then, 10 equivalents of 3-hydroxymethylpyridine was added to the NMR sample and once 
again !H-NMR spectra were recorded in which almost complete displacement of the 
original pyridine ligand was observed after heating for 5 hours at 80 °C. These 
observations demonstrate beyond doubt that complexes of the bidentate 
hydroxyterpyridine ligand are many times more labile than simple bipyridine analogues, 
Figure 3.10.
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Py coord.
Omin
8.0 7.0 6.0 5.0 4.09.0ppm(fl)
Figure 3.10. !H-NMR studies of the fluxional behaviour of terpyridine ligands.
Further investigations into the fluxionality of the 4 ’ -hydroxyterpyridine rhenium complex 
were carried out A series of variable temperature *H-NMR spectra of complex 3.6, 
[Re(CO)3(4' -OHterpy)C 1 ] were recorded in acetonitrile, ranging from 20 to 80 °C at 10 °C 
intervals. In the first three experiments, below a temperature of 40 °C, multiplets due to ten 
non-equivalent protons from the 4’-hydroxyterpyridine that are associated with a bidentate 
chelate complex are observed. At 50 °C the peaks start to broaden and at 80 °C the two 
signals belonging to the protons 5 and 5” coalesced, indicating rapid exchange of 
environments in the complex and hence, fluxionality of the 4’-hydroxyterpyridine 
complex, Scheme 3.18 and Figure 3.11.
OHOC Re— N
o /  *°N=,
Of* ^ocx f
OHOC
5 ”
Scheme 3.18. Fluxional processes of complex 3.6.
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5 and 5” .
80°C
70° C
60° C
T T T TT T T T
900 8 50 8.00 750
ppm (fl)
7.00
Figure 3.11. VT !H-NMR spectra of complex 3.6.
Although no higher temperature experiments were carried out in order to see coalescence 
of any other peaks, the coalescence of 5, 5” was used to calculate an approximate energy 
barrier for the process using the Eyring equation (eq 5.1).13
X: Transmision coefficient
k = x T e-^ G*/RT (eq. 5.1) ( usually assumed to be
h exactly 1)
/  \  kB: Boltzman constant
AGC = 4  58 TC f 10.32 + log -j-Cj ca] moi-l (cq. 5 .2 ) ( 3.2995-1 O'34 cal K 1)
( 1.3805-10"23 J K"1)
A G | =19.14 Tc ^ 10.32 + log j  mol-i <„. 5.3, h: Planck constant
( 1.5836-10"34 cal s) 
( 6.6256-10'34 J s)
Figure 3.12 Free energy of activation (AG4) from Eyring equation.
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For a coalescence temperature Tc the rate constant kc of the fluxional process is given by 
the equation shown below, (eq. 5.4).
exchange.
Figure 3.13. Formula for the rate constant at the coalescence temperature.
Av is determined experimentally from the spectra recorded at temperatures which are far 
below the coalescence temperature and whose sharp peaks indicated slow (on the NMR 
time scale) exchange between the species. Specifically for complex 3.6, the spectrum 
recorded at 293 K was taken as the example of slow exchange. The separation between the 
signals of the protons 5 and 5” (Av) has a value of 34.03 Hz and hence, kc has a value of 
75.59 s '1 (eq. 5.4). Finally the energy barrier is calculated by substitution of Tc (353 K) 
and kc in eq. 53, affording a value of 74.24 kJ mol*1, see Figure 3.14
Figure 3.14. Result of the energy barrier calculation.
By using the equation 5.1, the rate of the exchange process at room temperature can also be 
calculated. Therefore, k is 0.59 s '1 at 298 K
Importantly, this rate for the fluxional process at room temperature indicates that while the 
exchange is slow on the NMR timescale, the rate of exchange is high in real terms, 
happening 0.59 times per second. Thus, if the exchange process is involved with the 
displacement of axial ligands then this too would be a rapid process.
3.4.3.2 Reactivity of complexes 3.7,3 .8 ,3 .9.
Complexes 3.7, 3.8 and 3.9 differ from complex 3.6 through functionalisation of the 
hydroxyl group on the terpyridine ligand. This would not only avoid the formation of the 
trinuclear species 3.10 when the complexes are reacted with silver, but also might stop the 
fluxional process occurring as the functionalised terpyridines are less electron rich in 
comparison with complex 3.6.
k r=  - AV (eq. 5.4)
(2)l/2
AV: Separation in Hz between 
two signals in absence of
AG| = 74.24 kJ mol'1
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The activation reaction of these terpyridine complexes was then attempted, starting with 
the reaction of complex 3.8 and AgBF4 in dry acetonitrile. Unfortunately, lH-NMR 
spectroscopic experiments showed formation of species 3.10, indicative of an ester 
hydrolysis reaction. Possibly, the coordination of the terpyridine derivative to the rhenium 
makes the ester less stable due to the lower electron density in the terpyridine fragment, 
therefore making the oxygen a better leaving group. This observation agrees with a 
previous investigation carried out by Williams et al. that demonstrated a big shift of pKa 
values of 4' -hydroxyterpyridine upon coordination to Ir(IlI) (from pKa(HOterpy) = 10 to 
pK*(HOterpy-Ir) = 8, i.e. after coordination, the negative charge is more delocalized and 
hence, the R-OH acidity increases).5
OH o c  Re^-N O’ + HO
OC COOC CO.
Better leaving group Charge more stabilised
+ e‘ defficient
O* + HO
o 2n
Worse leaving group Charge less stabilised
Scheme 3.19. Possible hydrolysis process of terpyridine derivative complexes.
The relative rate of ester hydrolysis of these complexes and of the corresponding ligands 
was studied (10 mg of studied species, 3 pi D2O, 1.5 ml CD3CN). The experiment was 
carried out on a NMR scale and monitored by this technique. Hydrolysis of the ester of 
complexes 3.7, 3.8, 3.9 occurred in less than 30 minutes, whereas the corresponding 
ligands did not show any ester hydrolysis for more than 12 hours. Complex 3.9 was the 
most rapidly hydrolysed, in line with the principle that it does not have the extra resonance 
stabilisation between the terpyridine and the aromatic ring which is present in complex 3.8.
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Complex 3.7 turned out to be the most stable which can be explained on the basis of 
stabilisation of the intermediate water adduct by the NO2 group in complexes 3.8 and 3.9, 
see Scheme 3.20.
H—O
8-0
OC— Re— N (o-i
Scheme 3.20. Possible activation of the terpyridine derivative complexes.
Since these complexes undergo facile hydrolysis reactions, they are not suitable to be used 
as imaging agents for biological issues due to their instability in aqueous biological media. 
Therefore, no further studies of their properties were undertaken and attention turned to the 
next aim, the development of water soluble imaging probes.
3.4.4 Approach towards a Re complex bearing water soluble a-diimine with 
an extended ir-system.
As was discussed in Section 33.2, the water solubility required for fluorescent probes for 
applications in biological systems will be provided by using a commercially available 
water soluble a-diimine, 1,10-bathophenanthroline sulphate disodium salt. This chelating 
ligand would replace the conventional bipyridine used in previous complexes.
Due to the low solubility of all complexes derived from this ligand in non-aqueous 
solvents, it was not possible to access the final target using the traditional reaction 
conditions.14 For this reason a counterion exchange process was performed prior to 
reaction with Re(CO)$Cl, Scheme 331. The commercial disodium salt was treated with 
two equivalents of tetrabutylammonium hydrogen sulphate in water. After an extraction 
with DCM, the product was isolated from the organic phase as an easily handleable pink 
anhydrous solid.
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SO^Na*
S03*Na+
S 0 3 Bu4 N+
i: BU4 NSO4 H, H2 0 , DCM
S 0 3*Bu4 N+
3.13
Schem e 3.21. Counterion exchange process.
The tetrabutylammonium salt 3.13, was reacted with cloro pentacarbonyl rhenium in 
toluene for 2 hours affording the desired complex, 3.14, as an orange solid in 84 % yield, 
Schem e 3 .2 2 . The sim ilarity o f the frequencies o f the carbonyl stretching bands (2018, 
1910 and 1883 cm '1) to those reported for analogous com plexes14 indicated the success o f 
the reaction. Further complex characterisation ( !H-NMR and 13C-NMR spectroscopy and 
mass spectrometry) corroborated this result. The activated rhenium complex was then 
synthesised by stirring complex 3.14 with trifluoromethylsulfonic acid as previous work 
with sim ilar species dem onstrated that this was a fast and clean method to obtain the 
activated species.
Re(CO)5Cl
— N
3.14
CF3SO
= Nii
3.15a
i: 3.12, toluene, 84% 
ii: F3 CSO3 H, 99 %
(Bu4 N)+
Schem e 3.22. Synthesis o f the activated water soluble rhenium complex, 3.15.
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The activated rhenium complex was heated to reflux with pyridine in acetonitrile and with 
3 -hydroxymethylpyridine in THF. The desired product, in each case, was obtained 
successfully after 5 and 7 days respectively, Scheme 3.23.
CF3 S0 3 L|
/Re(CO)3 
/= N  N = \
i 7 Re(CO)3 
/= N  N = \
CI/  \3 O W
OjS 3.15» SO3- O3 S SO3
i: Py, CH3CN, 43 % c=> 3.16
i: 3-HOCH2Py, THF, 46 % 3.17
Scheme 3.23. Substitution of the triflate for the desired pyridine derivative.
A new approach was considered in order to diminish these protracted reaction times. 
Another activated species was synthesised by heating 3.14 with AgCFjSCh to reflux in an 
acetonitrile solution in order to abstract the chloride and insert a more labile ligand 
(CH3CN). Then, the new activated rhenium complex 3.15b was reacted with a range of 
pyridine derivatives in methanol, which was found to be a more suitable solvent for these 
reactions than THF as the reaction time decreased from ca. 5 days to between 5 and 10 
hours. This result might be explained by the better solubility of the starting material, 3.15b, 
in polar solvents, which were not used in an initial stage due to their coordinating 
character, Scheme 3.24. The reactions were monitored by 'H-NMR spectroscopy where 
the shift of protons (6) in bathophenanthroline to lower field and the new set of peaks 
belonging to the coordinated axial pyridine derivative indicated that the reaction was 
complete.
Unfortunately, when compound 2.5 (3-TBD0 (CH2)30C0 CH2Py) was used as an axial 
ligand, a mixture of complexes was obtained, including the expected product. Mass 
spectrometry confirmed its formation: (ESI) 1070.3 [M]+, 870.1 [M-C0 (CH2)30TBD]+,
761.1 [M-PyCH20C0 (CH2)30TBD]+ with a good match to the expected isotope pattern. 
However, further attempts to purify the product by precipitation or washing with a variety 
of solvents were unsuccessful.
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r=N
3.15b
i: Py, MeOH 45 % «zj> 3.16
i: 3-HOCH2Py, MeOH 43 % O  3.17
i: 3-TBDCKCH2)30C0 CH2Py (2.5), MeOH=> 3.18
Scheme 3.24. Synthesis of complexes 3.16,3.17 and 3.18.
In order to demonstrate the possibility of further functionalisation of the complexes once a 
pyridine derivative was coordinated, compound 3.17 was reacted with mystiric acid in the 
presence of EDCI and DMAP in DCM, giving a much more lipophilic complex than the 
three previously synthesised analogues, Scheme 3.23. In the JH-NMR spectrum, the 
observed shift of the methylene protons (7) from 4.38 to 4.83 ppm was indicative of the 
success of the reaction; further characterisation corroborated this result.
3.19
OH
=N
3.17
i: Mystiric acid, EDCI, DMAP, DCM, 62 %
Scheme 3.25. Coupling reaction of the preformed complex 3.17.
After having synthesised a variety of sulphonated rhenium complexes as 
tetrabutylammonium salts, the recovery of the water solubility was then achieved using ion
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exchange chromatography with Amberlite IR 120-H, as the ammonium form. Therefore 
final complexes were obtained as the water-soluble ammonium salts.
3.5 The “Self Destruction" Experim ent.
3.5.1 SOB: self destructing device.
Due to the lack of success in synthesising the rhenium complex bearing ligand 3.2 and also 
the ease of the ester hydrolysis reaction observed for complex 3.7 (a functionalised 
terpyridine), no attempts to measure the cyclisation rate were undertaken for these 
complexes.
3.5.2 NOr-derivatives: self-destructing device.
The procedure followed to study the self destruction mechanism of the NO2 derivatives 
entails the use of NADPH* in stoichiometric amounts to provide the hydride needed for the 
reduction of the nitro group and the enzyme nitroreductase as a catalyst. Changes of 
NADPH absorption bands in the UV spectrum would indicate the reduction of the nitro 
groups but it would not confirm whether the cyclisation reaction has taken place or not, 
Scheme 3.26. ‘H-NMR spectroscopy is needed to demonstrate the presence of species a, 
therefore the experiments need to be done on a considerably larger scale than if using UV 
techniques. Unfortunately, high concentrations of substrates inhibit the enzyme, nitro­
reductase, and in addition, complexes 3.8 and 3.9 undergo easy hydrolysis, a reaction 
indicating their unsuitability for use in biological media, so no “self destruction” 
experiments were carried out with these targets either.
c NADPH: Nicotinamide adenine dinucleotide phosphate, the reduced from of NADP\ provides the reducing 
equivalents for oxidation-reduction reactions. Both forms absorb strongly in the ultraviolet due to the adenine 
base. The difference in the ultraviolet absorption spectra between the oxidized and reduced forms makes it 
simple to measure the conversion of one to another, and therefore the percentage of reaction conversion.
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C, N 7/ 
\/
nitroreductase OC— Re— N 
NADPH/NADP+ 00
UV spectroscopy 
monitor the reduction
OC— R e— N OH + Q
H a
*H-NMR spectroscopy 
needed to confirm 
cyclisation
HO-N
Scheme 3M . Sensing processes for complexes whose sensor is a nitro group.
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3.6 Photophysical Studies.
The fluorescence behaviour of the complexes 3.6 - 3.9 and 3.16,3.17,3.19 was examined 
to assay their suitability for cell microscopy applications. Table 3.1 records the bands 
observed by UV spectroscopy, which correlate with the data reported in the literature for 
similar complexes.15 Two distinct absorption bands are observed for the two types of 
complexes, ligand n —>iC and MLCT (cbc(Re) —► x*(N-N)) transitions. The IL transitions 
occur between 213 nm and 336 nm for all the complexes, while the MLCT transitions 
occur at ca. 371 nm for the complexes bearing the terpyridine as the chromophore, red- 
shifted by around 10 nm for those complexes bearing the more conjugated 
bathophenanthroline system.
Complex *IL W n m , (e/dm3mor1cm 1) !MLCT, >*b*/nm, (e/dn^mol^cm'1)
3.6, 243 (9282), 292(8093) 358(1687)
3.7, 205 (8391), 264 (4095), 295 (3579) 375 (453)
3.8, 240 (11977), 254 (9911) 299 (9911) 376(1830)
3.9. 235 (22557), 260 (14839) 295 (11405) 374 (1546)
3.16b 231 (11325), 260 (11325), 285 (12297) 381(3205)
3.17b 235 (7888), 282 (7765) 382(4196)
3.19b 213 (30584), 292 (19711), 336 (6958) 391(3430)
a. CH3CN as solvent.
b. MeOH as solvent.
Table 3.1. Absorption bands of complexes 3.6-3.9 and 3.16,3.17,3.19.
The excitation and emission spectra for the same complexes were recorded in CH3CN for 
the terpyridine complexes and in MeOH or water for the bathophenanthroline derivatives. 
Table 3.2 summarises the values recorded for the excitation and emission maxima, which 
do not differ from those that are expected for complexes of the type, y&c-Re(NN)(CO)3L. 
All showed broad excitation maxima ranging from 360 to 396 nm and emission maxima 
ranging from 543 to 585 nm, originating from the lowest energy 3MLCT (drc(Re) —► x*(N- 
N)) excited state.
An important conclusion can be drawn comparing the emission and excitation values given 
by both types of complexes, the hydroxyterpyridine derivative complexes 3.6 - 3.9, and the 
water soluble extended n a-diimine complexes, 3.16, 3.17 and 3.19. The self-destruction
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device is more effective when placed on the a-diimine than when on the axial ligand, i.e. 
the luminescence of the complexes is significantly more affected after the self-destruction 
has taken place (compare the values of the destructed species 3.6, and complexes bearing 
the self destruction devise on the a-diimine 3.7, 3.8, and 3.9, with the destructed species
3.17 and 3.19, complex analogue to a species bearing a self destruction device in the axial 
ligand). This difference is presumably due to the modification of the electronic properties 
on the a-diimine which is directly implicated in the 3MLCT [cbt(Re) —► 7t*(diimine)] 
transition.
Complex Excitation X/nm Emission X/nm Lifetimes r/ns
3.6,* 385 585 —
3.7,** 393 563 —
3.8,** 360 543 —
3.9b** 370 559 —
3.16b 375 566 756c
3.17b* 378 563 764c
3.19b 393 558 2590c
a CHjCN as solvent, 
b MeOH as solvent, 
c Water as solvent.
** Complex bearing self destruction device.
* Complex after self destruction.
Table 3.2. Excitation, emission maxima and lifetimes for complexes 3.6 - 3.9 and 3.16,
3.17 and 3.19.
In addition, the lifetimes of the water soluble complexes 3.16, 3.17 and 3.19 were 
measured, see Table 3.2. The latter, which not only has the bathophenanthroline a- 
diimine, but also a C13 lipophilic chain, has a lifetime of 2.59 ps which is considerably 
larger than the lifetimes of species 3.16 and 3.17 (756 and 764 ns respectively). It is 
speculated that the lipophilic chain in the axial ligand is interacting with the a-diimine and 
thus affecting the relaxation and/or quenching processes of the complex, thus increasing 
the lifetime of the unit. This interaction could be driven by hydrophobic forces, making an 
interaction between the lipophilic chain and the bathophenanthroline unit favourable and 
thus protecting the excited state from solvent interactions.16 However, whether this 
interaction involves aggregation, micelle formation or unimolecular conformations has not 
been determined.
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Only a few examples of quantum yields of compounds of the general formula 
[Re(bisimXCO)3X] are available in the literature. Their values range from 0.7 in the case of 
isonitrile complexes of the type [Re(bisimXCO)3CNR]+ where R is a /-butyl or n-alkyl 
group16 to 0.0001 in [Re(4,4’-(N02)2bipyXC0)3Cl].1 A general trend is observed that an 
increase in the level of conjugation in the bisimide ligand increases the value of the 
quantum yield, as does as the introduction of electron donating groups. However, to arrive 
at a general estimate for these kinds of complexes based on the literature is not straight 
forward, as reported data shows great variations in quantum yield for apparently minor 
structural variations (<!>([Re(bipyXCO)3NCMe]+) = 0.015, OflReCphenXCO^NCPr]*) =
0.069).17 These variations imply either a very complex set of parameters which determine 
the overall value, or unreliability in the literature data. Unfortunately, it was not possible to 
carry out any quantum yield analysis of the novel rhenium complexes due to technical 
problems. Nevertheless, in an attempt to estimate some likely values for the range and 
variations in the quantum yields of these complexes, the data reported by Meyer1 in 1991 
were considered as the most useful and reliable guideline. These suggest that those cationic 
rhenium complexes bearing a pyridine derivative in the axial position would have greater 
quantum yields than the neutral analogous chloride complexes (d>([Re(bipy)(CO)3(4- 
EtPy)]*) = 0.18, <D([Re(bipyXCO)3Cl]) = 0.0045). In addition, complexes with an extended 
conjugated chelate ligand, such as the bathophenanthroline sulphonates, would also be 
expected to have greater quantum yield values than the less conjugated bipyridine 
complexes (<D([Re(bipyXCO)3Cl]) = 0.0045, <I>([Re(phenXCO)3Cl]) = 0.036).
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3.7 Discussion Of Crystal Structures
3.7.1 Crystalline structure of complex 3.6.d
Single crystals of complex [Re(OH-terpy)(CO)3Cl] suitable for X-ray crystallography were 
grown by the slow evaporation of an acetonitrile solution of the complex. Crystallographic 
refinement data are given in Table 3.3. The perspective ORTEP drawing of the complex 
3.6, with selected atomic numbering is shown in Figure 3.15 and selected bond lengths 
and angles are summarised in Table 3.4.
Figure 3.15. ORTEP representations of the structure of 3.10 with thermal ellipsoids drawn 
at the 50% level.
The rhenium coordination sphere can be described as a slightly distorted octahedron where 
the three carbonyl ligands are arranged in a facial geometry. The 4-hydroxyterpyridine and 
the two carbonyls tram  to it describe the equatorial plane. The third carbonyl and the 
chloride ligand are placed in the apical plane. Deviation from an ideal octahedron mostly 
originates from geometric restraints imposed by the chelate ligand with a chelate angle of 
N(5)Re(l)N(7): 74.9(3)° instead of the ideal angle of 90°. It is worth noting that the non­
coordinated pyridine has a torsion angle of 58.48° with respect to the two, almost coplanar,
d Crystal structure measured and solved by Richard Arthur at Cardiff University.
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coordinated pyridyl fragments, with the nitrogen pointing in the same direction as the Re- 
C1 bond.
N(7)
C(I4k
co 2/;
Re(l
C(l)
Figure 3.16. Mercury representation showing the chelate and torsion (pendant pyridyl) 
angles of complex 3.6.
The non-coordinated pyridine has intermolecular contact with three other species, see 
Figure 3.17. A contact exists between the nitrogen of the non-coordinated pyridyl in 
species A with the 6-hydrogen of another non-coordinated pyridyl from adjacent species 
A ’, N(1)H(16): 2.599 A. A third molecule, species B, also has a short interaction between 
the chlorine and the 3-hydrogen of the pendant pyridyl unit, C1(1)H(1A): 2.847 A. Finally 
a fourth species C interacts with the non-coordinated pyridyl unit via a contact between a 
carbonyl oxygen and the pyridyl 4-hydrogen, 0(5)H(7): 2.683 A. All of these interactions 
are presumably predominantly electrostatic as they are too long to be considered as
1Rconventional strong hydrogen bonds.
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H(7)
N(l) H(16)
H(1A)
Figure 3.17. Line drawing of complex 3.6 showing non-coordinated pyridyl 
intermolecular contacts with three surrounded species.
The distortion from planarity displayed by the chelate ligand between the two coordinated 
pyridyl rings (torsion angle N(7)-C(17)-C(9)-N(5): 7.34 °) can be rationalized as a packing 
effect. The environment and interaction of each of the coordinated pyridyl unit is different, 
presumably due to the hydroxyl substituents placed at the 4’ position. The hydroxyl moiety 
interacts with a chlorine atom from an adjacent molecule (blue highlight 3.050 A) as well 
as with a hydrogen from a second molecule (green highlight, 2.499 A) and finally with a 
pyridyl carbon from a third molecule which was omitted for clarity (red highlight, 3.217 
A), Figure 3.18.
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H(18)
  2.499 A
Figure 3.18. Mercury representation of complex 3.6 showing the intermolecular contacts 
of the hydroxyl group with the surrounding species: green-blue highlight shows interaction 
0(3)-Cl(l), green-grey highlight shows interaction 0(3)-H(18), green-red highlight shows 
interaction 0(3)-C(19).
The carbonyl bond distances at ca. 1.909 A and Re-Cl bond length at 2.517(2) A are 
consistent with those found for similar rhenium (I) tricarbonyl complexes. Selected bond 
lengths and angles are given in Table 3.4.
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Empirical Formula C26Hi6ClN407Re a (A) 6.5227(2)
Molecular weight 718.08 b(A) 10.4890(3)
Crystal system Triclinic c(A) 13.3433(4) A
Space group P-l «(°) 100.6910(10)
Volume (A3) 879.81(5) P(°) 92.6110(10)
Z 1 Y(°) 100.2530(10)
Table 33. Refinement data of complex 3.6.
Re(l)-C(4) 1.906(8) C(6)-Re(l)-N(5) 172.8(3)
Re(l)-C(5) 1.910(8) C(4)-Re(l)-N(7) 171.2(3)
Re(l)-C(6) 1.929(9) C(5)-Re(l)-N(7) 96.0(3)
Re(l)-N(5) 2.152(7) C(6)-Re(l)-N(7) 101.4(3)
Re(l)-N(7) 2.216(6) N(5)-Re(l)-N(7) 74.9(3)
Re(l)-Cl(l) 2.5187(19) C(4)-Re(l)-Cl(l) 94.6(2)
C(4)-Re(l)-C(5) 87.1(3) C(5>Re(l)-Cl(l) 178.2(2)
C(4)-Re(l)-C(6) 86.8(4) C(6)-Re(l)-Cl(l) 90.5(3)
C(5)-Re(l)-C(6) 89.2(3) N(5)-Re(l)-Cl(l) 82.95(18)
C(4)-Re(l )-N(5) 96.6(3) N(7)-Re(l)-Cl(l) 82.35(18)
C(5)-Re(l)-N(5) 97.3(3)
Table 3.4. Selected bond lengths (A) and angles (°) of complex 3.6.
3.7.2 Crystalline structure of complex 3.10.c
Slow evaporation of an acetonitrile solution of complex 3.10 afforded crystals suitable for 
analysis by X-ray diffraction techniques. Crystallographic refinement, selected bond length 
and angle data, and perspective ORTEP drawings of the complex, 3.6, with atomic 
numbering are given in Table 3.5, Table 3.6, Figure 3.19 and Figure 3.20 respectively. 
Complex 3.10 is formed by three distorted octahedral units, yac-[Re(Oterpy)(CO)3], where
* Crystal structure measured and solved by Richard Arthur at Cardiff University.
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the terpyridine molecules are acting as both bidentate ligands coordinated through nitrogen 
to one rhenium atom and as bridging molecule to form a triangular shape, see Figure 3.19.
0(15)
Ag(4)(
0(14)
Figure 3.19. ORTEP representations of the structure of 3.10 with thermal ellipsoids drawn 
at the 50% level.
In addition, the three pendant pyridyl units are attached to a silver atom located in the 
central position of the triangle formed by the rhenium units, see Figure 3.20. Its position is 
displaced by 0.516 A, from the plane formed by the three nitrogen atoms bound to it 
(Figure 2.21).
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Figure 3.20. ORTEP representations of the structure of 3.10 with thermal ellipsoids drawn 
at the 50% level.
Figure 3.21. Mercury representations o f the structure of 3.10. presenting the different 
distances along the cavity.
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The deviation from the ideal octahedral geometry in each rhenium unit mostly originates 
from geometric restraints imposed by the hydroxyterpyridine which not only behaves as a 
bridging molecule, binding a second rhenium unit through its axial position, but also as the 
ligand for silver. Therefore in each unit, the terpyridine displays two pyridine units bound 
to the rhenium in an almost coplanar relationship whereas the third pyridine is bound to 
Ag(I) see Figure 3.22.
N( Is!
7n\S47J  N<1>74 32 ,7621
Re<2)
i 1359
( ( 21)
C< 19)
Figure 3.22. Three rhenium units.
This combination of coordination geometries presents a cone shape that is ca. 7.3 A deep 
and 7.0 A wide, measured from the three nitrogen atoms at the top and bottom of the 
“cone” respectively, Figure 3.23. The silver atom defines the bottom of the cone and one 
of the chelated pyridyl units of each rhenium unit defines the base. Thus, overall the three 
triangular rhenium containing units are connected to form a conical vessel which is closed 
at one end by the AgPy3 unit to give a tetrametallic molecular basket.
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8.009 A 8.275 A
7.992 A 728 )
7.377 A
N(9|
4.014 A 3.606 A
M i l )
3.800 A
Figure 3.23. ORTEP representations of the structure of 3.10 inside of a cone to give a 
tetrametallic molecular basket perspective.
In order to describe the packing of complex 3.10. only one of the three rhenium units 
(Re(l)) is displayed to simplify the view of the structure and also to help understanding. 
The unit cell is formed by four complexes (AB-CD) where each pair is a mirror image and 
they are flipped 180° as indicated by the space group of the system (P2 I/C), see Figure
3.24
Figure 3.24. Packing of complex 3.10, viewed along a axis
The four units (AB-CD) are not aligned; they are placed in a zig-zag shape. Figure 3.25 
shows the packing of complex 3.10 with an increment in the number of units, 3 * (AB- 
CD), along the a axis.
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Figure 3.25. 3 x (AB-CD) units of complex 3.10.
The growth of units along the b axis shows the same pattern as in the previous case, i.e. 
four units (AB-CD) where each pair is a mirror image and they are flipped 180°. It can be 
seen easily when fragments are grown along axis b as in Figure 3.26.
c D
Figure 3.26. Complex 3.10 grown 2 x (AB-CD) on axis a and 2 x (AB-CD) on axis b.
Finally the growth of fragments along the c axis shows a pattern that does not differ from 
that observed in the a axis, i.e. the four units in the unit cell (AB-CD) are placed just 
over/below another four (AB-CD). Figure 3.27 shows the view along the axis a where 
there is a fragment growth o f 2 x (AB-CD) on axis b and 2 x (AB-CD) on axis c.
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f l
C D
(AB-CD) on axis c.
Em pirical Formula C54H3oAgClN90i2Re3 a (A) 13.468(3)
M olecular w eight 1698.79 b(A) 38.005(8)
Crystal system Monoclinic c(A) 13.015(3)
Space group P 2i/c «(°) 90
Volume (A3) 6277.55 P O 109.55(3)
Z 4 Y(°) 90
Table 3.5. Refinement data o f complex 3.10.
Re(l)-C(46) 1.897(17) Re(2)-N(18) 2.165(12)
Re(l)-C(7) 1.924(13) Re(3)-C(12) 1.882(16)
Re(l)-C(34) 1.945(18) Re(3)-C(47) 1.901(16)
R e(l)-0(7) 2.114(9) Re(3)-C(37) 1.928(17)
Re(l)-N(28) 2.149(12) Re(3)-0(3) 2.138(10)
Re(l)-N(8 ) 2.204(11) Re(3)-N(10) 2.186(12)
N(l)-Re(3) 2.186(10) N(28)-Re(l)-N(8) 74.6(4)
Re(2)-C(5) 1.876(15) N(2)-Re(2)-N(18) 76.0(4)
Re(2)-C(20) 1.897(16) N(10)-Re(3)-N(l) 75.7(4)
Re(2)-C(50) 1.96(2) N(ll)-Ag(4)-N(14) 125.7(4)
Re(2)-0(5) 2.115(9) N( 11)-Ag(4)-N(9) 113.5(4)
Re(2)-N(2) 2.159(11) N(14)-Ag(4)-N(9) 105.5(5)
Table 3.6. Selected bond lengths and angles of complex 3.10.
K B( D
Figure 3.27. Complex 3.10 growed 2 x (AB-CD) on axis b and 2 *
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3.8 T rirhen ium  Com plex, Expansion A ttem pts And Inclusions.
3.8.1 Synthesis.
Complex 3.10 is a rhenium “trimer” in a conical shape where a silver atom defines the 
bottom and one of the chelated pyridines of each rhenium unit, yac-[Re(Oterpy)(CO)3], 
defines the top or entrance to the cone. Its accidental synthesis was improved by the 
addition o f a base, triethylamine. The base helps the trimer formation by deprotonating the 
hydroxyl substituent of the terpyridine.
Figure 3.28. Complex 3.10 modified with a cartoon to help visualise the cavity in the 
tetrametallic basket.
3.8.2 Expansion attem pts.
The silver atom potentially acts as a template, preorganising the monomeric units in a 
favourable arrangement for formation of the complex. Therefore, several attempts were 
made to synthesise new polynuclear rhenium complexes using other metals besides silver. 
Selection of the possible template metals was made based on their preferred coordination 
geometries, i.e. only metals that could lead to an approximately planar geometry at the 
base o f the cup, possible if the metal allows a trigonal planar or distorted tetrahedral 
coordination were chosen. Unfortunately, even though a range of metals (Cul, ZnCh, 
NaBHO was used, none of the solids isolated from those reactions was the desired product. 
Their poor solubility and complicated 'H-NMR spectra, suggest a mixture of products, 
possibly polymers, which were impossible to characterize by standard methods.
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3 .83  Inclusions.
As the crystallographic data had demonstrated, complex 3.10 has a conical shape around
7.4 A deep and 8 A wide which may allow the inclusion of small linear molecules and 
more interestingly, given that 3.10 is luminescent, their sensing, if after the inclusion 
process there is a change in the photophysical properties of the whole unit. Therefore, this 
novel luminescent trirhenium complex could have important applications as a small 
molecules sensor, an important issue in safety and environmental chemistry, e.g. CN~, F  
etc. Three different substrates were chosen for the inclusion experiment: nitric oxide, 
known as being a signalling moleculef in the body as well as a toxic air pollutant, 3- 
(cyclopentadienyl-bis(triphenylphosphine)rutheniumpropionitrile, L(l) and 3-(4- 
(dimethylamino)phenyl)propionitrile, L(2) in order to mimic acetylene, which is a 
colorless, odorless and extremely flammable gas. These linear acetonitrile analogues not 
only should mimic the target linear molecules such as acetylene or cyanide and fit into the 
cavity of the complex, but could also coordinate to the silver ion, giving enhanced binding. 
Moreover, the high level of conjugation of these species might lead to a bigger change in 
luminescence of the whole unit upon inclusion of the guest molecule. Such an effect could 
arise from an electronic interaction (accepting or removing charge) with the emission states 
of the tetrametallic species.
(PhfeP
3-[(cyclopentadienylbis- 3-(4-(dimethylamino)phenyl)
(triphenylphosphine)ruthenium] propionitrile
propionitrile L(2)
L<1)
Figure 3.29. Chemical structure of L(l) and L(2).
After combining the two reagents, luminescence measurements were carried out to assess 
any change in the photophysical properties of the trimer, which could indicate the inclusion 
of the guest molecule. The experiments were carried out in neat acetonitrile in the first 
instance, then increasing the amount of water present up to a ratio of 1: 7 (acetonitrile:
f Species that transmit information between cells and regulate a diverse range of physiological and cellular 
processes.
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water) in order to enhance the inclusion of the guest in the cavity by hydrophobic forces. In 
the case of NO, the experiment was performed in a sealed cuvette due to the toxicity and 
air-sensitivity of the gas. Table 3.7 and Table 3.8 summarise the photophysical properties 
of the isolated and combined host and guests before and after the addition of water.
Complex Ex. X/nm Em. X/nm Host-guest Ex.
X/nm
Em. X/nm
3.10. 371 571
3.10(i:i) 372 571
3.10(1:3) 369 541
3.10(1:7) 370 541
L (l). 346 366,386 sh 3.10+ L (l), 371 573
344 569
Lflfcl:!) 345 391,412sh 3.10+ L(1)(1:1) 371 564
345 391,414* 3.10+L<1)(,:3) 371 544
3.10+L(1)(,:7) 371 544
L<2), 275 384,454 3.10+ L(2), 279 553
381 432,453 356 432, 553sh
381 453, 557sh
L(2Xl:l) 381 430,454 3.10+ L(2)(i:i) 275 430sh, 514
396 455,467sh, 577*
3.10+ L(2)(i^) 275 413
396 491
a CHjCN as solvent. 
(X:X):(CHjCN:H2Q) 
sh: shoulder
Table 3.7. Emission and excitation maxima of complex 3.10 when L(l) or L(2) are used as 
guest.
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Complex IL MLCT Host-guest IL MLCT
3.10. 260 354
3.10(i:i)
3.10(i:j)
3.10(1:7)
258 352
L<1). 214,291 3.10+ L(l)« 214sh,
240,
287sh,
356
m xisi) 206,229 3.10+ L(1)(1:1) 212,
234sh,
250sh,
299sh
360
L(2). 210,230, 
317, 359
3.10+ L(2). 237,314,
359
U2h:l) 204,230, 
332,359
a CH3CN as solvent. 
(X:X):(CH£N:H20) 
sh: shoulder
Table 3.8. Absorption bands of complex 3.10 when L(l) or L(2) is used as guests.
The excitation spectra of the trirhenium complex 3.10 showed a broad excitation band 
ranging from 280 to 395 nm with its excitation and emission maxima at 371 nm and 570 
nm respectively. Addition of the ruthenium complex does not lead to any significant 
change in the luminescent properties, and even the addition of water did not modify the 
luminescence as the observed blue shift of the emission to 544 nm is the same as observed 
for the complex 3.10 alone in water. On the other hand, the emission maximum from the 
ruthenium complex at 366 nm seems to disappear after mixing with complex 3.10. While 
this loss of emission from the guest could indicate inclusion, this was not taken as 
conclusive proof, and in any case the useful luminescence of the proposed sensor (complex 
3.10) could not be used to sense any such inclusion.
In the case of applying an organic compound (L2) as the guest, the maximum Re(I) 
3MLCT emission is shifted from 571 to 553 nm i.e. 18 nm blue-shift, immediately upon 
addition of the guest to an acetonitrile solution of complex 3.10. Addition of water to the 
mixture does not displace the maximum peak to 544 nm as in the previous experiments, 
indicating that, in this case, the complex has undergone a modification that affects its
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energetic levels. Moreover it is worth noticing that upon excitation at 279 nm, where both 
species absorb, the emission observed came only from complex 3.10, at 553 nm, which 
means that there had been a loss of emission from the guest, presumably due to an energy 
transfer from the organic ligand to the complex and therefore demonstrating a connection 
between both species.
Complex Excitation X/nm Emission X/nm Lifetimes x/ns
3.10. 371 571 21
3.10+NO 352,365,379,3% 542 10
3.10+NO (degassed) 352,365,379,395 530
3.10+NO (areated) 353,365,379,392 529
Table 3.9. Emission and excitation maxima of complex 3.10 when NO is used as guest.
The luminescent properties of the complex 3.10 are altered to a greater degree after the 
addition of NO to an acetonitrile solution. A blue shift of the emission maximum (from 
571 nm to 542 nm) as well as a more structured excitation spectrum8 is observed upon 
bubbling NO through an acetonitrile solution of the complex. Further degassing of the 
mixture, in order to get rid of the excess NO remaining in solution and allowing only the 
NO strongly encapsulated in the trimer cavity to remain, led to an even further blue shift in 
the emission maximum, 542 nm to 530 nm. On the other hand, a structured excitation 
spectrum was observed upon NO addition, whose intensity increased after degassing of the 
sample. These preliminary results could be interpreted as an indication of NO inclusion, 
which would provide a useful method of NO sensing. In an attempt to test the reversibility 
of the sensing process, i.e. if the removal of the guest molecule would lead to the 
recovering the initial luminescent properties of the complex, the sample was aerated. 
Unfortunately, neither a red shift in the emission maximum, nor a less structured excitation 
spectrum was observed, only a loss in emission intensity, therefore suggesting the process 
is irreversible, see Figure 330.
* A structured excitation spectrum indicates population of higher vibrational levels of the electronically 
excited state of the molecule and such transitions are vibronic.
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Excitation spectrum: T rimer + NO
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Trimer + NO 
Trimer + NO + degas.
Trimer+NO + Degas + aerate
Figure 330. Excitation spectrum of complex 3.10 (“trimer”) when NO is used as guest.
An additional study of the lifetime of complex 3.10 in the presence and absence of NO was 
carried out in order to further investigate the sensing process. However, due to the 
similarity of the values obtained, 21 ns for the complex alone and less than 10 ns in the 
case of the inclusion experiment, no conclusion could be drawn from this experiment.
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3.9 C onclusions.
Investigations into the modulation of the self-destruction rate of cyclisation, the 
luminescent properties and solubility of complexes of the type [Re(bisim)(CO)3L]n+, where 
L is a pyridine derivative (n = 1) or a chloride (n = 0), were discussed in this chapter.
i. Modulation of the self-destruction cyclisation rate led to the successful synthesis of 
a quinoline derivative which, unfortunately, did not coordinate to Re(I) and to a new range 
of terpyridine derivatives and their corresponding ^c-tricarbonylrhenium chloro- 
complexes. Unfortunately, the ease of hydrolysis upon coordination to the transition metal 
prevented these novel complexes from being used as biological fluorescent probes. 
Moreover, the fluxional behaviour of the terpyridine derivative in these complexes 
prevents successful inclusion of axial pyridine derivatives. But when a silver salt is used to 
abstract the chloride placed in the axial position, an unpredicted tetrametallic molecular 
basket is synthesised instead.
Attempts to increase the size of the cavity in the tetrametallic species by changing the 
central metal (Ag) were unsuccessful since a mixture of highly insoluble solids was 
obtained which were impossible to separate and characterize by standard methods. On the 
other hand, this tetrametallic species might be useful as a luminescent sensor for linear 
molecules, but the inclusion of molecules such as NO, 3 -(cyclopentadienyl- 
bis(triphenylphoposphine)rutheniumpropionitrile, and 3-(4-
(dimethylamino)phenyl)propionitrile promoted no reversible changes in its luminescent 
properties.
ii. Modulation of solubility was achieved by using bathophenanthroline sulphonate as 
a diimine ligand. Therefore, the synthesis of a range of novel water soluble rhenium 
complex of the type [Re(bisimXCO>3L]+, where L are pyridine derivatives with different 
lipophilicities, was accomplished.
These results indicate the viability of tuning the solubility of this kind of rhenium complex. 
However, it highlights the difficulty in increasing the cyclisation rate by conjugating the 
self-destruction device directly to an aromatic system, as this increases secondary 
processes such as ester hydrolysis, making the whole system unusable in biological media.
A possible solution might be to consider the insertion of a quencher in the chain of the self 
destruction device, which would not only accelerate the self-destruction mechanism by the
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Thorpe-Ingold effect but would also function as an switch on/off switch, making the 
recognition process easier, Schem e 3.27.
Improved Design
1-2
= N
OH
Analyte
N
/ R ^C O ) 3
— N
Non Luminescent Complex 
Switched O ff
Luminescent Complex 
Switched On
Sensor 
Quencher 
S03 Water solubility 
Schem e 3.27. An improved target designed following the results obtained in this chapter.
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3.10 Experim ental.
6-(4-leif-butyldimethylsilyloxybutanoate)quinoline (3.2).
To a mixture of EDCI (1.28 g, 6.68 mmol) and 
DMAP (408 mg, 3.34 mmol) in DCM (6  ml) was 
added a solution of 4-tert-
butyldimethylsilyloxybutanoic acid (2 .2 ) (0.66 g,
3.04 mmol) in DCM (2 ml) at 0 °C. After 15 min stirring at this temperature and under a 
nitrogen atmosphere, a suspension of 6-hydroxyquinoline (485 mg, 3.34 mmol) in DCM 
(4mL) was added to the reaction mixture, and stirring was continued at room temperature 
for 4 h. The mixture was diluted with sat. aq. NH4CI (24 ml) and an aqueous layer was 
extracted with Et20  (4 * 20 ml). The combined organic extracts were dried over MgSC>4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
column (petrol :ethyl acetate, 1:1) to provide 3.2 (232 mg, 20%) as a white crystalline solid, 
m.p. 150 °C. 8H (CDCI3) 8.82 (1H, m, CH(2)% 8.01 (2H, m, C/f(8,4)), 7.58 (1H, d, J=  2.5 
Hz, C//(5)), 7.35-7.4 (2H, m, C/f(3,7)), 3.68 (2H, t, J** 6.0 Hz, C//2(15)), 2.68 (2H, t, J  =
7.4 Hz, CH2( 13)), 1.92 (2H, m, CH2( 14)), 0.85 (9H, s, SiC(C//3)3), 0.0 (6H, s, Si(C/fe)2); 
8C (CDC13) 171.2 (C(12)), 149.2 (C(2)), 147.5 (C(6)), 145.2 (C(9)), 134.8 (C(4)), 129.9 
(C(8)), 127.5 (C(10)), 123.8 (C(7)), 120.5 (C(3)), 117.4 (C(5)), 60.7 (CH2(15)), 29.8 
(CH2(13)), 26.8 (CH2(14) ), 24.9 (SiC(CH3)3), 17.3 (SiC). V|Mx (CDC13) 1772 (CO); APCI
346.2 [MH]+.
l,5-bis(2’-pyridyl)pentane-l,3*5-trione (int.1).10
A solution of acetone (0.36 ml, 5.30 mmol) and ethyl 2- 
pyridine carboxylate (2.02 ml, 13.2 mol) in dry 1, 2 
dimethoxymethane (10 ml) was added very slowly and via 
syringe to a suspension of sodium hydride (0.83 g, 34.6 
mol) in dry DME (10 ml) maintained under a nitrogen atmosphere. It was stirred for 30 
minutes while the colour of the suspension changes from grey to orange. Then it was 
heated to reflux for 6 hours. The solvent was removed in vacuo using an external trap. The 
orange paste was carefully treated with 20 ml of cold water. The orange solution was 
filtered through Celite and the filtrate was adjusted to pH 7 using diluted hydrochloric acid. 
The yellow solid so obtained was collected by filtration and washed with water. Then it
13^^15 OTBD
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was dissolved in diethyl ether and dried over magnesium sulphate as this solid retains 
water tenaciously, (1.1 g, 52 % yield). Characterization already reported by Constable et 
al.10
2,6-Bis(2’-pyridyl)4-pyridone (int.2).10
A solution of l,5-bis(2’-pyridyl)pentane-l,3,5-trione (0.85 g,
3.13 mmol) and ammonium acetate (1.70 g, excess) in 
ethanol (25 ml) was heated to reflux for 6 hours. After this 
time the dark solution was concentrated to half volume. It 
was cooled and the yellow precipitate formed was washed 
with diethyl ether to afford a white solid which was recrystallised as white needles from 
ethanol. Occasionally other products may contaminate the crystals, and in these cases 
further purification by Kugelrohr is required (0.403 g, 46 % yield). 6H (CDCI3) 12.0 (1H, 
bs, O//), 8.75 (2H, d, J=  4.3 Hz, C//(6, 6” )), 7.9-7.8 (4H, in CH(3, 4, 3” , 4” )), 7.4 (2H, 
m, C//(5, 5” )), 7.12 (d, 2H J  = 1.7 Hz, CH(3\ 5’)). Characterization already reported by 
Constable et al.10
N.B. In complexes 33  -  3.9 the slight broadening of the signal for C//(6 ,6” ) leads to an 
apparent doublet, while the multiplicity of C//(4.4” ) indicates a V  coupling of ca. 1.6 Hz 
should be observed.
4-(4-#r/f-butyIdimethylsilyloxybutanoate)-2,6-bis(2’-pyridyI)-pyridme (33).
To a mixture of EDCI (0.13 g, 0.66 mmol) and DMAP 
(0.04 g, 0.31 mmol) in DCM (5 ml) was added a 
solution of 4-tert-butyldimethylsilyloxybutanoic acid 
(23) (0.16 g, 0.31 mmol) in DCM (3 ml) at 0 °C. After 
15 min stirring at this temperature and a under nitrogen 
atmosphere, a solution of 2,6-bis(2’-pyridyl)-4-pyridone 
(75 mg, 0.31 mmol) in DCM (3 ml) was added to the reaction mixture, and stirring was 
continued at room temperature for 1 h. The mixture was diluted with sat. aq. NH4CI (10 
ml) and an aqueous layer was extracted with Et20  (4 * 15 ml). The combined organic
5’
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extracts were dried over MgSC>4, filtered, and concentrated in vacuo. The residue was 
purified by flash chromatography column (ethanol: ethyl acetate, 1:3) obtaining 33 as a 
white solid, 26 mg, 20 % yield, m.p. 104 °C; 6H (CDC13) 8.60 (2H, d J  = 4.1 Hz, CH(6, 
6” ), 8.54 (2H, d, J  = 7.8 Hz, C//(3, 3” ), 8.18 (2H, s, CH(3\ 5’)), 7.79 (2H, t, J  = 7.8, 
C/f(4,4” )), 7.26 (2H, m, CH(5, 5” » , 3.62 (2H, t, 5.9 Hz, CH2(\ 1)), 2.65 (2H, t, J=  7.4 
Hz, CH2 (9)), 1.92 (2H, m, C//2(10)), 0.82 (9H, s, SKXCftfe), 0.00 (6H, s, Si(Ctf3)2); 6C 
(CDC13), 170.0 (CO), 158.8 (C(4’», 156.6 (C(2\ 6’)), 154.5 (C(2, 2” )), 148.1 (C(6, 6” )),
135.9 (C(4, 4” )), 123.0 (C(3, 3” )), 120.3 (C(5, 5” )), 113.4 (C(3\ 5’)), 60.8 (C(ll)), 29.9 
(CH2(9)), 26.9 (CH2(10)), 25.0 (SiC(CH3)3), 17.3 (SiQ, -6.3 (Si(CH3)2); Vmax (CHC13): 
1766 (CO); APC1450.2 [MH]+.
4-(2-nitrobenzoate-2,6-bis(2’-pyridyI)-pyridine (3.4).
2-nitrobenzoic acid (67 mg, 0.40 mmol) was added to a 
mixture of EDCI (168 mg, 0.8 mmol) and DMAP (54 mg,
0.40 mmol) in dry DCM (5 ml) at 0 °C. After 15 min 
stirring under a nitrogen atmosphere, a solution of 2,6- 
bis(2’-pyridyl)-4-pyridone (100 mg, 0.40 mmol) in dry 
DCM (3 ml) was added to a reaction mixture, and stirring 
was continued at room temperature for 12 h. The mixture 
was diluted with sat. aq. NH4CI (10 ml) and an aqueous 
layer was extracted with Et20  (4 * 20 ml). The organic layer was dried over MgSC>4, and 
concentrated in vacuo. The residue was purified by washing with ethanol affording the 
product as a white solid (75 mg, 47 %), m.p. 160 °C. 6H, (CDC13) 8.65 ( 2H, d, J=  4.7 Hz, 
C//(6, 6” )), 8.57 (2H, d, J = 7.8 Hz, CH(3, 3” )), 8.32 (2H, s, CH(3\ 5’)), 8.02 (1H, d ,J  =
7.9 Hz, CH(l 1)), 7.87 (2H, d, J  = 7.4 Hz C//(14)), 7.81 (2H, td, J  = 7.8, 1.7 Hz, C//(4, 
4” ), 7.75-7.65 (2H, m, C//(12,13)), 7.35-7.26 (2H, m, CH(5, 5” )). 8C (CDC13) 162.0 
(CO), 158.4 (C(4’)), 156.6 (C(2\ 6’)), 153.8 (C(2, 2” )), 147.9 (C(6, 6” )), 147.0 (C(10)),
136.2, 133.4, 131.4, 129.2, 125.9, 123.3 (C(3, 3” ), C(9)), 120.6 (C(5, 5” )), 113.2 (C(3\ 
5’)). Vmax (CHC13): 1761 (CO); APCI 399.1 [MH]+.
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4-(2-NitrophenyIethanoate-2,6-bis(2’-pyridyl)-pyridine (3.5).
2-Nitrophenylethanoic acid (76 mg, 0.4 mmol) was 
added to a mixture of EDCI (168 mg, 0.8 mmol) and 
DMAP (54 g, 0.4 mmol) in DCM (5 ml) at 0 °C affording 
a reddish solution. After 15 min stirring at this 
temperature and under a nitrogen atmosphere, a solution 
of 2,6-bis(2’-pyridyl)-4-pyridone (100 mg, 0.4 mmol) in 
DCM (3 ml) was added to a reaction mixture, and stirring 
was continued at room temperature for 3 h. The mixture 
was diluted with sat. NH4CI (15 ml) and an aqueous layer was extracted with Et20  (4 * 20 
ml). The combined organic extracts were dried over MgSC>4 and concentrated in vacuo. 
The light brown solid was purified by washing with methanol affording the product as a 
white solid (60 mg, 36 %), m.p. 119 °C. 5H (CDCI3) 8.63 (2H, d, J=  4.5 Hz, CH(6, 6” )), 
8.53 (2H, d, J  = 7.8 Hz, CH(3, 3” )), 8.19 (2H, s, CH(3\ 5’)), 8.14 (1H, d, J=  8.1 Hz, 
C //(ll)), 7.78 (2H, td, J=  7.8, 1.7 Hz, CH(4, 4” )) 7.60 (1H, m, C//(14)), 7.51-7.41 (2H, 
m, C//(13, 15)) 7.30 (2H, m, C//(5, 5” )), 4.25 (2H, s, CH(9)); 6C (CDC13) 166.4 (CO),
159.8 (C(4’)), 156.5 (C(2\ 6 ’)), 154.1 (C(2, 2” )), 148.0 (C(6 , 6 ” )), 147.6 (0(11)), 136.0 
(C(4, 4” )), 132.9, 132.5, 128.1, 127.9, 124.4(C(12)), 123.1 (C(3, 3” )), 120.4 (C(5, 5” )),
113.3 (C(3\ 5’)). Vmax (CHCI3): 1771 (CO); APC1413.1 [MH]+.
/iic-IRe(2,6-Bis(2’-pyndyl)-4-pyndmeKCO)3Cl](3.6).
Re(CO)5Cl (50 mg, 0.14 mmol) and 2,6-bis(2’-pyridyl)-4- 
pyridone (26 mg, 0.14 mmol) were heated at reflux in dry 
toluene (2.5 ml) for 1 hour. The yellow product precipitated 
from solution and was collected by filtration and washed with 
toluene (70 mg, 89 % yield), m.p. 160°C (decomposition).
6(H) (CD3CN) 8.98 (1H, d J=  5.5 Hz, C//(6)), 8.69 (1H, d, J  
•  4.6 Hz, C//(6” )), 8.30 (1H, d, J =  7.8 Hz, C//(3)), 8.11 (1H, 
td, J = , 7.8, 1.2 Hz, C//(4)), 7.85 (1H, td, J  = 7.8, 1.6 Hz, CH(4” )), 7.82 (1H, d, J =  2.4 
Hz, C//(3’)), 7.68 (1H, d, J=  7.8 Hz, C//(3” )X 7.52 (1H, m, C//(5)), 7.46 (1H, m, C(5” )X 
7.12 (1H d, J  = 2.4 Hz, CH(5y)); 6C, (CD3CN) 166.2, 162.9, 158.3, 157.9, 156.4, 152.4,
149.0, 139.4, 136.4, 126.7, 124.8, 124.4, 124.0, 114.5, 111.1, vmax (CH3CN): 2020, 1915,
OC Re— N
n r  CO /
o c  n= 6 '
OH
3.6
O NO;
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1892 (CO), Vm, (Nujol): 2019, 1888 (CO); m/z (ESI) 560.9. [M-C1+CH3CN]+, 556.0 
[MH]+, 520.0 [M-C1]+, 492.0 [M-Cl-CO]+, 464.0 [M-Cl-2CO]+, 436.0 [M-Cl-3CO]+. 
Theoretical isotope pattern [M-C1+CH3CN]+ 559.1 (58%), 560.1 (12%), 561.1 (100%),
562.1 (21%), 563.1 (3%), [M-Cl] 518.0 (58%), 519.0 (11%), 520.0 (100%), 521.0 (20%),
522.0 (2%). Actual isotope pattern [M-C1+CH3CN]+ 559.0 (57%), 560.0 (11%), 560.9 
(98%), 561.9 (20%), 563.1 (5%), [M-Cl] 518.0 (60%), 519.0 (10%), 520.0 (100%), 520.9 
(20%), 522.0 (3%). HRMS (ESI) calculated [M-C1+CH3CN]+ = 559.0539, measured [M- 
C1+CH3CN]+ = 559.0545. X-ray: CitHisClN.OjRe, M = 718.08, yellow block, 0.2 * 0.2 x 
0.2 mm3, space group P-l, a = 6.5227(2) A, i  = 10.4890(3) A, c = 13.3433(4) A, a = 
100.6910(10)°, P = 92.6110(10)°, y = 100.2530(10)°, V= 879.81(5) A3,Z =  1,DC= 1.3551 
mg cm-3, F(000) = 348, Reflections collected = 13815, 4013 Reflections unique, R(int) = 
0.1758; Goodness-of-fit on F2 = 0.989, Final R indices [I>2sigma(I)]: R1 -  0.0566, wR2 = 
0.1439.
</oc-[Re(4-(4-/£rf-biityldiinetliylsilyloxybutanoate)-2,6-bis(2,-pyridyl)pyridineXCO)3 
Cl] (3.7).
Re(CO)5Cl (21 mg, 0.06 mmol) and 33  (26 
mg, 0.06 mmol) were heated at reflux in dry 
toluene (1 ml) for 4 hours. The yellow solution 
was cooled in an ice bath and a yellow 
precipitate formed which was collected by 
filtration, then purified by recrystallisation 
from hot toluene to give the title compound as 
a yellow solid (35 mg, 80 % yield), m.p. 170 °C. 5(H) (CDC13) 9.05 (1H, bd, J=  4.4 Hz 
CH(6)\ 8.76 (1H, bs, CH(6” )), 8.13-7.88 (5H, m, CH(3, 4, 3’, 3” , 4” )), 7.58 (1H, bs, 
C//(5’)), 7.40 (2H, m, C//(5, 5")), 3.68 (2H, t , J =  5.8 Hz, C//2(l 1)), 2.69 (2H, t, J  = 7.2 
Hz CH2(9)), 1.91 (2H, m, C//2(10)), 0.85 (s, 9H, SiC(C//3)3), 0.00 (6H, s, Si(C//3)2); 5(C) 
(CDC13) 195.6 (CO), 192.6 (CO), 189.0 (CO), 169.2, 162.7, 158.5, 157.7, 156.0, 155.3,
152.2, 148.4, 137.9, 136.3, 125.9, 124.6, 124.1, 122.9, 119.1, 114.5, 60.5 (C(ll)), 30.1 
(CH2(9)), 26.4 (CH2(10)), 24.9 (SiC(CH3)3), 17.3 (SiQ, -6.0 (Si(CH3)2); (CHC13):
2019, 1910, 1895, 1777, (CO); m/z (ESI) 720.1 [M-C1]+, 520.0 [M-Cl-CO(CH2)3OTBD]+,
592.0 [M-Cl-CO(CH2)3OTBD-CO]+. Theoretical isotope pattern [M-C1]+ 718.2 (55%),
719.2 (22%), 720.2 (100%), 721.2 (38%), 722.2 (12%). Actual isotope pattern [M-Cl]
OC-----Re— N
o p  CO / i  
0 0  N=C2'
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718.1 (54%), 719.1 (21%), 720.1 (100%), 721.1 (32%), 722.1 (10%). HRMS (ESI) 
calculated [M-C1]+ = 720.1534, measured [M-C1]+ = 720.1541.
/oc-[Re(4-(2-nitrobeiizoate)-2 ,6-bis(2 ’-pyridyl)pyridineXCO)3Cl] (3.8).
ReCOsCl (58mg, 0.16mmol) and one equivalent of
3.4 (64 mg, 0.16 mmol) were dissolved in toluene (4 
ml) and heated to 100 °C for 2 hours. The yellow 
solid precipitated from the solution was separated 
by filtration and washed with toluene, (68 mg, 60 % 
yield), m.p. 160 decompose. 6(H) (CDCI3) 9.05 (1H, 
d, J  = 5.0 Hz, CH(6)), 8.77 (1 H, d, J  = 4.5 Hz,
C//(6” )), 8.21-8.10 (4H, m, CH(3, 3” , 11, 14)), 7.94-7.72 (5H, m, C//(3,’4, 4” 12, 13)), 
7.67 (1H, d, J  = 2.03 Hz, CH(5’)), 7.49 (2 H, m, Ci/(5, 5” )), 6(C) (CDC13) 164.8(CO), 
162.7(C(4)), 159.5, 159.4, 157.4, 156.5, 153.5 (2C), 150.1, 139.4, 137.5, 134.5, 133.4,
130.6, 127.5, 126.3, 125.8, 125.6, 124.9, 124.7, 120.58, 116.17 v ^  (Nujol): 2024, 1928, 
1917 (CO); m/z (ESI) 710.1 [MH]+, 562.1 [M-COQRiCNC^f, 520.1 [M-CH3CN- 
C0 C6H4(N02 ) ] \ 491.1 [M-CH3CN-C0 C6H4(N02)-C0 ]+. Theoretical isotope pattern [M- 
BF4]+ 708.1 (60%), 709.1 (20%), 710.1 (100%), 711.1 (32%), 712.1 (7%). Actual isotope 
pattern [M-BF4]+ 708.1 (60%), 709.1 (19%), 710.1 (100%), 711.1 (33%), 712.1 (5%). 
HRMS (ESI) calculated [MH]+ = 708.0652, measured [MH]+ = 708.0656.
/<ic-[Re(4-(2-Nitrophenylethanoate)-2,6-bis(2’-pyridyl)pyridine)CO)3Cl] (3.9).
A solution ofRe(CO)5Cl (44 mg, 0.12 mmol) and
3.5 (50 mg, 0.12 mmol) in 3 ml of diy toluene 
was heated at 70 °C for 2 hours. The yellow solid 
precipitate was collected by filtration, washed 
with toluene and dried under vacuum (50 mg,
57% yield). 6(H) (CD3CN) 9.04 (1H, d, J  = 5.4 
Hz, C//(6)), 8.76 (1H, d, J  = 4.4 Hz, C//(6” )),
8.41 (1H, d, J=  8.1 Hz, C//(3)), 8.29 (1H, d, 7 =  2.3 Hz, Ci/(3’)), 8.19 (2H, m, C/f(12, 
3” )), 7.95 (1H, m, C//(14)), 7.80-7.55 (7H, m, CH(4, 5, 5’, 4” , 5” , 12, 13)), 4.37 (1H, s, 
C//(10)). 6(C) (CD3CN) 177.7(CO), 167.5(C(4)), 159.5, 152.6, 152.4, 149.3, 139.6, 136.5,
Re— N
OC---- Re— N
/=  ^ oc CO /  N = f 2 '
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136.3, 136.1, 134.6, 133.7, 129.1, 128.3, 127.9, 127.1, 125.0, 124.8, 120.0, 119.4, 116.3, 
111.13, 39.1(Cff2). Vum (Nujol): 2021, 1911, 1886, 1766 (CO); m/z (ESI) 719.1[MH]+,
683.1 [M-C1]+, 520.1 [M-C1-C0CH2C6H4(N02)]+, 492.1 ^C 1-C 0C H 2C6H4(N02-C0]+,
436.2 [M-C1-C0CH2C6H4(N02-3C0]+. Theoretical isotope pattern [M+H]+ 717.0 (50%),
718.0 (17%), 719.0 (100%), 720.0 (34%), 721.0 (35%), 722.0 (10%). Actual isotope 
pattern [M+H]+ 717.1 (29%), 718.1 (9%), 719.1 (68%), 720.1 (20%), 721.1 (21%), 722.1 
(11%). HRMS (ESI) calculated [M+H]+ = 717.0310, measured [M+H]+ = 717.0316.
/«c-[Re(2,6-Bis(2’-pyridyl)-4-oxypyriduieXCO)3]3AgCl, (3.10).
Silver tetrafluoroborate (63 mg, 0.3 mmol) was added 
to an acetonitrile (20 ml) solution of complex 3.6 (60 
mg, 0.1 mmol) and triethylamine (14 pi, 0.1 mmol).
After heating for two hours at 80 °C, the yellow 
solution was filtered through Celite. The solvent was 
then removed at high vacuum to give a yellow gel 
which was purified by washing with diethyl ether.
Finally the product was obtained as yellow crystals by 
slow evaporation of an acetonitrile solution (110 mg,
65 % yield). 5(H) (CD3CN) 8.89-8.83 (2H, m, CH(6, 6” )), 8.03-7.71 (3H, m, CH(3, 4, 
3” )), 7.69-7.91 (2H, m, C//(4” , 5” )), 7.41 (1H, m, CH(5)), 6.70 (2H, d, J  = 2.4 Hz 
C//(3’)), 6.47 (1H, d, J  = 2.4 Hz CH(5’)). 5(C) (CD3CN) 196.1 (CO*,), 195.9 (COap),
194.9 (CO), 176.6(C(4’)0), 162.9, 157.7, 157.0, 156.5, 153.1, 152.2, 150.1, 149.5, 140.2,
139.8, 137.7, 126.9, 126.1, 125.8, 124.9, 124.6, 123.9, 123.4, 115.8, 112.2. v,** (Nujol):
2016, 1888 (CO); m/z (ESI) 1664.8 [M-C1+H]+, 1145.5 [M-Cl-(Re(OterPy)(CO)3)]+, 597.8 
[M-Cl-2(Re(OterPy)(CO)3)-CO]+. Theoretical isotope pattern [M-C1+H]+, 1659.0 (8%),
1660.0 (3%), 1661.0 (43%), 1662.0 (25%), 1663.0 (95%), 1664.0 (58%), 1665.0 (100%)
1666.0 (59%), 1667.0 (48%), 1668.0 (24%), 1669.0 (9%). Actual isotope pattern [M- 
Cl+H]\ 1658.8 (7%), 1659.8 (5%), 1660.8 (42%), 1661.8 (26%), 1662.8 (90%), 1663.8 
(55%), 1664.8 (100%), 1665.8 (57%) 1666.8 (50%), 1667.8 (23%), 1668.8 (17%), 1669.8 
(3%). X-ray: C s^oA gC lN ^uRes, M  = 1698.79, yellow block, 0.2 * 0.2 * 0.2 mm3, 
space group P2i/c, a = 13.468(3) A, b = 38.005(8)A, c = 13.015(3) A, /? = 109.55(3)°, V — 
6277.55 A3, Z  = 4, Dc = 1.797 mg cm"3, F(000) = 3208, 40145 Reflections collected,
OC
Re— N
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12833 Reflections unique, R(int) = 0.0977; Goodness-of-fit on F2  = 1.161, Final R indices 
P>2sigma(I)]: RJ = 0.0751, wR2 = 0.1870.
[ 1,10-Bathophenanthroline sulphonate tetrabutylammonium salt] (3.13).19
An aqueous solution (1 ml) o f  tetrabutylammonium 
hydrogen sulfate (0.14 g, 0.42 mmol) was added to a 
solution o f bathophenanthroline disulfonic acid disodium 
salt hydrate (0 . 1 0  g, 0.18 mmol) in the same solvent ( 1  ml).
The resulting pink solution was extracted with DCM ( 4 x 2  
ml) and then dried with MgSC>4 . The removal o f  the solvent 
at high vacuum afforded 3.13 as a pink solid (0.172 g, 95 % 
yield), m.p. 58 °C. m/z (ESI) 732 [M+B114N]", 491 [M H]\
245 [B m N f Theoretical isotope pattern [M+B114N ]' 732.3 
(100%), 733.3 (50%), 734.3 (30%), 735.5 (7%). Actual isotope [M + B u ^ ] '732.3 (100%),
733.3 (49%), 734.3 (31%), 735.5 (8 %).
/hc-[Re(l,10-bathophenanthroline sulphonate)(CO)3 Cl](Bu4N) 2  (3.14).
To a suspension o f Re(CO)sCl (31 mg,
0.085 mmol) in dry toluene (2 ml) was 
added 3.13 ( 8 8  mg, 0.085 mmol). The 
mixture was heated for 2  h under N 2  
atmosphere to afford an orange gel. The 
solvent was decanted and the gel formed 
was washed several times with diethyl 
ether until it became a solid which was then dried under vacuum to give 3.14 as a yellow 
solid (92 mg, 84 % yield), m.p. 105 °C. SH (CD 3CN) 9.40 (2H, m, C//(2,9)), 8.02-7.85 
(6 H, m, 4C//(o), CH(5,6)), 7.62 (4H, m, 4C//(m )), 7.25 (2H, m, C//(3,8)), 3.09 (16H, m, 8  
x N C //2), 160 (16H, m, 8  x NCH2 C //2) 135 (16H, m, 8  x C/f2 CH3), 0.98 (24H, m, 8  x 
C //3). SC (CD3CN) 197.5 (COeq), 190.0 (COap), 152.4 , 150.1 (2C), 147.0, 146.0 (2C),
136.1, 135.1, 130.7, 130.6, 129.4 (2C), 128.7, 128.5, 128.4, 128.3, 127.8, 126.8 (2C),
126.7, 126.1 (2C), 125.2 (2C) 57.9, 22.9, 18.9, 12.5. v max (Nujol) 2018, 1910, 1883 (CO);. 
m/z (ESI) 1038.3 [M-Bu4N]\Theoretical isotope pattern [M-B114N ]' 1036.2 (47%), 1037.2
mm
3.14
r
„S0 3Bu4N+
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(25%), 1038.2 (100%), 1039.2 (52%), 1040.2 (50%), 1041.2 (30%), 1042.2 (8%). Actual 
isotope [M-BmN*]' 1036.3 (50%), 1037.3 (37%), 1038.3 (100%), 1039.3 (49%), 1040.3 
(50%), 1041.3 (20%), 1042.3 (10%).
fac- [ Re( 1,10-bathophenan throline sulphonateXCO)3C F3S03) (BU4N) (3.15a).
To a solution of 3.14 (100 mg, 0.07 
mmol) in DCM (3 ml) was added 10.45 
equivalents of trifluoromethylsulfonic 
acid (0.07 ml, 0.8 mmol) and the mixture 
was stirred for one hour under nitrogen 
atmosphere, then n-hexane was added 
using a pressure funnel until a yellow 
precipitate was formed. The solvent was 
removed via cannula and this operation was repeated twice in order to eliminate residual 
triflic acid. Finally, the solid was dried under vacuum to give 3.15a as a yellow powder 
(0.123 mg, 99 %). 8H (CD3OD) 9.52 (2H, d, 7 =  5.4 Hz, C//(2,9)), 8.15 - 7.63 (12H, m, 
C//(3,5,6,8), 4 x c H(o,m))9 3.13 (16H, m, 8 x NCH2\  1.56 (m, 16H, 8 x NCH2CHj) 1.32 
(16H, m, 8 x C//2CH3), 0.95 (24H, m, 8 x c//3). v,** (Nujol) 2030,1926,1902 (CO).
/oc-[Re(l ,1 0 -bathophenanthroline sulphonateXCO)3(CH3CN)](NH4) (3.15b).
3.14 (0.90 g, 0.70 mmol) and AgCF3S03 
(0.20 g, 0.74 mmol) were heated to 
reflux in CH3CN (30 ml) for 4 hours.
After 12 hours of further stirring at room 
temperature the white solid formed 
during the reaction was removed by 
filtration through Celite. Then the 
solvent was removed at high vacuum, 
and the yellow slurry was dissolved in a small amount of methanol to precipitate the excess 
of AgCF3S03 and/or AgCl formed during the reaction. The white solid was separated by 
filtration through Celite; this process was repeated twice. Finally a yellow solid was 
obtained after removing the solvent under a high vacuum, (0.70 g, 95 %), m.p. 163 °C. 6H
m m
m
3.15b
CF 3SO3
-=N
3.15a
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(CD3 OD) 9.54-946 (2H, m, C//(2,9», 8.6 (2H, s, CH(5,6)) 8.04-7.62 (10H, m, CH(3,8), 4 
x CH(o,m)\ 3.13 (16H, m, 8 x NCH2), 2.07 (2H, s, C//3)>, 1.94 (1H, s, Ctf3), 1.54 (m, 
16H, 8 x NCH2C//2), 1.32 (16H, m, 8 x C//2CH3), 0.93 (24H, m, 8 x CH3). (MeOH) 
2039, 1944 (CO).
yac-[Re(l,10-bathophenaiithroline sulphonateXCO)3Py](NH4) (3.16).
To a solution of 3.15a (O.lg, 0.07 mmol) in 
CH3CN (7 ml) was added 
diisopropylethylamine (0.7 ml, 0.4 mmol) 
and pyridine (0.06 ml, 0.7 mmol). After 
refluxing for five days under a nitrogen 
atmosphere the solvent was removed and the 
yellow solid was redissolved in the smallest 
possible volume of methanol. Dry diethyl 
ether was added until a precipitate formed 
then the supernatant liquid was removed via cannula and the remaining yellow solid was 
dried under high vacuum. The yellow solid was dissolved in the smallest possible volume 
of methanol and it was passed through an ion exchange column (Amberlite IR120 H resin 
as NH4* form) which had been previously washed with aqueous ammonia eluting with 
methanol/water. The yellow coloured fraction which eluted immediately was collected and 
evaporated and dried under vacuum to give 3.16 as a yellow solid (26 mg, 43 %) m.p. > 
150 °C. 8H (CD3OD) 9.72 (2H, m, CH(2,9)), 8.47 (2H, dd, J=3.62, 3.18, CH(2’,6 ’)) 8.09- 
7.92 (8H, m, 4 x CH(o,m)) 7.73 (1H, m, CH(4’)), 7.69-7.55 (4H, m, C77(3, 5, 6 , 8)) 7.25 
(2H, m, C tf(3\5’)). 8C (CD3OD) 197.1 (CO*,), 193.3 (COap), 155.0, 153.7, 153.6 (2C),
148.9, 148.5 (2C), 147.1 (2C), 141.6 (2C), 138.8, 137.2, 133.1 (2C), 131.5 (2C), 130.9 
(3C), 130.8 (2C), 129.1, 129.0, 128.7, 128.4, 128.2, 127.6 (2C). v max (Nujol) 3401, 2026, 
1893 (CO); m/z (FAB) 840.1 [MH2-NH4]+, 761.0 [MH2-Py-NH4]+ Theoretical isotope 
pattern [M]' 838.0 (57%), 839.0 (30%), 840.0 (100%), 841.0 (48%), 842.0 (16%), 843.0 
(5%). Actual isotope [M]* 838.1 (47%), 839.1 (37%), 840.1 (100%), 841.1 (40%), 842.1 
(17%), 843.1 (5%). HRMS (ESI-) calculated [M]‘ = 838.0098, measured [M]‘ = 838.0093.
m
m m
3.16
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/ac-[Re(l,10-bathophenanthroline sulphonateKCO>3PyCH2OH] [H4N] (3.17).
3-(Hydroxymethyl)pyridine (0.02 ml, 0.195 
mmol) and 3.15a (40 mg, 0.03 mmol) were 
heated at reflux in THF (5 ml) under a 
nitrogen atmosphere for a week followed by 
stirring for 2 more days. The solvent was 
removed under vacuum and the residue 
dissolved in the smallest volume possible of 
methanol to give a yellow solution. Dry 
diethyl ether was added until a precipitate 
formed then the supernatant liquid was removed via cannula and the remaining yellow 
solid was dried under high vacuum. The yellow solid was dissolved in the smallest 
possible volume of methanol and it was passed through an ion exchange column 
(Amberlite IR120 H resin as NH4* form) which had been previously washed with aqueous 
ammonia eluting with methanol. The yellow coloured fraction which eluted immediately 
was collected and evaporated and dried under vacuum to give 3.17 as a yellow solid (20 
mg, 46%), m.p. > 150 °C. 6H (CD3OD) 9.71 (2H, d, 4.83 Hz, CH(2,9)), 8.38 (1H, s, 
C//(2’)), 8.32 (1H, d, J=  4.95 Hz, CH{6 ’)), 8.05 (2H, d, 7 =  5.1 Hz, 2 x CH(o)) 7.95-8.01 
(3H, m, C//(4’), C//(5,6)), 7.93 (2H, d, J  = 6.7 Hz Hz, 2 x CH(o)) 7.55-7.7 (6H, m, 
C//(3,8) 4 x C//(m)), 7.18 (1H, m, CH{5’)), 4.38 (2H, s, PyC//20). 6C (CD3OD) 195.6 
(COeq), 191.4 (CO*), 154.4, 150.0 (2C), 150.7, 150.0, 147.4 (2C)„ 146.8, 146.4 (2C), 
141.2, 138.2 137.2, 135.7, 131.6, 130.0 (2C), 129.3 (3C), 129.2 (2C), 127.5, 127.4, 127.1,
126.6, 126.2, 126.1 (2C), 60.2. v ,^  (Nujol) 3414, 2028, 1906 (CO); m/z (FAB) 870.2
[MH2-NH4]+, 761.1 [MH2-PyCH20 -NH4]+. Theoretical isotope pattern [M]‘ 868.0 (55%),
869.0 (20%), 870.0 (100%), 871.0 (40%), 872.0 (18%), 873.0 (8%). Actual isotope [M]‘
868.2 (60%), 869.2 (23%), 870.2 (100%), 871.2 (40%), 872.2 (18%), 873.2 (4%). HRMS 
calculated [M] ‘ = 868.0203, measured [M]’ = 868.0204.
OH
=N
m
3.17
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/ac-[Re(l,10-bathophenanthroline sulphonate)(CO)3PyCH2OCO(CH2)l2CH3] [H4N] 
(3.19).
Mystiric acid (18 mg, 0.08 mmol) was 
added to a mixture of EDCI (26 mg, 0.1 
mmol) and DMAP (4 mg, 0.03 mmol) in 
dry DCM (5 ml) at 0 °C. After 15 min 
stirring under a nitrogen atmosphere, a 
solution of complex 3.17 (50 mg, 0.04 
mmol) in dry DCM (3 ml) was added to 
the reaction mixture, and stirring was 
continued at room temperature for 2 h.
The solvent was evaporated to dryness 
and the residue was washed with ethyl acetate to remove the excess of EDCI and DMAP. 
The yellow solid was dissolved in the smallest possible amount of methanol and it was 
passed through an ion exchange column (Amberlite IR120 H resin as NH^ form) which 
had been previously washed with aqueous ammonia eluting with methanol/water (1:1). The 
yellow coloured fraction which eluted immediately was collected and evaporated and dried 
under vacuum to give 3.18 as a yellow solid (27 mg, 62 %), m.p. 167 °C 6 H (CD3 OD) 9.71 
(2H, m C//(2,9)), 8.45 (1H, m, C//(6 ’)), 8.32 (1H, s, CH(T)\ 8.10-7.97 (8 H, m, 4 x 
CH(o), C//(3,5,6,8)) 7.78 (1H, dd, J =  1.5, 7.8 Hz C//(4’)), 7.69-7.70 (4H, m, 4 * C//(m)) 
7.25 (1H, t, J  = 7.8, 5.7 Hz, C//(5’)), 4.83 (2H, s, PyC//20), 2.03 (2H, t, J  = 7.4 Hz, 
CH( 10’)), 1.25-0.85 (22H, m, CH(\V-2V)\ 0.79 (2H, m, C//j(22)). 8 C (CD3 OD) 197.1 
(COeq), 192.9 (COap), 174.9 (CO(9)), 154.1, 152.6, 152.5 (2 C), 152.2, 147.0, 145.0, 143.7, 
140.4, 138.1, 131.9, 130.9, 130.6, 130.3, 129.8, 129.6, 128.1, 127.9, 127.6 (2C), 127.4 
(3C), 127.2, 127.1, 126.8 (2C), 126.6, 126.2, 62.6 (PyCH20), 33.9 (C(10)), 32.4 (C( 11)), 
30.0, 29.9 (2C), 29.7 (2C), 29.4, 29.1 (2C), 25.1 (C(20)), 23.0 (C(21)), 13.7 (C(22)). vmax 
(CH3 CN) 2030, 1826, 1738 (CO); m/z (ESI) 1080.3 [MH2 -NH4 ]+, 761.1 [MH2- 
PyCH2OCO(CH2)i2CH3-NR,]+. Theoretical isotope pattern [M]' 1078.2 (55%), 1079.2 
(30%), 1080.2 (100%), 1081.2 (58%), 1082.2 (38%), 1083.2 (6 %). Actual isotope pattern 
[M]‘ 1078.4 (42%), 1079.4 (45%), 1080.3 (100%), 1081.3 (60%), 1082.4 (21%), 1083.3 
(2%).
10-21
r=N
m
3.19
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4.1 Introduction.
4.1.1 Thiol-reactive transition metal complexes.
Thiol-selective compounds allow specific labelling of proteins due to the low number of 
free sulfhydryl groups present in proteins in comparison to an abundance of amino groups. 
Fluorophores such as maleimide derivatives of fluorescein, rhodamine and pyrene are 
traditionally used for this purpose; however these compounds have several drawbacks in 
their use as they are photochemically unstable, require UV excitation and have short 
lifetimes (less than 100 ns). In 1997, Lakowicz and co-workers1 synthesised the first 
sulfhydryl reactive metal complex [Ru(2,2’-bipyridine)2( 1,10-phenanthroline-5- 
maleimide)](PF6)2, which had far more suitable photophysical properties for use as a probe 
for biological molecules, i.e. a long lifetime (1.1 ps) and a large Stokes’ shift (145 nm) as 
well as being photochemically stable. Scheme 4.1 depicts the use of the ruthenium 
complex to label a variety of proteins such as Human Serum Albumin (HSA)a, p- 
galactosidaseb or Immunoglobin G (IgG)c.
HSA: Human serum albumin 
IgG: Immunoglobulin G
Scheme 4.1. First example of a thiol reactive transition metal complex.
The photophysical features of the metal complexes allow an increase in the sensitivity of 
detection and measurement. This then permits time gating, a technique that removes the 
autofluorescence of biological samples which typically have a lifetime of less than 10 ns, 
interfering with the fluorescence from the metal complex. Studies of the microsecond
• Blood protein produced by the liver whose function is to maintain the osmotic pressure. 
fc Enzyme that catalyses the hydrolysis o f P-galactosides to monosaccharide.
c Protein with four subunits (immunoglobulin) distributed equally in blood and tissues whose function is to 
protect the body against phatogens.
Protein"-1
Phosphate 
buffer, pH= 6.5
(bipy)2Ru,(bipyJaRu
HSA, 
p-galactosidase 
or IgGMaleimide(fluorescein
derivative)
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dynamics of proteins can be carried out using these probes as they display high 
fluorescence anisotropy in the absence of rotational diffusion. Anisotropy decay data are 
used to determine rotational correlation times of the proteins, which show local probe 
motions in addition to overall rotational diffusion.
Chemically, the reaction described in Scheme 4.1 between the sulfhydryl reactive metal 
complex and the protein fragment is known as a Michael addition or 1,4-nucleophilic 
addition, involving nucleophilic attack at an a,P-unsaturated carbonyl group. Thiol and 
amine groups are both able to react with a,P-unsaturated systems but in different ways 
defined by the hard-soft acid-base theory which classifies RNH2 as a hard base and RSH 
as a soft base. Therefore, RNH2 will react with hard electrophiles, such as the carbonyl 
carbon, whereas RSH will react with soft electrophiles, such as the Cp. Moreover, thiol 
groups tend to react more quickly as they are better nucleophiles due to the softer character 
that facilitates polarization, Figure 4.1.
Soft
electrophile
Hard
electrophile
\
RSH: Soft nucleophile 
R2NH: Hard nucleophile 
R: Generic hydrocarbon chain
RSH + r
O
R2NH + R
O
SR O
Figure 4.1. The relative reactivities of RSH and R2NH in Michael additions.
4.1.2 Chloro and iodo derivatives as sulfhydryl reactive groups.
A further series of thiol-reactive metal complex probes was described by Lakowicz and co- 
workers.2 Known thiol reactive groups such as chloro- and iodo-methyl groups on the 
ligand were used as triggers instead of relying on organic fluorophores already in use for 
this purpose. Two examples of these complexes are shown in Figure 4.2.
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r Nr -9 o
HI
[Ru(bipy)2(phen-CIA)J2+ [Ru(bipy)2(phen-IA)]2+
Figure 4.2. Thiol selective Ru(II) complexes.
Not only Ru(II) complexes were found to be suitable for this purpose, but also [Re(CO)3(a- 
diimide)]+ complexes (Figure 43)3 which, based on physical properties such as 
luminescence lifetime, Stokes’ shift, quantum yield and anisotropy data, were found to be 
suitable compounds for labelling free thiol groups in proteins. It is worth noting that the 
thiol reactive groups are also able to react with amine groups. However, the rate of the 
reaction for amine derivatives is much slower than for the thiol analogues as the amine 
moieties become more strongly solvated due to their smaller size and higher charge 
concentration thereby inhibiting the reaction path.
The work carried out on both the rhenium and ruthenium complexes has opened a new 
door for the use of transition metal complexes in biophysics and clinical chemistry.
CI(OC)3 Re;
Re(CO)3(phen-IA)Cl
Figure 43. A thiol selective Re(I) complex.
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4.2 Design O f A New Rhenium  Thiol-R eactive Fluorophore.
While numerous luminescent metal complexes have been synthesised and characterised, 
only a few have been prepared with suitable reactive groups present that would allow 
selective binding to proteins. Thus, the aim of the work described in this chapter is to 
investigate novel approaches to the synthesis of a rhenium complex which can react 
selectively with sulfhydryl residues.
4.2.1 The target structure o f the thiol-reactive fluorophore.
Following the guidelines established by Lakowicz the design of the thiol selective 
luminescent metal complex bearing a thiol-reactive group such as a halogen on a ligand 
was made. In particular, this work will describe such a compound comprised of a 
luminescent rhenium complex bearing a chloromethyl group susceptible to attack by free 
thiols. The specific target is shown in Scheme 4.2.
Cl
'N* 1 
1+
/ Re(CO)3 R: Generic hydrocarbon chain,
r \  ^  or biological entity
SR
A
Scheme 4.2. Designed target (A) to comply with the thiol selectivity.
43.2 Retrosynthetic analysis.
Using the same retrosynthetic analysis4 presented in Chapter 2 (see Scheme 2.4) the 
rhenium metal complex depicted in Scheme 4.2 was designed. For the axial ligand, two 
options were considered: introduce the preformed chloromethylated axial ligand, which is 
commercially available as a hydrochloride salt, to the metal centre (Option A, Scheme 
4 3 ); or chlorinate a reactive fragment on the ligand already coordinated to the metal, 
typically an alcohol group (Option B, Scheme 43).
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Cl
N
I
/Re(CO)3
// N N=(/
^ //
n c c h 3
Re(CO )3
+
Option A
OH +
n c c h 3
Re(CO)3
+
Scheme 43. Retosynthetic analysis of two possible routes for the axial ligand.
Option B
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4 3  R esults And D iscussion.
43.1 Approach towards a thiol-reactive Re complex using a prefabricated 
chlorinated ligand.
After carefully analysing the two options to reach the final target, a direct substitution 
reaction using the prefabricated chlorinated ligand was chosen for the first attempt, as the 
conditions for chlorination of alcohols are often harsh. The initial steps of the synthesis 
have been recorded in Chapter 2. A brief scheme of the reactions performed can be seen 
below.
Cl
ReCO«Cl _1
2.7
ii
2.8
i: bipy, toluene, 
98% 
ii: AgBF4, CH3CN, 
8 8 %
Scheme 4.4. Brief scheme of the reactions performed to synthesise the activated rhenium 
complex, 2.8 (i: formation of rhenium chelated adduct (2.7), ii: chloride abstraction).
Substitution of the labile axial acetonitrile ligand using the commercially available picolyl 
chloride was attempted using standard conditions, Scheme 4.5. However, the reaction of 
the activated species, 2.8, with the prefabricated chloride ligand, PyC^ClHCl, in 
presence of a base, Et3N, did not lead to the desired target, but instead, it gave an 
unexpected product, the precursor [Re(bipyXCO)3Cl], 2.7. Faced with this surprising 
result, the structure of the product obtained was carefully analysed using *H-NMR and IR 
spectroscopy by comparison with that of an authentic rhenium chloride adduct, 
[Refl>ipyXCO)3Cl], Figure 4.4.
NCCH3
Re(CO)3
(BF4)- /
I
Re(CO)3 
N N =>
i: PyCH2Cl HCl, Et3N, THF
(b f 4)-
Scheme 4.5. Unsuccessful acetonitrile substitution.
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n c c h 3
/ Re(CO) 3
- C K 7
4 3 3 4
2.8
+
(BF4y
ii
:: 2.7
Reported data for 2.7 *H-NMR 
6 (ppm): CDC13
9.0 (2H, d, C(6»
8.15 (2H, d, C(3))
8.0 (2H, t, C(4))
7.50 (2H, m, C(5))
6 3 II 4 5 1
n i l  i
_____ /L_ _Jl____ J 4 5 1 .........1
1-  1 1 1
9.0 8.5 8.0 7.5
!H-NMR spectrum of complex 2.8, the 
starting material of the reaction
"1. .. 1 .  1 1 -
9.0 8.5 8.0 7.5
*H-NMR spectrum of final product from 
the reaction of 2.8 and PyCH2ClHCl
Figure 4.4. 'H-NMR spectra of the starting material and product from the reaction of 2.8 
and PyCTfeCFHCl. Spectroscopic data of complex 2.7, [Re(bipyXCO)3Cl].
This unexpected reactivity can be explained by the small steric demand of the chloride ion 
as a nucleophile in comparison with the bulky pyridine derivative. In order to overcome 
this problem, silver tetrafluoroborate was introduced into the reaction mixture to 
precipitate the chloride ion as the silver salt. However, once again, the same product, 
[Re(bipyXCO)3Cl], was recovered from the reaction mixture. It is probable that the excess 
pyridine coordinates to the silver, solubilising the cation, leaving the chloride ions in 
solution and therefore available to react with the rhenium complex to form complex 2.7.
In a final attempt to eliminate any possible chloride ions form the reaction mixture, the 
picolyl chloride was pre-treated with silver tetrafluoroborate. Both reagents were dissolved 
in dry IPA and after precipitation of a white solid, assumed to be AgCl, the colourless 
solution was transferred, via cannula, into a second IPA solution of 
[Re(bipyXCO)3CH3CN]BF4, 2 .8 , and triethylamine (Et3N), Scheme 4.6.
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N
HC1
Cl
+ AgBF4 N
HBF4
Cl
+ AgCl
• transferred via cannula
♦
NCCH
Re(CO)3
“1 +
N
I
/ Re(CO)3
(b f 4>- (b f 4>-
2 . 8  « - x = /  >------- '  - i
Scheme 4.6. Attempted substitution of the acetonitrile ligand in complex 2.9.
Unfortunately, [Re(bipy)(CO)3Cl], 2.7, was, once again, the main product recovered from 
this reaction. The only explanation found for this unexpected result is the displacement of 
the chloride ion from the chloromethyl group. The coordination reaction of this chloride to 
the metal centre might be faster than the coordination of the desired pyridine derivative due 
to its smaller size, i.e. removing any electronic considerations.
43.2 Approach towards a thiol-reactive Re complex via a chlorination
Faced with the difficulty of displacing the acetonitrile with the pre-formed ligand, 
PyClfeCl-HCl, a second option was considered, entailing the synthesis of a complex 
bearing a reactive unit, an alcohol, and its subsequent tosylation, with tosyl chloride. The 
hydroxymethyl pyridine complex, 2.9, discussed in Chapter 2, was treated with tosyl 
chloride in the presence of a base, Et3N. After heating at reflux in DCM for 4 hours, 
surprisingly, the same result was obtained as in Section 43.1, that is, the formation of 
[Re(bipyXCO)3Cl], 2.7, along with decomposition products. Attempts to avoid the 
formation of complex 2.7, by addition of silver tetraflouroborate were unsuccessful, 
leading to a mixture of decomposition products, Scheme 4.7.
reaction.
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OH
2.9
OTs
Cl
I
m c o h  —
€ H 3
2.7
i: TsCl, Et3N, AgBF4, DCM 
Scheme 4.7. Attempted tosylation of 2.9.
This result can only be rationalized by activation of the pyridine ligand towards 
displacement during the reaction with the tosyl chloride. This reaction pathway is unusual 
and the mechanism is not clear. It is possible that the donor properties of the pyridine 
group decrease upon tosylation, making substitution for the chloride ion easier, Scheme 
4.8.
O-S
OH
TsCl
2.9
Re(CO)3
Scheme 4.8. Proposed mechanism of the displacement of the pyridine derivative for the 
chloride ion.
4 3 3  Approach towards a thiol reactive Re complex using thionyl chloride.
A recent report published by Coe et al. in 2007 prompted a revision of the proposed 
synthesis.5 In this report, by using thionyl bromide, a well know brominating reagent, the 
successful bromination of a similar system in 68 % yield was achieved, Scheme 4.9.
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OH
2.9
i: SOBr2 NH4PF6 
24h, rt, 68 %
Scheme 4.9. Bromination reaction.
Suprisingly, the harsher conditions described were the key to the synthesis of 
[Re(bipyXCO)3PyCH2Cl]PF6 , 4.1. Complex 4.1 was obtained in 78 % yield after stirring 
overnight at room temperature in neat thionyl choride followed by subsequent dropwise 
addition of a saturated aqueous solution of ammonium hexafluorophospate, NH4PF6. 
Scheme 4.10.
+OH
2.9 4.1
i: SOCl2> NH4PF6 (aq), 78 %
(pf6)-
Scheme 4.10. The synthesis of [Re(bipyXCO)3PyCH2Cl]PF6, 4.1.6
!H-NMR spectroscopy showed a shift of the methylene proton from 4.38 ppm to 4.58 ppm 
upon chlorination. These data agreed with those obtained by 13C-NMR, where a shift of the 
methylene carbon was observed from 59.6 to 41.1 ppm, a value typical for a chloromethyl 
group.7 Moreover, crystallographic studies corroborated the structure of complex 4.1, 
[Re(bipyXCO)3PyCH2Cl]PF6.
43.4 Crystal structure dicussion.d
Single crystals of complex [ReO>ipyXCO)3PyCH2Cl]PF6 were grown by the slow 
evaporation of a solution of the complex in chloroform. Crystallographic refinement data
* d Crystal structure measured and solved by Richard Arthur at Cardiff University.
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are given in Table 4.1. The perspective ORTEP drawing of the studied complex, 4.1, with 
atomic numbering is shown in Figure 4.5.
Figure 4.5. ORTEP representations o f the structure of 4.1 with thermal ellipsoids drawn at 
the 30 % level.
The three carbonyl ligands are arranged in a facial geometry and the rhenium coordination 
sphere can be described as a slightly distorted octahedron, where the chelate ligand, 
bipyridine, and two of the carbonyls trans to it form the equatorial plane. The third 
carbonyl and the chloromethylated pyridine ligand are placed in the apical plane. Deviation 
from ideal octahedral geometry (N(2)ReN(3): 75.01(2) instead of 90°) originates from the 
geometric restraints imposed by the chelate ligand,.
Selected bond lengths and angles are given in Table 4.2. The Re-C and Re-N bond 
distances are close to those reported for analogous rhenium structures [Re(bipy)(CO)3L], 
with L being a pyridine derivative. Only small differences in bond lengths were found on 
comparing complex 4.1 with its hydroxyl analogue, 2.9, probably because of the bulkier 
chloromethyl substituent. For example, the Re-N(3) bond length is 2.160(6) A in complex
4.1, whereas the distances between the same atoms in its analogue, 2.9, is 2.172 (4) A, 
perhaps due to the arrangement different interactions of the pyridine substituents that lead
Chapter 4
to a totally different packing. In particular, an intermolecular contact between the chlorine 
of one complex and the two equatorial carbonyl carbons of an adjacent complex was 
observed in the structure, Figure 4.7.
H(20A)
F(l)
H(19)
C(18)
*£536
C l(l)  ■
C(19)
Complex 4.1 Complex 2.9
Figure 4.6. Short interactions of pyridine substituents in complex 2.9 and complex 4.1.
■(18)
C l( l) C(19)
C( 19) 3 3 9 5 ^  CKl).>331
C(18)
Figure 4.7. Short interactions o f pyridine substituent in complex 4.1.
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Empirical
Formula
CuHuClFoNaOaPRe a (A) 13.7391(4)
Molecular
weight
698.95 b(A) 11.5590(4)
Crystal
system
Monoclinic c(A) 14.6082(5)
Space group P2,/c «(°) 90.00
Volume (A3) 2279.27(13) P(°) 100.743(2)
Z 4 Y(°) 90.00
Table 4.1. Collection and refinement data for complex 4.1.
Re-C(17) 1.914(9) C(18)-Re-C(19) 90.9(3)
Re-C(18) 1.918(8) C(17)-Re-N(3) 92.0(3)
Re-C(19) 1.922(8) C(18)-Re-N(3) 171.6(3)
Re-N(l) 2.225(6) C(19)-Re-N(3) 97.4(3)
Re-N(2) 2.172(6) C(17)-Re-N(2) 97.4(3)
Re-N(3) 2.160(6) C(18)-Re-N(2) 96.6(3)
C(17MX3) 1.156(10) C(19)-Re-N(2) 171.4(3)
C(18HX1) 1.152(9) N(3)-Re-N(2) 75.0(2)
C(19)-0(2) 1.145(9) C(17)-Re-N(l) 177.7(3)
C(3)-C(l) 1.636(13) C(18)-Re-N(l) 93.0(3)
C(1)-C1(1) 1.637(11) C(19)-Re-N(l) 91.6(3)
C(3)-C(1)-C1(1) 109.7(7) N(3)-Re-N(l) 86.4(2)
C(18)-Re-C(17) 88.8(3) N(2)-Re-N(l) 83.8(2)
Table 4 .2 . Selected bond length (A) and angles (°)for complex 4.1.
4.3.5 Photophysical studies of the chloromethyl complex 4.1
Prior to undertaking the study of the reactivity of the new chloromethyl rhenium complex,
4.1, its photophysical properties were analysed to confirm its suitability for biological 
imaging applications. The absorption properties of 4.1 do not differ from those expected of 
a cationic rhenium tricarbonyl bisimine, showing the typical MLCT as a broad band
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centred at 354 nm, with the maximum excitation at 364 nm and the emission maximum at 
551 nm. The large Stokes’ shift, 187 nm, will eliminate any self-quenching problems often 
found with commercially available probes such as Fluorescein, as well as allowing 
differentiation from interfering autofluorescence. The fluorescence lifetime of 131 ns is 
long in comparison with those of organic molecules, allowing the off-gating of any 
interfering autofluorescence from biological samples which typically display lifetimes in 
the order of 10 ns.
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4.4 Study Of The Reactivity Of Chloromethyl Complex 4.1.
Having successfully synthesised a choromethylpyridine substituted rhenium complex, 
whose photophysical properties make it suitable to be used as a biological probe, a variety 
of reactions with biologically relevant potential nucleophiles was then undertaken to test 
whether the desired thiol specificity had been replicated.
4.4.1 Reactivity with simple amino groups.
No reaction occurred between complex 4.1 and the esterified amino acid, leucine methyl 
ester hydrochloride, in the presence of a base after stirring for 2 days at room temperature 
in acetonitrile. Even heating at 50 °C for 5 days led to no formation of the expected 
product, Scheme 4.11.
Scheme 4.11. Attempted reaction of 4.1 with a leucine derivative.
On the contrary, when complex 4.1 was treated with two equivalents of isopropyl amine in 
acetonitrile, the reaction was complete after 4 days stirring at room temperature giving the 
amine adduct in an isolated yield of 77 %, Scheme 4.12. 'H-NMR and 13C-NMR 
spectroscopy confirmed the new structure in solution by the shift from 4.58 to 3.58 ppm 
and 41.1 to 45.3 ppm of the methylene group protons and carbon respectively. It is worth 
noting that the large chemical shift of the methylene group is probably due to anisotropy 
effects, le. even thought the methylene carbon has free rotation it may has as a preferred 
orientation with the proton pointing towards the bipyridine ligand because of steric effects.
COOMe
1 +
Re(CO) 3Re(CO) 3
i: Leucine methyl ester 
hydrochloride,
Et3N, CH3CN
4.1
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C T “N
I
RefCOfc
0- 0.
4.1
+
(PF6)*
c n fN
I
/Re(CO)3
C H 3
4.2
+
i: PrNH, CH3CN, 77 %
(pf6)-
Scheme 4.12. Reaction of 4.1 with isopropyl amine.
A more sterically hindered amine, cyclohexylamine, was then reacted with the 
chloromethylene complex, 4.1. Using the same conditions as in the synthesis of the 
isopropyl amine complex, the new product, 43, was synthesised successfully in 64 %
• 1   I ^ __yield. H-NMR and C-NMR spectroscopic studies showed the same trend in chemical 
shifts for the methylene constituents as observed for those in complex 4.2, i.e. a shift from 
4.58 to 3.38 ppm and 41.1 to 46.4 ppm respectively.
c r °N
I
RefCO)3
O h D .
4.1
i: C6H11NH2,CH3CN,64%i
43
Scheme 4.13. Reactivity of 4.1 with cyclohexylamine.
4.42 Reactivity of complex 4.1 with mixed N, S groups.
Having studied the reactivity of the chloromethyl complex, 4.1, with amino groups, the 
required thiol selectivity was tested using biologically relevant species containing both N 
and S moieties as potential nucleophiles. Cysteine methyl ester, a methylated amino acid 
with a thiol group, was chosen as the first mixed species to be tested with the studied 
complex, 4.1. Prior to the reaction, the amino acid was liberated from its hydrochloride salt 
as the free amine, then stirred with the chloromethyl complex, 4.1, in the presence of a
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base (Et3N) at room temperature for 1 hour until *H-NMR spectroscopy showed no starting 
material was left in the reaction mixture. A dark yellow solid was obtained after removing 
the solvent and washing the residue with water, Scheme 4.14.
SH
OMe
NH:
OMei or
4.1
i: Cys-methyl-ester, Et3N, CH3CN, 65 %
Scheme 4.14. Reactivity with Cys-methyl-ester.
A *H-NMR spectroscopic study showed a clear shift of the methylene protons from 4.58 to
3.50 ppm indicating the reaction had occurred. However, it is not certain which of the two 
possible nucleophiles, S or N, had reacted from !H-NMR spectroscopy alone, as a similar 
methylene shift was observed in the case of complexes 4.2 and 43 where N was the 
nucleophile. C-NMR spectral data revealed that S was, in this case, the only nucleophile 
that had undergone a SN2 reaction, as the methylene carbon resonated at 32.0 ppm in the 
final product, typical of the Ctt of a thioester,8 in contrast to a signal at 41.1 ppm for the 
starting material. In the case of complexes 4.2 and 43, the methylene carbon appears at
45.3 and 46.4 ppm respectively. Further characterization data are reported in the 
experimental section.
The fact that complex 4.1 had reacted selectively with a thiol group in the presence of both 
a thiol and an amine group represents a preliminary success in the search for a selective- 
thiol reactive complex. In order to confirm this result, a more complex biologically 
relevant thiol, reduced glutathione (GSH), was chosen in order to further demonstrate the 
selectivity of the chloromethyl complex 4.1. Figure 4.8.
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Glu
a L-glutathione: y-Glu-Cys-Gly
OH H .NH o
HS
OH
O
Gly
Figure 4.8. Structure of reduced glutathione.
L-Glutathione was treated with the chloromethyl complex 4.1 in the presence of a base, 
Et3N, in a mixture of degassed solvents (methanol, water). The desired glutathione 
complex was obtained as a yellow solid in 44 % yield.
4.1
i: reduced glutathione, Et3N, MeOH:H20 , 44 %
Scheme 4.15. Reactivity with L-glutathione.
Data from ^-NM R and 13C-NMR spectroscopy agreed with those reported for the 
cysteine complex 4.4, where the protons and carbon from the methylene group are 
observed at 3.62 and 38.9 ppm respectively, indicating once again selective nucleophilic 
attack of the thiol, Figure 4.9. Further characterization corroborating the structure of the 
new thiol complex 4.5 can be seen in detail in the experimental section, Section 4.7.
S —Glutathione Glutathione
Re(CO)3
1 +
Re(CO)3
or 1 +
,Re(CO)3
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6(C): 41.1 ppm
6(H): 4.58 ppm
4.1
S -C ys S—Glut
43 4.4 4.5
6(C): 45.3 ppm 6(C): 46.4 ppm 6(C): 35.2 ppm 8(C): 38.9 ppm
6(H): 3.38 ppm 6(H): 3.65 ppm 8(H): 3.50 ppm 8(H): 3.62 ppm
Figure 4.9. A summary of the !H-NMR and 13C-NMR spectroscopic data for the CH2 unit 
in 4.1 to 4.5.
These results show that not only has a new fluorescent thiol-reactive metal complex been 
synthesised, but also thiol selectivity has been demonstrated as in the presence of two 
nucleophiles, N and S, only S-alkylation is observed. This result is in concordance with the 
reactivity expected for these two species, where thiol compounds afford faster nucleophilic 
substitution reactions, S n 2 , than amino derivatives as they are better nucleophiles.
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4.5 Photophysical Studies Of Chloromethyl Complex 4.1 And Its 
Derivatives, Complexes 4.2-4.5.
The UV-visible absorption spectra of complexes 4.1 - 4.5 in CH3CN or MeOH, Table 43, 
exhibit an absorption band at ca. 350 nm. This band is assigned to metal-to-ligand charge- 
transfer (MLCT) d(ReI) —► Ji*(bipy) transitions, by analogy with previous studies on 
related complexes.9 Additionally, absorption bands between 247-319 nm have been 
assigned to spin-allowed intraligand (!IL) (n —► n )  (N-N and pyridine ligands) transitions.
Complex ^ ( W n m ) ‘MLCT ( W m n  )
4.1. 248, 268, 314 358
4.2. 260,318 350
4 3 . 260,318 349
4.4b 247,319 352
4.5b 246, 269, 309, 320 356
a. CHjCN as solvent.
b. MeOH as solvent.
Table 43. Electronic absorption spectral data for complexes 4.1 -  4.5.
The excitation and emission spectra were also recorded at room temperature in MeOH or 
CH3CN solutions. The excitation and emission maxima are placed at ca. 395 and 555 nm 
in the case of the amine adducts and at ca. 360 and 550 nm for the thiol adducts (Table 
4.4). In addition, luminescent lifetimes of complexes 4.4 and 4.5 were determined, 
showing values of 122 ns and 116 ns respectively. These excitation and emission 
properties, typical of a cationic rhenium tricarbonyl bisimine, together with their large 
Stokes’ shifts and the 100 nanosecond luminescent lifetimes suggest the phosphorescent 
nature of the emission, a 3MLCT [d7t(Re) —> 7i*(diimine)] transition.
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Complex Excitation A/nm Emission A/nm Lifetimes T/ns
4.2, 395 555 -
4 3 , 396 556 -
4.4b 360 550 122
4.5b 361 551 116
a CHjCN as solvent, 
b MeOH as solvent.
Table 4.4. Excitation, emission wavelengths and lifetimes for complexes 4.2 -  4.5.
4.6 Conclusions.
A thiol reactive rhenium complex, 4.1, has been synthesised and its thiol selectivity 
demonstrated by reacting the new probe with biologically relevant mixed nucleophilic 
species. Not only does it have a reasonably long fluorescence lifetime and large Stokes’ 
shift, but also affords derivatives with the same characteristics. This makes it a promising 
fluorescent probe for proteins in vivo: given the high concentration of reduced thiols in 
cells, the thiol adducts would be the major species present.
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4.7 Experimental.
/oc-[Re(bipyKCO)3PyCH2Cll(PF6), 4.1
A solution ofyac-[Re(bipy)(CO)3PyCH2OH](BF4), 2.5 (150 mg, 0.2 
mmol) in 3 ml of thionyl chloride was stirred under a nitrogen 
atmosphere overnight. The mixture was cooled in an ice bath and a 
saturated aqueous NH4PF6 solution was added very slowly, 
dropwise, with extremely rapid stirring until a yellow solid 
precipitate formed. The precipitate was separated from the mixture 
of solvents by filtration and washed several times with water to give 4.1 as a yellow solid 
(132 mg, 78 % yield), m.p. 180 °C. 8H (CD3CN) 9.18 (2H, d, J  = 5.4 Hz, C//(6) bipy),
8.42 (2H, d, J=  6.4 Hz, C//(3) bipy) 8.32 (3H, m, CH{2) Py, CH(4) bipy), 8.20 (1H, d, J=
5.5 Hz, C/f(6) Py), 7.91 (1H, d, J  = 4.5 Hz, C//(4) Py), 7.82 (2H, m, CH(5) bipy), 7.33 
(1H, m, CH(5) Py), 4.58 (2H, s, CH2). 8C (CD3CN) 195.0 (CO*,.), 191.2 (C(V ) 155.2 
(C(2), bipy), 153.4 (C(6), bipy),151.0, 151.1 (C(2), Py, C(6), Py), 140.7 (C(4), bipy), 139.0 
(C(4), Py), 136.6 (C(3), Py), 128.3 (C(3), bipy), 126.1 (C(5), Py), 124.2 (2C(5), bipy), 41.1 
(CH2). v^x (Nujol): 2027, 1922, 1895 (CO), m/z (ESI) 553.9 [MH]+ and 427.0 
[M-PF6-PyCH2Cl]+. Theoretical isotope pattern 552.0 (52%), 553.0 (11%), 554.0 (100%),
550.0 (22%), 556.0 (31%) and 557.0 (8%); observed isotope pattern 551.9 (50%), 552.9 
(11%), 553.9 (100%), 554.9 (22%), 556.0 (30%) and 557.0 (5%). HRMS (ESI) calculated 
[M-PF6]+ = 552.0248; measured [M-PF6]+ = 552.0252. ReC,9Hi403N3ClPF6 requires C, 
32.65; H, 2.02; N, 6.01; found C, 32.46; H, 1.92; N, 5.93%. X-ray: M=  698.95, yellow 
block, 0.2 x 0.2 x 0.2 mm, monoclinic, space group: P2 |/c, a = 13.7391(4) A, b = 
11.5590(4) A, c = 14.6082(5) A,f i=  100.743(2)°, V= 2279.27(13) A3, Z = 4, Dc = 1.934 
mg cm"3, F(000) = 1268, reflections collected = 33013, R(int) = 0.1529; Goodness-of-fit 
on F2 = 1.023, R1 = 0.0503, wR2 = 0.1094.
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/<ic-[Re(bipyKCO)3 PyCH 2NH ,Pr](PF6), 4.2.
2.5 equivalents of'propylam ine (17 ml, 0.17 mmol) was added 
to a solution ofyac-[Re(bipy)(CO)3 PyCH2 Cl](PF6), 4.1 (50 mg,
0.07 mmol) in acetonitrile (5 ml). The mixture was stirred for 3 
days stirring at room temperature and then the solvent was 
removed on a high vacuum line to afford a dark yellow slurry 
which was dissolved in THF. Diethyl ether was added dropwise 
to precipitate the product as a yellow solid (40 mg, 77 %), m.p.
98 °C. 5H (CD3CN) (ppm) 9.31 (2H d, J  = 5.2 Hz, CH(6) bipy), 8.49 (1H, s, CH(2) Py), 
8.40 (2H, d, 8.2 Hz, CH(3) bipy), 8.28 (2H, m, CH(4) bipy), 8.21 (1H, d, J =  7.1 Hz, 
CH(6) Py), 8.06 (1H, d, J =  7.1 Hz, CH(4) Py), 7.82 (3H, m, CH(5) bipy), 7.30 (1H, m, 
CH(5) Py), 3.82 (2H, s, CH2), 3.82 (1H, q, J=  6.3 Hz, CH), 1.30 (6 H, d, J=  6.3 Hz, CH3). 
5C (CD3CN) (ppm) 155.5 (C(3), Py), 153.8 (C(6 ), bipy), 152.2 (C(6 ), Py), 151.3 (C(2 ), 
Py), 141.0 (C(3), bipy), 140.5 (C(2), bipy), 139.6 (C(5), Py), 128.6 (C(4), bipy), 125.8 
(C(4), Py), 124.5 (C(5), bipy), 45.4(C(7)), 44.3 (C(9)), 14.3 (CH3). Vin»  (CH3CN): 2035, 
1931 (CO), m/z (ESI) 577.2 [MH]+ , 427.1 [M -PF 6-PyCH2NC(CH3)2]++. Theoretical 
isotope pattern 575.1 (60%), 576.1 (15%), 577.1 (100%), 578.1 (25%), 579.1 (4%), Actual 
isotope pattern 575.2 (65%), 576.2 (18%), 577.2 (100%), 578.2 (28%), 579.2 (5%), HRMS 
(ESI) calculated [M+PF6]+ = 721.0936, measured [M+PF6]+ = 721.0935.
/oc-[Re(bipyXCO)3 PyCH 2 NH(C 6 H „)](P F 6), 4 3 .
A mixture o f /ac-[Re(bipy)(CO)3 PyCH2 Cl](PF6), 4.1 
(50 mg, 0.07 mmol) and cyclohexylamine ( 2 0  ml, 0.17 
mmol) in acetonitrile (5 ml) was stirred for 3 days at 
room temperature. Then the solvent was removed on a 
high vacuum line to afford a dark yellow slurry which 
was dissolved in THF. Petroleum ether was added 
dropwise to precipitate the product as a yellow solid (35 
mg, 64 %). m.p. 95 °C. 8 H (CD 3CN) (ppm) 9.17 (2H, d, J  
d, J  = 8.1 Hz, CH(3) bipy), 8.30 (m, 2H, C //(4) bipy), 8.20 (s, 1H, CH(2) Py), 8.13 (d, 1H, 
J =  5.2 Hz, CH(6 ) Py), 7.82-7.78 (m, 3H, CH(4) py, CH(5) bipy), 7.22 (m, 1H, C(5) Py), 
3.65 (s, 2H, CH2\  2.17-0.91 (11H, m, Cy). 8 C (CD3CN) (ppm) 155.5 (C(3), Py), 153.6 
(C(6 ), bipy), 150.8 (C(6 ), Py), 149.8 (C(2), Py), 141.0 (C(3), bipy), 140.9 (C(2), bipy), 
138.9 (C(5), Py), 128.5 (C(4), bipy), 125.7 (C(4), Py), 124.3 (C(5), bipy), 55.3 (C(9)), 46.4
10 11
Re(CO) 3
= 4.9 Hz, CH(6) bipy,), 8.40 (2H,
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(C(7)), 32.8 (C(10)), 25.6 (C(12)), 24.2 (C( 11)). (CH3CN): 2035, 1929 (CO), m/z 
(ESI) 617.3 [MH]+ , 427.2 [M-PF6-PyCH2NH(C6Hn)]+. Theoretical isotope pattern 615.2 
(60%), 616.2 (18%), 617.2 (100%), 618.2 (30%), 619.2 (4%), Actual isotope pattern 615.2 
(62%), 616.3 (19%), 617.3 (100%), 618.3 (31%), 619.3 (4%), HRMS (ESI) calculated 
[MH]+ = 615.1528, measured [MH]+ = 615.1529.
/«c-[Re(bipyKCO>3PyCH2SCH2CH(NH2)COOMe](PF6), 4.4.
L-Cystine methyl ester (59 mg, 0.4 mmol) was added 
to a de-gassed solution of 5.1 (50 mg, 0.07 mmol) and 
triethylamine (0.04 ml, 0.3 mmol) in 10 ml of 
acetonitrile. After stirring for 1 h under a flow of 
nitrogen, the solvent was removed and the dark solid 
remaining was washed with water ( 2 x 2  ml) to afford
5.4 as a dark yellow solid (44 mg, 65.4 % yield), m.p.
185 °C. 6H (CD3CN) (ppm) 9.16 (2H, d, J=  5.3 Hz, CH(6) bipy), 8.28 (2H, d, J=  8.1 Hz, 
CH(3) bipy) 8.19 (2H, m, CH(4) bipy), 8.09 (1H, s, CH(2) Py), 8.03 (1H, d, J =  5.5 Hz, 
CH(6) Py), 7.70-7.75 (3H, m, CH(5) Py and CH(5) bipy), 7.18 (1H, m, CH(5) Py), 3.50 
(2H, s, CH2), 3.39 (1H, m, CH), 2.22-2.39 (2H, m, CH2(Cys)); 8C (CDCN3) (ppm) 195.3 
(COeq ), 192.3 (COap.) 155.6 (C(2), bipy), 153.8 (C(6), bipy), 151.6 (C(2), Py), 150.3 (C(6), 
Py), 141.0 (C(4), bipy), 140.1 (C(4), Py), 138.0 (C(3), Py), 128.7 (C(3), bipy), 126.2 (C(5), 
Py), 124.5 (C(5), bipy), 54.2 (CH), 51.5 (CH3), 35.2 (CH2), 32.0 (CH2(Cys)). v™* 
(CH3CN): 2036, 1931 (CO). m/z (ESI) 653.1 [MH]+ and 427.0
[M-PF6-PyCH2SCH2CH(NH2)COOMe]+. Theoretical isotope pattern 651.1 (55%), 652.1 
(18%), 653.1 (100%), 654.1 (29%) and 655.1 (10%), observed isotope pattern 651.1 
(58%), 652.1 (16%), 653.1 (100%), 654.1 (27%) and 655.1 (9%). HRMS (ESI) calculated 
[M-PF6]+ = 653.0863; measured [M -  PF6]+ = 653.0868.
4n=
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fac-
[Re(bipyXCO)3PyCH2SCH2CH[NHCO(CH2)2CH(NH2)COOH]CONHCH2COOH]
4.5.
L-Glutathione (44 mg, 0.14 mmol) was added to 
a yellow suspension of 4.1 (50 mg, 0.07 mmol), 
and triethylamine (0.04 ml, 0.28 mmol) 
introduced in 15 ml of de-gassed methanol.
Next, 3 ml of de-gassed water was added to the 
suspension, affording a dark solution, from 
which a dark precipitate appeared after a few 
minutes of stirring at 40 °C. The mixture of solvents was removed under vacuum and the 
dark solid remaining was dissolved in water, from which the impurities were filtered off. 
The solvent was then removed, and the residue was redissolved in the smallest possible 
volume of water and passed through an ion exchange column (Amberlite IR120 H resin, 
NRj+ form) that had previously been washed with aqueous ammonium chloride, eluting 
with water. The yellow coloured fraction that eluted immediately was collected, 
evaporated and dried under vacuum to give 4.5 as a yellow solid (26 mg, 44 % yield), m.p. 
168 °C. 8H (D2O) (ppm) 9.17 (2H, d, J  = 5.5 Hz, Cff(6) bipy), 8.22 (2H, d ,J =  8.2 Hz, 
CH(3) bipy) 8.08-8.10 (4H, m, CN(4) bipy, C//(6,2) Py), 7.62-7.69 (3H, m, CH(4) Py, 
CH(S) bipy), 7.08 (1H, t, J  = 7.7 Hz, CH(5) Py), 4.10 (1H, m, C//(3)), 3.62 (5H, m, 
PyC//2, C//2(2), CH(12)), 2.23-2.32 (4H, m, C//2(6), C//2(10)), 1.98 (2H, m, CH2( 11)). 8C 
(JhO) (ppm) 196.0 (COeq ), 192.0 (COap), 176.4 (4C(2COOH, 2CON), 174.9, 174.2,
171.6, 157.0 (C(2), bipy), 153.9 (C(6), bipy), 151.7 (C(2), Py)), 150.9 (C(6), Py), 141.2 
(C(4), bipy), 140.3 (C(4), Py), 137.6 (C(3), Py), 128.7 (C(3), bipy), 126.5 (C(5), Py), 124.6 
(C(5), bipy), 54.3 (C(6)), 52.6 (C(12)), 43.5 (C(2)), 38.9 (CH2(glu)), 32.0 (C(3)), 31.6 
(C(ll)), 26.4 (C(10)). vmax (CH3CN): 2022, 1915, 1897 (CO), m/z (ESI) 825.1 [MH]+ and
427.0 [M-PF6-PyCH2SCH2CH[NHCO(CH2)2CH(NH2)COOH]CONHCH2COOH]+. 
Theoretical isotope pattern 823.1 (54%), 824.1 (21%), 825.1 (100%), 826.1 (36%) and
827.1 (11%). Actual isotope pattern 823.1 (58%), 824.1 (20%), 825.1 (100%), 826.1 (34%) 
and 827.1 (12%). HRMS (ESI) calculated [M-PF6]+ = 823.1319; measured [M-PF6]+ = 
823.1333.
6 \  ^ 2 N
I +
Re(CO)3
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C hapter 5
5.1 In troduction  To E lectrochem istry .
5.1.1 Relevance of redox potentials in cell biology: Cyclic voltammetry.
The knowledge of the electrochemical behaviour of a metal complex can be used to 
provide a measure o f the complex’s chemical reactivity associated with redox processes, 
and therefore it is a quantification of the stability of the complex core and ligands in the 
presence of redox agents. As the MLCT process involves oxidation of metal and reduction 
of ligand, a knowledge o f these redox potentials can help to predict the photophysics of the 
complexes. Additionally, a metal complex which undergoes redox changes in the range of 
biological redox processes could act as a sensor for the redox state of a cell. For both these 
reasons, an important feature when it comes to synthesising complexes to be used as 
biological probes is the relative values o f the redox potentials of processes for the 
complexes compared to the redox potentials o f biological reducing and oxidising agents.1,2 
An electrochemical study o f the novel rhenium complexes must be therefore carried out to 
know if the imaging agents are stable in biological media, and consequently, to confirm 
their suitability to be used as luminescent cell probes.
Cyclic voltammetry is a technique that studies the electrochemical behaviour of electro­
active species over a wide potential range. The method consists of cycling the potential 
between two electrodes which are immersed in a degassed and unstirred solution of the 
analysed species and an electrolyte, and measuring the resulting current. A schematic 
drawing showing an electrochemical cell for voltammetry is below show.
Working electrodeInert gas inlet
Auxiliary electrode
Reference
Electrolyte and 
studied sample 
solution
166
Chapter 5
Figure 5.1. Cell for voltammetry.
• Inlet gas: inert gas to degas the solvent between each measurement.
• Reference electrode: provides a known reference potential which is insensitive to small 
variations of temperature or the passage of a small current within solution, e.g. Saturated 
Calomel Electrode (SCE).
• Working electrode: the electrode on which the investigated process takes place.
• Auxiliary electrode or counter electrode: completes the circuit with the working electrode.
Cyclic voltammetry is characterised by a smooth increase of a working electrode potential 
from one potential limit to the other and back. Both the potential limits and the potential 
sweep rate are the basic adjustable parameters. The current at the working electrode is then 
plotted versus the applied voltage to give the cyclic voltammogram trace, Figure 5.2.
Current
■0.1
Figure 5.2. Typical cyclic voltammogram showing the important parameters: EpC reduction 
potential, Ep* oxidation potential, Ipc, Ipa current intensity.
Generally there are two limiting cases for all systems, either a reversible electrode process 
or an irreversible electrode process. The potential difference between the reduction and 
oxidation peaks is theoretically 59/n mV (n: number of electron associated with the 
process) for a reversible reaction. In practice, the difference is typically 70-100 mV. Larger 
differences, or non-symmetric reduction and oxidation peaks are an indication of a non- 
reversible reaction.3
For a yfac-[Re(bisimXCO)3L]ll+ complex it is expected to observe an oxidation peak both 
for ligand and metal. However, the ligand oxidation is not always observed as it is 
sometimes at too high a voltage. In the reduction wave the first peak is typically the
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reduction of the ligand, and sometimes reduction of the metal is also observed. The two 
easiest processes therefore, metal oxidation and ligand reduction, are associated with the 
MLCT process.
It is important to consider that in cyclic voltammetry experiments reduction gives a radical 
anion centred on the ligand, but the whole complex is reduced, while in the MLCT process, 
the ligand radical anion is formed at the same time as the metal is oxidised, so the energies 
of both processes are not exactly correlated. However, for a series of similar complexes a 
trend of variations in redox potentials should correlate with the energy of the MLCT as 
observed by the absorption and emission spectra.4
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5.2 Electrochemistry Discussion
Electrochemical behaviour of the newly prepared complexes 2.9, 3.6, 3.10, 3.12 and 4.1 
depicted in Figure 53, as representatives of each family of compounds synthesised in this 
thesis, was studied.
O C -R e OH
3.9
OH
=N
2.9
— N
4.1
OH
=N
3.17
Re N O—
OC
CO
AgCI
3.10
Figure 53. Complexes 2.9,3.6,3.10,3.12 and 4.1
Each experiment was carried out in dry, deoxygenated acetonitrile solution under a 
nitrogen atmosphere, using tetrabutylammonium hexafluorophosphate 0.1 M as the 
supporting electrolyte. A glass cell with a platinum bead working electrode, a platinum 
wire counter electrode and a silver wire reference electrode was used as the 
electrochemical cell system. In addition, ferrocene was used as internal standard. The 
redox potentials are listed in Table 5.1.
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Complex Oxid. Ej/2 (V) Red. E1/2 (V) Excitation A/nm Emission A/nm
2.9«,b 0.66
1.42
-1.57 (65) 
-1.91
365 556
3.9, 0.74
1.09
-1.59 370 559
4.1, 1.40 -1.61
-1.95
364 551
3.17, 1.44 -1.44 378 563
a From cyclic voltammetry in acetonitrile/0.1 M in TBAP. Potentials are in volts vs. Fc/Fc+ at a sweep rate of 
100 mVs'1. The difference between cathodic and anodic peak potentials (mV) is given in parentheses.
b Irreversible; potential is given for the cathodic wave.
Table 5.1. Redox potential values of complexes 2.9,3.9,3.17 and 4.1.
All complexes present an irreversible oxidation between 1.09 and 1.44 V that can be 
associated with a metal centred oxidation, Re(I)/Re(II), as has been observed before for 
similar species.5 It is worth noting that the complexes with either a bipyridine or a 
bathophenanthroline chelate ligand (2.9, 4.1 and 3.17) have oxidation potentials at ca. 1.42 
V, whereas for complex 3.9, the oxidation value is 1.09 V. This is in concordance with the 
fact that the more extended conjugation in the chelate ligand renders the metal site less 
electron rich and hence decreases the ease of oxidation. The nature of the N-based axial 
ligand also affects the ease of metal oxidation i.e. the stronger the o donor, the easier the 
metal oxidation. However, for the complexes 2.9 and 4.1 the oxidation potential remains 
practically the same (1.42 and 1.40 V respectively). Their structural difference is in the 
substituents on the axial ligand, 3-CH2OH vs. 3-CH2CI respectively, with similar electronic 
effects over the pyridine-rhenium bond. In addition, irreversible oxidation potentials at ca 
0.70 V were observed in the cases of complexes 2.9 and 3.9 which might be connected to 
the axial ligand oxidation6 in the case of complex 2.9, and to the oxidation of the hydroxyl 
group in the chelate ligand in the case of complex 3.9.
All the complexes studied showed a first reduction potential that could be related to the 
chelate ligand reduction, NN07', ranging from -1.44 (in complex 3.17) to -1.61 V (in 
complex 4.1). The bathophenanthroline adduct, complex 3.17, has the least negative 
reduction potentials as a consequence of greater conjugation which makes the ligand more 
easily reducible. A second irreversible reduction potential was observed in complexes 2.9 
and 4.1, which might be associated with the reduction of the metal, Re(I)/Re(0).7
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It can seen from the trend of oxidation potentials in Table 5.1 that 3.9 is the most readily 
oxidised, which is expected as this is a neutral complex, while the others are cations. 
Complexes 2.9 and 4.1 are essentially the same, which is expected as a different non­
conjugated substituent in the axial position should have practically no effect. Complex 3.17 
shows a slightly higher oxidation potential which can be explained as its increased 
conjugation lowers the unoccupied n levels to allow better back donation from the Re cbi 
orbital, and electron withdrawing -SO3' groups also remove electron density from the 
metal.
The trend in reduction potentials can be explained in terms of the high conjugation and 
electron withdrawing effect of -SO3' in 3.17, giving the lowest reduction potential with the 
remaining complexes showing similar reduction behaviour. While complex 3.9 has a very 
different ligand structure to 2.9 and 4.1, their reduction potentials are similar. Probably it is 
due to the fact that the extra pyridyl, which increases the resonance of the system and 
therefore should decrease the reduction potential, is compensated by the hydroxyl group in 
the chelate ligand, which is a donating group and hence should increase the reduction 
potential.
Doing a comparison of cyclic voltammetry with spectroscopic studies, complex 3.9 shows 
the lowest oxidation potential, indicating a high energy level for the metal d orbitals; as the 
ligand reduction potential is similar to that in the other complexes, therefore the energy gap 
should be smaller. Complexes 2.9 and 4.1 have practically identical oxidation and 
reduction potentials but 3.17 shows a slightly higher oxidation and considerably lower 
reduction potential, and should therefore have a lower energy MLCT band than 2.9 and 
4.1. These predictions agree qualitatively with the spectroscopic data (see Table 5.1) while 
a quantitative correlation is much more complex and would require more closely related 
examples.4
The electrochemistry of a more complex species, complex 3.10, was also analysed, and the 
data are reported in Table 5.2. Cyclic voltammetry measurements of this species were 
carried out using the same conditions described before. A first irreversible oxidation is 
observed at 0.10 V possibly due to the silver oxidation followed by two more irreversible 
oxidation potentials at 1.51 and 1.89 V that might be associated with a two-step oxidation 
of two rhenium centres in sequence, i.e. Re(I, I, I)—► Re(II, I, I)—► Re(II, II, I). The fact that 
two oxidations are observed that might be associated with rhenium oxidation implies some 
kind of communication between them. If the three rhenium atoms were not communicating
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with each other, only one oxidation potential (the same EoX value for all of them) should be 
observed, a three electron process. On the other hand, if they are interacting with each 
other, complex 3.10 should have three different oxidation potentials. Therefore a possible 
explanation for observing only two values, 1.27 and 1.65 V, could be that once the silver 
and two rheniums have been oxidised, a greater potential needs to be applied to oxidise the 
third rhenium atom. Since the experiment was performed using a window o f-2.3 to 2.0 V, 
there was not sufficient potential to oxidise the third rhenium atom.
3.10 oxidation
6.00E-05
5.00E-05
4.00E-05 2 x Re / Re
3.00E-05 Ag V Ag1
2.00E-05
1.00E-05
0.5 2.5
Figure 5.4. Representation of the oxidation window of complex 3.10.
Only two values for the reduction potentials of complex 3.10 were recorded, occurring at - 
1.63 and -1.87 V. Comparison with the previous values obtained for complexes 2.9 and 4.1 
(1.91 V and 1.95 V vs. Fc/Fc+ respectively) suggests a possible metal-based character. The 
presence of two potentials might be associated with two rhenium step-wise reductions, i.e. 
Reft I, I)—♦ Re(0,1,1)—► Re(0, 0 ,1), again indicative of some kind of interaction between 
the three rhenium metal atoms in the complex. Unfortunately, only two reduction values 
were recorded, again probably due to the high potential needed to reduce the third metal. 
An alternative explanation for these two reduction potentials could be that they are just a 
ligand reduction and a metal reduction, i.e. the orbitals involved in the oxidation are better 
coupled than those orbitals involved in the reduction. These possible explanations need to 
be further analysed to reach a certain conclusion.
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Complex Oxid. E1/2 Red. Ei/2
3.10, 0.10 -1.63
1.27 -1.87
1.65
a From cyclic voltammetry in acetonitrile/0.1 M in TBAP. Potentials are in volts vs. SCE at a sweep rate of 
100 mV/s. The difference between cathodic and anodic peak potentials (mV) is given in parentheses.
Table 5.2. Redox potential values of complex 3.10.
Mixed valence complexes can be divided into three classes depending on the degree of 
interaction between the metal centres (Robin and Day classification).8 Class 1 are those 
complexes where there is no interaction between the metal centres. Class 3 are those where 
electronic charge is completely delocalised along the complex. Finally, Class 2 includes 
complexes where some communication between the metal centres is observed. This 
category contains the largest number of mixed valence complexes and is probably where 
complex 3.10 fits.
The comproportionation constant, a measure of the thermodynamic stability of the first 
oxidation product, indicates the nature of communication between the metal centres and is 
calculated from the equation shown below in Equation 5.1.
F: Faraday constant, 9.6584* 104J mol'1
R: 8.314 JK '1 mol'1 „  w p (AE) F
N :  R X
T :298 K
Equation 5.1. Equation of comproportionation constant.
If complex 3.10 does undergo step-wise oxidation and reduction processes, the calculated 
comproportionation constant using the equation presented in Figure 5.5 would be 1.1*104 
for the reduction and 2.7* 106 for the oxidation. This would indicate that the mixed valence 
of the tetranuclear complex is more stable than the isovalent forms* and therefore there is 
communication between the metal centres. Comparing these values with those reported in 
the literature for similar rhenium complexes9 or analogous ruthenium complexes,10 
emphasise the necessity of further studies to verify that such communication between the 
metal centres is taking place.
* The isovalent form in a statistical equilibrium would have a comproportionation constant of <4.
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AE,ed = 0.24 V ^  K« = 1.1-104
AEox = 0.38 V ^  K* = 2.7-106
5 3  Electrochemistry Conclusions.
The electrochemical properties of a variety of rhenium complexes of the type 
[Re(bisimXCO)3L]n+, where bisim represents a bisimine derivative, i.e. bipyridine, 
phenanthroline or derivatives, and L is either a pyridine derivative (n = 1) or chloride (n = 
0), were studied. All of them showed an irreversible oxidation as well as in the case of 
complex 2.9 and 4.1 an irreversible reduction of the metal centre. However, no redox
trends were found in any redox processes associated with the ligand.
Examination of the tetrametallic species 3.10 showed possible two-step reduction and 
oxidation sequences. Its calculated high comproportionation constant (compared with those 
found in the literature)9,10 encourages further studies in order to examine the possible use 
of this tetrametallic species as a redox sensor or molecular wire.
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5.4 Membrane Permeability
An obvious requisite for cellular imaging is that the luminescent probe must be membrane 
permeable unless it is to enter the cell by an active transport process. The lipophilicities of 
the complexes can be assayed by their interactions with liposomes, lipid bilayer vesicles 
which are often used as models for cell membranes. 11 A variety of different experiments 
can be performed to study the ability o f luminescent probes to penetrate cell membranes. 
Method 1 first encapsulates the complex to be studied, then, after chromatographic 
separation from the initial solution, a solution of a non-membrane permeable quencher is 
added to the liposomes. Method 2 uses the opposite approach where the non-membrane 
permeable quencher is encapsulated in liposomes followed by addition of the luminescent 
probe, see Figure 5.5. In both cases, any interaction between the solutes will lead to 
differences in luminescence. This assesses the grade o f permeability of the luminescent 
probe, as encapsulation ensures that only in membrane-permeable solutes will such an 
interaction occur.
Over time
«=t>
B
Encapsulated 
species are non­
membrane 
permeable
Encapsulated 
species are 
membrane 
permeableo Complex studied 
o Quencher non-membrane permeable ^
° Complex quencher 
o Liposome
Figure 5.5. Illustration of a quenching experiment to test the permeability of the species 
encapsulated in the liposomes following Method 1.
5.4.1 E ncapsu la tion  o f calceine.
Prior to the study of the cell permeability behaviour of the novel, water soluble, rhenium 
complexes, a test experiment was done in order to validate the formation of liposomes and
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the quenching experiments. Following a procedure from the literature, 12 an encapsulation 
experiment was performed using calcein (a well known fluorescent, non-membrane 
permeable species) as the encapsulated solute and cobalt (II) chloride as the quencher. The 
experiment consisted of forming liposomes with calcein encapsulated within the inner 
compartment (see Section 5.5.1 for liposome generation), by adding a calcein solution at 
the lipid hydration stage. At this point, examination o f the liposome sample under a UV 
lamp corroborated the presence o f calcein in the sample. This, however did not indicate 
whether the liposome formation has been successful. Subsequent addition of a cobalt 
chloride solution only partially quenched the observed luminescence demonstrating the 
success of the encapsulation experiment and thus, the formation of liposomes. In the 
absence of liposomes, all o f the luminescence would be quenched, as it is only by the 
physical separation of calcein and cobalt (II) ions by the liposome membrane that total 
quenching is avoided.
As can be seen in Figure 5.6 solutions o f liposomes without calcein (Figure 5.6 A: vial 1) 
and calcein in a liposome-free buffer (Figure 5.6 A: vial 3) were used as blank-x and 
blank-y solutions respectively. Vial 2 (reaction vial) contains liposomes with encapsulated 
calcine, reaction vial. After the addition of quencher, the luminescence of the blank-y 
solutions (Figure 5.6 B: vial 3) was switched off completely, luminescence of the reaction 
vial (Figure 5.6 B: vial 2) was partially quenched and the blank-x solution (Figure 5.6 B: 
vial 1) remained the same since it does not have any calcein. Therefore, the procedure of 
encapsulating water soluble species in liposomes by our methodology was validated.
C0 C12 ►
Figure 5.6 (l)-liposomes without calcein, (2)-liposomes with encapsulated calcein and (3)- 
buffer solution with calcein. Left picture (A): before addition of the quencher, right picture 
(B): after addition of the quencher.
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5.4.2 Encapsulation of water soluble species with an internal standard.
Liposomes encapsulating the novel water soluble rhenium complexes 3.17 and 3.19 were 
generated in order to address the relative lipophilicity of these species, their affinity for 
lipid or aqueous phases (i.e. their partition behaviour between water and membrane) and 
their permeability through the lipid bilayer. An impermeable internal standard 
(bathophenanthroline) was also encapsulated in order to facilitate the recognition of 
changes in the observed luminescence after the addition of quencher, Figure 5.7. The 
procedure followed was similar to that already described (see Section 5.4.1) for the 
encapsulation of calcein, except for the fact that this time the liposomes were passed 
though a GPC column (Sepharose 4B, see liposome generation in Section 5.5.2) to ensure 
that all the luminescence observed comes from the encapsulated species. Unfortunately, 
luminescent measurements did not shown any emission from the MLCT states, suggesting 
that either all the species are membrane permeable, so that there is an extremely low 
concentration of the dye in the liposome, or that the luminescence of the internal standard 
obscured the MLCT emission, or possibly that it acted as a quencher.
OH
-=N
Internal
Standard
3.17 3.19
Figure 5.7. Chemical structure of complexes 3.17 and 3.19 and the internal standard.
5.4.3 Encapsulation of luminescent rhenium species and the study of their 
behaviour in the presence of quenchers.
The complexes examined were two anionic water soluble complexes, 3.17 and 3.19, and a 
cationic lipophilic species, 2.9, Figure 5.8. The same procedure was followed to generate
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the liposomes encapsulating these species (see experimental discussion in Section 5.4.2), 
except for the generation of liposomes with compound 2.9. The non-water soluble species
2.9 was mixed with the phospholipids in chloroform at the solubilisation stage. In addition, 
the concentration of the different dyes in the bulk phospholipid solution as increased from 
9-10*9 to 21 O'7 mM in order to avoid non-detectable luminescence. Also no internal 
standard was added.
O
OH
OH
Re(CO)3
■=N - = N
= N
2.9 3.17 3.19
Figure 5.8. Chemical structure of complexes 2.9,3.17 and 3.19.
Examination of the emission of the 3 aliquots showed that the encapsulation experiment 
was successful, as the samples' luminescence remained after the liposomes had been 
passed though a GPC column in order to wash the outside of the vesicle (see liposome 
generation in Section 5.5.2 for understanding the vesicle cleaning process). Then, an 
aqueous solution of C0CI2 (10 pi, 10 mM) as added to the liposomes encapsulating 3.19. 
Measurement of the MLCT emission over time showed a strange trend especially at the 
first stages of the quenching process, Figure 5.9. Initially only small changes were 
observed which are assigned to experimental error; then only more than one hour after the 
addition of Co(II) a progressive quenching of the MLCT emission was observed. It would 
seem unlikely that a membrane permeability process would have an initial delay, and thus 
it is possible that processes other than permeation followed by quenching (maybe lipidic 
bilayer hydrolysis processes due to the presence of C0CI2, a Lewis acid) are responsible for 
these results.
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Species 3.19
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1.8E+06 
1.6E+06 
1.4E+06 
1.2E+06 
1.0E+06 
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6.0E+05 
4.0E+05 
2.0E+05 
O.OE+OO
380 430 480 530 580 630 680
Figure 5.9. Variation with time of the emission spectra of liposomes encapsulating 
complex 3.19 before and after C0 CI2 addition.
These ambiguous results cast doubt on the effectiveness of using C0 CI2 as a quencher to 
switch off the MLCT emission of rhenium complexes, which had been anticipated by 
analogy with the similar [Ru(bipy)3]2+ MLCT process. 1314 Therefore, 30 pi C0 CI2 10 mM 
was added to a water solution of 0.18 mM of complex 3.19 or 3.17 and after demonstrating 
the low quenching behaviour, a range of other known water soluble quenchers of MLCT 
systems as tested against these complexes, such as CoCl2, C1CI3, CUSO4, Nal (Figure 5.10, 
5.11). Unfortunately none seemed to be an effective rhenium complex quencher since, 
even though a decrease in the luminescence intensity of the MLCT transition was 
observed, it could be due to a more diluted sample as the experiment entailed the addition 
of the quencher to the same liposome aliquot.
no quencher 
1 min.
15 min.
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Species 3.19
1.6E+07 -j 
1.4E+07 
1.2E+07 
1.0E+07 
8.0E+06 
6.0E+06 
4.0E+06 
2.0E+06 
O.OE+OO - 
400
 Series 1
 Series2
Series 3 
Series4
 Series5
 Series6
Series 1: No quencher; Series 2: 30 pi, 10 mM C0 CI2; Series 3: Several drops, 10 mM 
C0 CI2; Series 4: 30 pi, 10 mM C1CI3; Series 5: Several drops, 10 mM C1CI3; Series 6: 
Several drops, 10 mM CUSO4.
Figure 5.10. Variation o f the emission spectra of complex 3.19 in buffer after addition of 
common quenchers.
6.0E+06
5.0E+06
4.0E+06
3.0E+06
2.0E+06
1.0E+06
0.0E+00
Species 3.17
 Series 1
 Series2
Series3
Series4
 Series5
 Series6
 Series7
Series 1 : No quencher; Series 2: 30 pi, 10 mM C0 CI2; Series 3: Several drops, 10 mM 
C0 CI2; Series 4: 100 pi, 10 mM C1CI3; Series 5: 300 pi, 10 mM C1CI3; Series 6: Several 
drops, 10 mM CuS04; Series 7: Several drops, 10 mM Nal.
Figure 5.11. Variation of the emission spectra of complex 3.17 in buffer after addition of 
common quenchers.
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Ascorbic acid, a well known electron acceptor, was also tested as a possible quencher, but 
once again a confusing result was obtained, Figure 5.12. Not only was no quenching 
observed, but also the relative emission intensities of the two bands in 3.17 changed, and 
the overall emission intensity in the case of complex 3.19 increased. The increase can 
possibly be explained on the grounds that ascorbic acid acts as an oxygen scavenger and 
thus the intensity increases as [O2] lowered since it reduces dioxygen quenching. However, 
in the case of 3.17, although the change in the relative intensities of the MLCT (556 nm) 
and IL (440 nm) bands could be explained by the different sensitivity of the MLCT band to 
dioxygen quenching, it appeared that the MLCT band lowered in intensity in absolute 
terms (although no internal standard was used to verify this). It thus seems that there is 
some complex and interesting behaviour to be discovered concerning the interaction of 
ascorbate and Re complexes. However, for these purposes, ascorbate is not an effective 
quencher.
Species 3.17
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Ascorbic acid
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Figure 5.12. Emission spectra o f complexes 3.19 and 3.17 in buffer before and after the 
addition of 30 pi of 10 mM solution of ascorbic acid.
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5.4.4 Encapsulation of luminescent rhenium species using phospholipids: 
cholesterol (80:20) and the study of their behaviour in the presence of 
methyl viologen (MV2*)
After these negative results methyl viologen (MV2+),b another potential MLCT quencher, 
which has been shown to efficiently quench a range of rhenium bisimine complexes,13,15 
was tried. Although the procedures found in the literature assume methyl viologen to be a 
non-membrane permeable species, a mixture of cholesterol and phospholipid was used for 
preparation of the liposomes for these experiments. Cholesterol fills all the possible 
channels that form in the lipidic bilayer helping to block molecules that could fit in such 
channels. Cholesterol was only incorporated in a 20:80 ratio (cholesterol:phospholipid) due 
to the difficulty that higher percentanges of cholesterol can cause at the hydration stage, 
(see liposome generation in Section 5.43.)
5.4.4.1 Water soluble rhenium complex bearing a hydrocarbon chain.
Experiment A: titration of complex 3.19.
After the first addition of MV (5 pi, 0.15 M) to a sample of liposomes containing 
complex 3.19 which had been passed through a GPC column, there was a blue shift of the 
emission maximum from 554 to 533 nm (Figure 5.14 series 2). This suggests that there 
has been some kind of interaction between the quencher and the rhenium species.
b l,r-Dimethyl-4,4’-dipyridinium is an extensively studied molecule due to its electron acceptor properties, 
also known as paraquat and formerly used as herbicide.
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Increasing MV2+ concentration: Species 3.19
 Series 1
 Series2
Series3
Series4
 Series5
 Series6
 Series7
5.0E+05 
4.5E+05 
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3.5E+05 
3.0E+05 
2.5E+05 
2.0E+05 
1.5E+05 
1.0E+05 
5.0E+04 
0.0E+00 t -  
400
Series 1: No quencher; Series 2: 5 pi, MV2+, 0.15 M; Series 3: 10 pi, MV2+, 0.15 M; 
Series 4: 15 fil, MV2+, 0.15 M; Series 5: 20 nl, M V2+, 0.15 M; Series 6: 25 jil, MV2+, 0.15 
M; Series 7: 30 pj, MV2+, 0.15 M.
Figure 5.13. Variation of the emission spectra of liposomes encapsulating complex 3.19 
with an increasing concentration of MV2+.
One possible explanation for this process could be that this complex, which is water 
soluble because of the sulphonate groups, but at the same time contains the most lipophilic 
unit of all the complexes studied (a C 12 chain), might be forming part of the lipid 
membrane and therefore locating its luminescent core (ReBisimine) in an equal ratio either 
towards outside or the inner side o f the liposome, allowing easy quenching of the 
luminescence. In addition, the species that are not part of the membrane might be 
distributed in the inside of the liposome close to the lipidic membrane, probably interacting 
with the polar heads (MejN*) of the phospholipids, forming micelles in order to protect the 
hydrocarbon chain from the aqueous environment (Figure 5.14). Therefore, there might be 
a high concentration o f rhenium complex concentrated along the lipidic membrane, and 
probably within the Forster distance. As a result of this, the complex molecules might be 
susceptible to being quenched by the methyl viologen.
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Figure 5.14. Assumed distribution of a water soluble rhenium complex bearing a long 
hydrocarbon chain in a liposome.
In consecutive additions of MV2+, the maximum emission value reached 513 nm and it 
remained the same even with further addition of quencher. Since series 5, 6  and 7 (Figure 
5.15) are essentially just the spectrum o f MV2+, only series 1, 2, 3 and 4 were analysed. A 
big but not total loss of emission was seen in the first addition, meaning that some but not 
all o f the Re emission is quenched by MV2+. Given that we know that this addition of 
MV2+ totally quenches this concentration of Re if there are no liposomes, or if the Re is 
rapidly membrane permeable, this indicates that some of the Re is encapsulated or not 
available for quenching as it is in the membrane with the luminescent core pointing toward 
the inner compartment. Furthermore, if no rhenium complexes were encapsulated not only 
would there be a total loss of emission observed, but also an immediate, not gradual, 
maximum emission shift to the MV position.
It can be concluded that the lipophilic water soluble rhenium complex 3.19 might 
preferably be in the inner and outer membrane rather than exclusively encapsulated in the 
inner aqueous compartment, as it has been shown that a water soluble membrane 
impermeable species encapsulated in liposomes and passed through a GPC, does not lose 
emission upon addition of MV2+.
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Experim ent B: Behaviour o f com plex 3.19 over time.
Initial addition of the quencher produces a decrease in intensity of the luminescence as 
well as a slight (1-2 nm) blue shift o f the emission maximum. This decrease in intensity 
and the blue shift of the emission maximum continues with time. The fact that 3 hours after 
the addition of the quencher, the emission maximum is placed at 542 nm, i.e. 10 mn lower 
than the starting point, indicates a dynamic process associated with the rhenium dye 3.19. 
As the sample had been passed through a column to remove all the luminescent species in 
the outer part of the liposome prior to the luminescence examination, this confirms the 
assumption that complex 3.19 is a membrane permeable species. (Initially no Re species 
are outside the liposome. Over time, the concentration of Re equilibrates therefore, more 
rhenium is outside the liposome and thus quenched allowing MV2+ to have a dominant 
emission), see Figure 5.15.
Increasing time: Complex 3.19
 Series 1
 Series2
Series3
Series4
 Series5
 Series6
 Series7
 Series8
Series 1: No quencher; Series 2: 1 pi, MV2+, 0.15 M; Series 3: 5 min; Series 4: 2 pi, 
MV2+, 0.15 M; Series 5: 35 min; Series 6: lh; Series 7: 2h, Series 8: 2h 40 min; Series 9: 
3h.
Figure 5.15 Variation of the emission spectra of liposomes encapsulating complex 3.19 
with the time after the addition of MV2+.
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5.4A.2 N on-w ater soluble rhenium  com plex .
Experim ent A: Titration o f com plex 2.9.
The same behaviour as that seen for 3.19 was observed for the non-water soluble species 
2.9, i.e. a blue shift in the emission maximum, from 554 to 536 nm, and also a drop in 
intensity. Figure 5.16. This can be rationalized by assuming that complex 2.9 is forming 
part of the lipidic membrane due to its hydrophobicity. It may not show as much 
localisation within the membrane region as predicted for 3.19 as it does not have the same 
polar head plus lipid chain as a membrane lipid, although it might have a preference for a 
lipophilic environment. Therefore an increase of quencher concentration in the outside of 
the liposome promoted the complete quenching of the luminescence provided by the 
MLCT state.
Increasing MV2+ concentration: Complex 2.9
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1.2E+06 
1.0E+06 
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2.0E+05 
O.OE+OO
400 450
Series 1: No quencher; Series 2: 5 pi, MV2+, 0.15 M; Series 3: 10 pi, MV2+, 0.15 M; 
Series 4: 15 pi, MV2+, 0.15 M; Series 5: 25 pi, MV2+, 0.15 M; Series 6: 45 pi, MV2+, 0.15 
M.
Figure 5.16. Variation of the emission spectra of liposomes encapsulating complex 5 with 
an increasing concentration of MV2+.
Experim ent B: Behaviour o f com plex 2.9 over time.
Examination of the change in luminescence with time showed an initial blue shift of the 
emission maximum from 558 to 546 nm and a large drop in intensity. Over the following 
three hours, a progressively smaller decay in luminescence intensity accompanied by a
T
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slight blue shift to 543 nm was observed (Figure 5.17). Once again, these changes 
suggested the possibility o f membrane permeability of the rhenium complex as any change 
over time indicates a mixing of the MV2+ and Re phases, which, given that MV2+ is known 
to be membrane impermeable, implies some permeation of Re from the inner compartment 
to the outer compartment or membrane. Although 2.9 has low water solubility, a very 
small quantity could have partitioned into the inner aqueous compartment, and it is 
presumably the subsequent transport o f this portion into a region which is subjected to 
quenching which is responsible for the small but definite decay in luminescence intensity.
Increasing time: Species 2.9
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Series 1: No quencher; Series 2: 1 pi, M V2+, 0.15 M, 1 min; Series 3: 10 min; Series 4: 2h 
min; Series 5: 3h.
Figure 5.17. Variation of the emission spectra of liposomes encapsulating complex 2.9 
with the time after the addition of MV2+.
Experim ent C: Lum inescent exam ination after 48 hours o f liposom e preparation.
The luminescence of liposomes encapsulating complex 2.9 was examined 48 hours after 
their generation and dilution with a NaCl buffer solution 0.15 M, see experimental Section 
5.5.2. This delay time allows the equilibration o f the concentration of the encapsulated dye 
between the outside and inside of the liposome, in case the encapsulated species is 
membrane permeable. Prior to the measurement, the sample was passed through a GPC 
column in order to remove any luminescent species which were not encapsulated in the
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interior compartment or in the liposome membrane. The spectrum obtained showed that 
there is still MLCT emission but its intensity is much lower than in the previous 
experiment, see Figure 5.18. and compared to Figure 5.16 or 5.17 (Series 1: No 
quencher), demonstrating the loss of luminescent species, and therefore membrane 
permeability. N.B. the concentration of the sample used for this experiment is similar to the 
concentration used in previous experiments (5 mM lipidic membrane, 0.045 mM rhenium 
species). The same treatment of the sample was done when it came to passing it for a 
second time through a GPC column, see experimental Section 5.43.
GPC column after 48h: Species 2.9
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Figure 5.18. Emission spectra of liposomes encapsulating complex 2.9 purified on a GPC 
column 48 hours after being formed.
5.4.43 Water soluble rhenium complex.
Experiment A: titration of complex 3.17.
The behaviour of the water soluble complex 3.17 when it was treated with increasing 
amounts of quencher was completely different from that observed for complexes 3.19 and
2.9 (compare Figure 5.19 with Figure 5.13 and 5.16). These results are highly significant 
as 3.17, a highly polar, charged, anionic species was presumed to be membrane 
impermeable, and thus its behaviour allows confirmation of some of the assumptions made 
in the discussion of the results for 3.19 and 2.9. Initial additions of quencher, up to 50 pi, 
did not affect the emission maximum band as in previous cases and the decrease in the 
intensity is barely appreciable. This is presumably a result of the slight dilution of the 
sample and the inner filter effect, as the excitation wavelength (350 nm) is absorbed by
188
C hapter 5
MV2+ and thus the intensity of excitation is decreased It is worth remembering that 
complex 2.9 and complex 3.19 underwent a blue shift from 554 to 536 ppm and from 554 
to 527 ppm respectively after the addition o f the first 5 pi of quencher. This time, 500 pi of 
MV2+ was needed in order to obtain a noticeable maximum emission shift, 570 to 525 
ppm, indicative of the lipophobicity of the complex 3.17. As a consequence, the water 
soluble species 3.17 is assumed to be dispersed in the interior of the aqueous compartment 
of the liposome and not in contact with the lipidic bilayer (Figure 5.20). In this case, there 
is no possibility o f collisional quenching as the complex is separated from MV by the 
membrane, and additionally this assumption avoids any possible quenching process by 
FRET as the Forster distance would be smaller than the real distance between the quencher 
and the complex.
 Series 1
 Series2
Series3
 Series4
 Series5
 Series6
 Series 7
 Series 8
 Series9
Series 10 
Series 11 
Series 12 
Series 13 
Series 14
Series 1: No quencher; Series 2: 5 pi, MV2+, 0.15 M; Series 3: 10 pi, MV2+, 0.15 M; 
Series 4: 15 jil, MV2+, 0.15 M; Series 5: 20 nl, MV2+, 0.15 M; Series 6: 25 (xl, MV2+, 0.15 
M; Series 7: 30 (0, MV2+, 0.15 M; Series 8: 40 nl, MV2+, 0.15 M; Series 9: 50 jil, MV2+, 
0.15 M; Series 10: 70 (J, MV2+, 0.15 M; Series 11: 100 |il, MV2+, 0.15 M. Series 12: 200 
Hi, MV2\  0.15 M; Series 13: 300 jil, MV2+, 0.15 M; Series 14: 500 jil, MV2+, 0.15 M.
Figure 5.19. Variation of the emission spectra o f liposomes encapsulating complex 3.17  
with an increasing concentration of MV2+.
Increasing MV concentration: Species 3.17
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Figure 5.20. Assumed distribution of a water soluble rhenium complex in a liposome.
A new experiment was performed in order to compare the behaviour of complex 3.17 
encapsulated in liposomes with that of the same complex in a buffer solution, to prove that 
MV2+ indeed acts as a quencher for this species. Figure 5.21 shows that the quenching 
process occurs after the addition of 10 pi of MV2+, 0.15 M. There is no significant change 
in the position of the band but the drop in intensity is notable and confirms the efficiency 
of MV2+ as a quencher for this complex.
Species 3.17
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Series 1: No quencher; Series 2: 10 pi, M V2+, 0.15 M.
Figure 5.21. Variation o f the emission spectra of complex 3.17 in buffer after the addition 
of 10 pi, MV2+, 0.15 M.
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Experim ent B: Behaviour o f com plex 3.17 over time.
The variation in luminescence activity of complex 3.17 over time differs from those seen 
so far at the initial stages of the experiment. In this case, there is no drop of intensity in the 
MLCT emission as in the case of complexes 3.19 and 2.9, suggesting again, that these two 
complexes might reside or be close to the lipidic membrane. Nevertheless, after three hours 
of experiment, there is a small decrease in the intensity indicating that the water soluble 
species retains some small membrane permeability, see Figure 5.22.
Increasing time: Species 3.17
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Series 1: No quencher; Series 2: 1 pi, M V2+, 0.15 M; Series 3: 15 min; Series 4: 45 min.; 
Series 5: 1 h 40 min ; Series 6: 3 h; Series 7: 10 pi, MV2+, 0.15 M; Series 8: 4 h 15 min.
Figure 5.22. Variation of the emission spectra of liposomes encapsulating complex 3.17 
with time after addition of M V2+.
Experim ent C: Lum inescent exam ination after 12 hours o f liposom e preparation.
12 hours after generation of the liposomes encapsulating complex 3.17, their luminescence 
was examined for evidence of loss of the complex through membrane permeability, N.B. 
the liposome sample was diluted to approximately 5 mM just after its generation in order 
to allow equilibration of the species in case they were membrane permeable. As in the case 
of 2.9 above (see Section 5.4.4.2, experiment C), prior to the measurement, the solution 
was passed through a GPC column to eliminate external species. The spectrum obtained 
showed an intense MLCT emission, see Figure 5.23, demonstrating the difficulty this 
species has in crossing the lipidic bilayer, and thus the need for a lipophilic part in any 
luminescent probe for cell imaging. This could be incorporated, either as a hydrocarbon
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chain in the axial ligand or a lipophilic chelate ligand, e.g. bipyridine. Finally, the 
sulphonated ligands which give good water solubility, unless they are balanced with lipid 
chains, prevent permeation across lipid membranes.
GPC column after 12 h: Species 3.17
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Figure 5.23. Emission spectra of liposomes encapsulating complex 3.17 washed using a 
GPC column 12 hours after being formed.
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5.5 Experimental Procedures For Liposome Generation.
5.5 .1  E xp erim en ta l: E n ca p su la tio n  o f  ca lce in e .
Egg phosphatidylcholine (15 mg, 0.02 mmol) was dissolved in chloroform (1 ml). The 
chloroform was then removed by rotary evaporation, using an adequate spin-speed to 
obtain a clear film along the walls of the round bottom flask. Further evaporation under 
high vacuum was carried out for 1 h. The lipid was then hydrated with buffer solution (1 
ml, MBSE: 0.15 M NaCl / 0.01 M Mops (pH 7) / 0.1 EDTA) and a calceine buffer solution 
(2 pi, 0.01 M) was added affording a yellow suspension which was homogenised after 
further stirring. The solution underwent ten cycles of freezing in a mixture of liquid 
nitrogen and ethyl acetate and thawing (5 min in frozen solution + 5 min in a warm water 
bath + 5 min in 50-60°C water bath with high speed stirring) to ensure an equilibration 
between the trapped and bulk solutions. The initially formed multilamellar vesicles (LMV) 
were extruded eleven times through a polycarbonate filter (400 nm diameter) using a 
liposofast pneumatic actuator affording unilamellar vesicles (SUV), see Figure 5.24.
A- Hydration process: the solutes get equilibrated
B- Extrusion process: the LMV are extruded through a polycarbonate filter and SUV 
are generated
Figure 5.24. a) Illustration of liposome generation, and b) the pneumatic liposofast 
actuator used to convert LMV to SUV.
a)
b)
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5.5.2 Experimental: Encapsulation of water soluble species with an internal 
standard.
The same procedure was followed in each case. Egg phosphatidylcholine (15 mg, 0.02 
mmol) was dissolved in chloroform (1 ml). The chloroform was then removed by rotary 
evaporation, using an adequate spin-speed to obtain a clear film along the walls of the 
round bottom flask. Further evaporation under high vacuum was carried out for 1 h. The 
lipid was then hydrated with buffer solution (1 ml, MBSE: 0.15 M NaCl / 0.01 M Mops 
(pH 7) / 0.1 EDTA) and a bathophenanthroline buffer solution (1 pL, 0.18 mM) and the 
complex in question (5 pL, 0.18 mM) was added affording a light yellow suspension which 
was homogenised after further stirring in a 50 °C water bath for 1 h. The solution 
underwent ten cycles of freezing in a mixture of liquid nitrogen and ethyl acetate and 
thawing (5 min in frozen solution + 5 min in a warm water bath + 5 min in 50-60°C water 
bath with high speed stirring) to ensure an equilibration between the trapped and bulk 
solutions. The initially formed multilamellar vesicles (MLV) were extruded eleven times 
through a polycarbonate filter (100 nm diameter) using a liposofast pneumatic actuator. 
Then, a liposome sample (0.5 mL) was diluted with an aqueous solution of NaCl (1.5 mL 
0.15 M). Finally a sample of this dilution (1 mL) was placed in the GPC column 
(Sepharose 4B) which had been previously homogenised with the same buffer (aqueous 
solution of NaCl, 0.15 M). The volumes of fractions collected were about 1-1.5 ml; the 
clean liposome sample is easily detectable due to its cloudiness. If the column set up is 10 
cm of Sepharose in a 1.5 cm diameter column, the liposome is recovered in 4 aliquots after 
approximately the seventh fraction, see Figure 5.25.
194
Chapter 5
If the encapsulated  
species are non­
membrane permeable
4
N o equilibration o f  
concentration between  
the outside and inside
tag
If the encapsulated  
species are 
membrane permeable
equilibration o f  
concentration between  
the outside and inside
C- GPC: gel permeation chromatography differentiates the solutes by size, i.e. 
entrapping smallest size particles in their pores allowing the elution of larger 
particules first.
Figure 5.25. Illustration of the process of cleaning the out side liposome using a GPC 
column.
5.5 .3  E xp erim en ta l: E n cap su la tion  o f  rh en iu m  com p lexes in lip osom es 20:80  
ch o lestero l p h osp h o lip id  resp ectiv e ly .
The same procedure was followed in every case except for liposomes encapsulating 
compound 2.9 which was mixed with the phospholipid and cholesterol at the stage of 
solubilizing the phospholipids in the organic solvent. Sphingoyelin from chicken egg yolk 
(11 mg, 16* 1 O'3 mmol) and cholesterol (1.5 mg, 4-10° mmol) were dissolved in 1 ml of 
I PA. Then, the solvent was removed by rotary evaporation, using an adequate spin-speed 
to obtain a clear film along the walls of the round bottom flask. Further evaporation under 
high vacuum was carried out for 1 h. Then, the lipid was hydrated with Tris HCl buffer 
solution (1 ml, 100 mM, pH 7) and the complex in question (210 '4mmol) was added 
affording a light yellow suspension which was homogenised after sonicating in a water 
bath at 50 °C for 1 h. The solution underwent ten cycles of freezing in a mixture of liquid 
nitrogen and ethyl acetate and thawing (5 min in frozen solution + 5 min in a warm water 
bath + 5 min in 50-60°C water bath with high speed stirring) to ensure an equilibration
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between the trapped and bulk solutions. The multilamellar vesicles (MLV) were extruded 
eleven times through a polycarbonate filter (400 nm diameter) submerged in a warm water 
bath heated to around 30-40 °C. Then, 0.5 ml of liposome sample was diluted with 1.5 ml 
of an aqueous solution of NaCl 0.15 M. Finally 1 ml of this dilution was placed in the GPC 
column which has been previously homogenised with the same buffer (aqueous solution of 
NaCl 0.15 M).
5.6 Membrane Permeability Conclusions.
The membrane permeability behaviour of a range of differently charged complexes with 
diverse lipophilicities was studied. Liposomes were used as lipidic membrane mimics to 
assess whether the different dyes were membrane permeable and to determine their affinity 
for different parts of the vesicle, i.e. inner compartment and/or lipidic membrane. Among 
the variety of quenchers tried (C0CI2, C1CI3, C11SO4, Nal, ascorbic acid and MV2+) only 
MV2+ seems to be suitable to quench the luminescence of rhenium complexes.
The cationic and anionic lipophilic complexes, 2.9 and 3.19 respectively, behaved in a 
similar manner. An initial addition of quencher (MV2+) decreased the emission intensity 
considerably, suggesting their affinity for the lipophilic lipidic membrane. Furthermore, 
examination of the luminescence properties over time suggests an important permeability 
gradient as the emission maxima shifted gradually towards the quencher emission (514 
nm). On the other hand, the anionic and non-lipophilic complex 3.17 showed preferred its 
affinity for the inner compartment as initial additions of quencher did not affect the 
luminescence of the dye. In addition, the diffusion of the complex across the lipidic 
membrane is much slower than for 2.9 and 3.19.
This study has demonstrated the possibility of tuning the membrane permeability 
properties of a luminescent rhenium complex of the type [Re(bisim)(CO)3L], either by a 
hydrocarbon chain in the axial ligand or by using a organic neutral chromophore as the 
bisimine ligand. This approach might be useful for design of future luminescent rhenium 
imaging probes.
196
Chapter 5
5.7 Confocal Fluorescence Microscopy
Electronic imaging systems and imaging processing16 have had a major impact on 
fluorescence microscopy due to the demand for better imaging technology with the ability 
to provide images with a three dimensional architecture. The limitation of ordinary 
fluorescence microscopy o f ‘slicing’ the species into thin sections to be imaged, and thus 
the loss of the third dimension information has been overcome with the confocal 
fluorescence microscopy technique.
Confocal optics allow the operator to focus on a chosen plane in a thick specimen while 
rejecting the light that comes from the out-of-focus region, i.e. above and below that plane, 
thus imaging an optical section. From a series o f optical sections taken at different depths 
of the imaged specimen, a virtual three dimensional image can then be constructed. This 
technique involves the illumination by a spotlight onto a single point of the sample, and 
hence pinpoint illumination is required, i.e. a laser. The incident light is aligned by a 
confocal pinhole orthogonal to the plane of the sample and detector, reflected through a 
dichroic mirror and focused by the objective lens. The fluorescence emitted from the 
sample is refocused by the objective lens and transmitted by the dichroic mirror before 
being collected in a detector though a pinhole. The light from the regions out of the plane 
of focus of the spotlight is also out of focus at the pinhole detector and thus rejected (see 
Figure 5.26).
Detector B
I I
Confocal —  
pinholes
Dichoic
mirror
Laser | £ >
Objective
Point o f  
focus
Figure 5.26. Simplified diagram of a basic arrangement of standard confocal fluorescence 
microscope.17
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A: Fluorescent sample illuminated with a focused point of light from a pinhole.
B: Emitted fluorescent light from the in-focus point which reaches the pinhole at the 
detector.
C: Emitted fluorescent light from the out-of-focus point which is excluded from the 
pinhole at the detector.
As a result, confocal fluorescence microscopy is a powerful, high resolution technique in 
biological imaging and specific fluorescent staining techniques make it especially useful 
for diagnostic investigations of tissue samples.
5.8 Confocal Fluorescent Microscopy With Rhenium Complexes In 
Cells.
In order to test the viability of the species described previously in this thesis to be of use as 
imaging agents in cell microscopy, the ability of selected complexes to act as microscopy 
stains was tested, initially in Spironucleous vortex and then in yeast, Saccharomyces 
Cerevisiae (IFO 0233) cells and in Human adenocarcinoma cells (MCF-7).
5.8.1 Incubation with Spironucleous vortens.
1 fiSpironucleous vortens, a parasitic flagellate found in many species of fish, was chosen in 
the first instance as it is known to be a prolific feeder and there was an expectation that the 
organisms would actively take up the complexes, avoiding any possible consideration 
about cell-specific issues of active transport. Spironucleous vortens suspension was 
incubated with the different complexes: 2.9, 3.16, 3.17,
[ReO>ipyXCO)3PyCH2OCO(CH2)12CH3]c (CW), [Re(bipyXCO)3PyCH2OCO(CH2)i6CH3]d 
(JH) and Re(Phen)(CO)3Cl (Figure 5.27) a following a procedure described in the 
experimental section, Section 5.10. Synthesis of Re(Phen)(CO)3Cl has been reported 
previously in the literature by Itukazo et al.19 The fluorescence observed in all cases was
c Complex synthesised and fully characterised by Craig Williams, B.Sc. Research Project, Cardiff University, 
2006.
d Complex synthesised and fully characterised by Jacob B. Hess, B.Sc. Research Project, Cardiff University, 
2007.
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strongly associated with the cell fragments suggesting a successful fluorophore uptake and 
the viability of using complexes of the type [Re(bisim)(CO)3L]'/0/+ as cell fluorophores.
OH
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Figure 5.27. Chemical structures of complexes incubated with Spironucleous vortens.
The neutral complex, Re(PhenXCO)3Cl, showed accumulation in the cell domain but it 
was observed to be toxic, as the cells were immobile (<Spironucleous vortens is a rapidly 
moving flagellate and when healthy is difficult to image due to rapid motion) and also to 
be rapidly photobleached. This photobleaching process cannot be associated with a photo­
assisted hydrolysis of the complex, as it was demonstrated that the analogous aqua 
complex is highly emissive. Fortunately, no other complex appeared to suffer from 
photobleaching under the same conditions; therefore this undesirable process can be 
associated with the chloride placed in the axial position, which in the other complexes 
studied has been substituted by less labile pyridine derivatives.
The most lipophilic complexes CW and JH, which contain long hydrocarbon chains (Cj3 
and Cn respectively), showed similar behaviour. Both of them were toxic at high 
concentrations (40 ml of a 2 mM solution incubated with 200 ml of cell suspension), 
apparently disrupting the membranes and leading to cell lysis (Figure 5.28A). The
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fluorescence, however, was strongly associated with cell fragments indicating that uptake 
had occurred. At lower concentrations (20 mL of a 2 mM solution) lysis was avoided and 
the complexes appeared to be associated with internal membranes partitioning cell 
compartments and with the constituents within organelles (Figure 5.28B).
CW-A I 17.74
Figure 5.28. Top pictures: complexes CW and JH  incubated with Spironucleous vortens 
at high concentrations. Bottom pictures: complexes CW and JH  incubated with 
Spironucleous vortens at low concentrations (scale in pm).
[Re(bipy)(C0)3PyCH20H], 2.9, a simple example of a rhenium bisimine complex with no 
water solubilising groups, or lipophilic chains, showed accumulation in all the studied cells 
but it seemed to be more toxic by comparison with its sulphonate analogue, 3.17, as the 
cells were dead after 2 hours. Although the images are poor (typical o f a dead cell which is 
losing membrane potential and internal structure) it appears that this complex was localised 
in certain internal compartments. However, as Spironucleous vortens is a poorly 
characterised species, the nature of these compartments is not clear. The two sulphonated 
derivatives were the most successful imaging agents as, apart from accumulating in the 
cell, they were observed to be localized in certain cell domains, which appear to be 
digestive vacuoles forming during phagocytosis (see Figure 5.29). The main difference in
200
C hapter 5
properties observed between 3.16 and 3.17 is the toxicity index, as the cells stained with 
3.17 were alive after 2 hours of experiment and consequently, moving in the incubation 
media. These results encouraged us to continue investigating the [Re(bisim)(CO)3L]'/0/+ 
complexes as possible cell imaging agents since these first applications of rhenium 
complexes in cell imaging demonstrated that they retain their luminescent properties in 
biological media and that there is no intrinsic toxicity associated with rhenium complexes. 
In addition, the observed toxicity of some species can be modulated by tuning the ligands 
in the complex.
Figure 5.29. Complexes 2.9, 3.16 and 3.17 incubated with Spironucleous vortex cells 
(scale in pm).
5.8.2 Incubation  w ith hum an  b rea s t can ce r cells, M C F-7 ad en o carc in o m a 
cells.
As the sulphonate derivatives 3.16 and 3.17 had shown not only accumulation in 
Spironucleous vortens, but also interesting localization and low toxicity, they were 
incubated with human breast cancer, MCF-7 adenocarcinoma cells, in a tentative 
experiment to test their behaviour in mammalian cells. In contrast to Spironucleous vortens 
which feeds by engulfing its environment, transport into mammalian cells is much more 
complex and must occur either by membrane permeation or by an active uptake 
mechanism (see C hapter 1, Section 1.1.2). In addition, species 2.9 and the lipophilic 
complex CW were also incubated with MCF-7 cells in order to allow a comparison 
between the patterns of uptake and localization of the complexes with different levels of 
lipophilicity. At this stage, given the lack o f literature precedent for the application of 
rhenium complexes in cell imaging only very tentative predictions of uptake and 
localisation could be made, and thus the behaviour of all complexes was of interest.
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The simplest rhenium complex 2.9 was taken up by the mammalian cells, with the entire 
population showing high levels of the luminescent species, Figure 5.30. As it is not 
expected that such complexes will be actively transported, it is possible that the 
lipophilicity, together with the cationic character of the species 2.9 could be the reason for 
its cell permeability, i.e. passive diffusion across the cell membrane due to a positive 
electrochemical gradient. In addition, the complex appears to be localised in certain 
organelles in the perimeter o f the cytosol within the cell membrane. Apart from an intense 
luminescence from these specific domains, a slighter luminescence was observed 
surrounding them, indicating that the complex had also localised, at a lower concentration, 
in some other organelles in the cytoplasm. This staining pattern, like grains, could be 
indicative of an interaction of the dye with the endoplasmatic reticulum6, which is spread 
throughout the cytoplasm surrounding the nucleus. No nucleus-staining appears to have 
occurred as seen by the dark centre to the cells (which have larger than usual nuclei, 
typical of carcinoma cells).
Figure 5.30. Rhenium complex 2.9 incubated with breast cancer cells (scale in pm)
The lipophilic cationic complex, CW, also shows accumulation in MCF-7 cells but 
contrary to its behaviour in Spironucleous vortens cells, did not disrupt the cell membrane 
as the MVF-7 cells appeared to be healthy, Figure 5.31. Again, the grainy luminescence 
observable in the cell could be indicative of localisation in the endoplasmatic reticulum, 
Figure 5.32. An interesting feature is that the cell nucleus seems to be stained as well, as 
shown by the absence of the dark ring in the centre, which might be explained in terms of 
the affinity of the anionic bases in the DNA for cationic species.
e ER is a labyrinthine, membrane bounded organelle.
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CW *
Figure 5.31. Complex CW incubated with breast cancer cells (scale in pm).
Figure 5.32. This is an image of endoplasmic reticulum in human cancer cells incubated 
with Calreticulin (note the large dark nucleus) published by Louie Naumovski et a l20
The two water soluble, sulphonated complexes, which differ in chemical structure only by 
a hydroxymethyl group, seem to behave very differently to each other in the presence of 
carcinoma cells. While 3.16, the simple pyridine complex, was taken up by the cell, the 
analogous hydroxymethyl complex 3.17 exhibited some interaction with the outside of the 
cell membrane and no take up process was observed (see Figure 5.33). The species 3.16 
was distributed throughout the whole cell, with a particularly high concentration in a 
specific organelle. Its membrane transport could have been mediated by protein channels, 
narrow hydrophobic pores in the cell membrane, as this kind of species, anionic and highly 
polar, should not show passive diffusion across the membrane against the potential 
gradient. On the contrary, species 3.17 seems to stain the outside of the cell, with a higher 
concentration near the cell membrane. It is likely that the anionic complexes interact with 
the positively charged cholinef groups from the lipidic bilayer, allowing a clear definition 
of the shape of the cell. It is worth noting that, in addition to a strong luminescence arising 
from the surface of the cell membrane, there is an aureole of light, possibly provided by
f Phospholipid constitution in the cell membrane: (hydrophobic tail)2--(polar head):(fatty acid)-(glycerol- 
phosphate-choline).
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interactions of the anionic dye with positively charged residues in the glycocalyx,8 the cell 
coat.
Figure 5.33. Complexes 3.16 and 3.17 incubated with human breast cancer cells (scale in 
pm).
5.8.3 Incubation  w ith  Saccharomyces Cerevisiae (IF O  0233) yeast cells.
Further studies were then carried out in order to elucidate which organelles were stained by 
each of the new dyes. Hence, Saccharomyces Cerevisiae (IFO 0233) yeast cells were 
chosen for the next investigation as this is a well known species, long studied by biologists 
and where localisation sites o f the rhenium dyes within the cells might be identifiable with 
reference to the literature.
The complexes selected for this experiment were the water soluble sulphonated complexes 
3.16 and 3.17, the lipophilic complexes CW and JH  {vide supra Figure 5.27) and also 
complex 4.1 {vide infra Figure 5.34) to test whether it has the same affinity for thiol- 
containing biomolecules in a genuine biological environment as was shown in vitro in 
C hapter 4.
g Glycocalyx describes the carbohydrate rich zone on the surface o f  the cell. They are oligosaccharide chains 
covalently bound to the membrane proteins (glycoproteins) and polysaccharide chains o f  the integral 
membrane proteoglycan molecules.
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4.1
Figure 5.34. Chemical structure o f complex 4.1.
Examination of the incubated cells with the sulphonated complexes showed a very low 
percentage of the population had taken up any fluorophore at all; most of the cells showed 
no luminescence. Moreover, and even more surprisingly, only those cells that were in the 
budding phase appeared to be the ones that had taken up the fluorophores, suggesting that 
the sulphonated dyes were able to differentiate between the different stages in the cell life­
cycle (Figure 5.35). Yeast has a rather substantial cell wall and it may be only at the stage 
of budding when the wall is weakened at the point of separation that the complex can enter 
the cells. Furthermore, no specific organelle localization was observed, as the stained cells 
seemed to have the dye within the entire cytoplasm, indicating that their polar hydrophilic 
nature makes them more attracted to cytosol (the polar, aqueous, intracellular fluid) than 
the more lipophilic membranes around many organelles.
Figure 5.35. Complexes 3.16 and 3.17 incubated with yeast cells (scale in pm).
In the case of the highly lipophilic rhenium complexes CW and JH , again only a low 
percentage of cells took up the dye (again, presumably at the budding stage) but contrary to 
the sulphonated water soluble dyes, CW  and JH  seemed to differentiate between 
organelles and they are localized specifically in certain compartments with no general 
luminescence observed in the cytosol, F igure 5.36.
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Figure 5.36. Top pictures: complex CW  incubated with yeast cells. Bottom pictures: 
complex JH  incubated with yeast cells (scale in pm).
The selectively thiol-reactive complex, 4.1, appears to also stain the same kind of cells as 
in the previous cases, again only those in the budding stage. In addition, complex 4.1 
seemed to become localized in some cell domains, mainly organelles near to the cell 
membrane (Figure 5.37). The pattern o f localisation seemed to be more specific than the 
one observed in the case of the lipophilic complexes, CW and JH , where the domains in 
which they are localized appear to be more spread throughout the cell rather than 
concentrated close to the cell membrane. The domains close to the cell membrane are 
thought to be mitochondria as this is the known distribution of yeast mitochondria, and, 
moreover mitochondria bear a high concentration of thiol groups for which complex 4.1 
has high affinity. Although these results appear to show that 4.1 is a mitochondrial 
selective agent, given the low level o f uptake further proof was needed, and a cell line 
which does not have the rigid wall of yeast, such as mammalian cells was the next target.
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Figure 5.37. Complex 4.1 incubated with yeast cells.
5.8.4 Incubation  of com plex 4.1 w ith  hum an  b reast can cer cells, M C F-7 
adenocarcinom a cells.
Further studies were undertaken in order to confirm the assumption that complex 4.1 might 
specifically stain mitochondria, this time using human mammary adenocarcicoma cells 
(MCF-7), which unlike the yeast cells possess a less rigid cell wall, which may 
accelerate the permeation of the dye. The entire population took up the dye and no 
evidence of toxicity was seen as the cell membrane remained healthy throughout the 
experiment. Once again, the complex appeared to be localised in certain cell domains that 
were thought likely to be mitochondria due to their position close to the cell membrane, 
Figure 5.38. These images are somewhat similar to those obtained when the analogous 
hydroxyl complex was incubated with the mammary adenocarcinoma cells, vide supra 
Figure 3.30 which was localised in some domains also close to the cell membrane. This 
similarity is discussed in detail below in Section 5.8.6.
I  njfrpni
Figure 5.38. Complex 4.1 incubated with human mammary adenocarcinoma cells.
An additional experiment using a commercially available mitochondria-selective dye was 
performed in order to test the hypothesis that 4.1 was localising in mitochondria.
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Tetramethylrhodamine ester (TMRE),23 a well known specific mitochondrial probe, was 
incubated with human mammary adenocarcinoma MCF-7 cells under the same conditions 
as in the case of the rhenium complex 4.1. Some of the images of the TMRE incubation 
obtained by confocal fluorescence microscopy are shown in Figure 5.39. These do not 
differ significantly in the shape of the organelle or in the distribution within the cell from 
pictures taken previously of the rhenium complex 4.1 incubated in the same type o f cells, 
adding further evidence that 4.1 accumulates in mitochondria. Figure 5.38.
6.7V urn 6.7V uni
Figure 5.39. Images of TMRE incubated with human mammary adenocarcinoma cells.
5.8.5 Colocalisation experim en t: C om plex  4.1 and  T M R E .
Finally, a co-localization experiment was carried out using the complex 4.1 and the 
mitochondrial selective dye TMRE as a co-imaging agent. Co-localisation is a technique in 
which two imaging agents with different emission wavelengths are applied to the same 
cells simultaneously. Two different images of the emission (and thus localisation) are then 
recorded first at one wavelength, and then at the other. If the agents have localised in the 
same organelles then the two images overlap, and the colouring of the overlapped image 
gives a visual measure of the degree to which the agents localise in the same areas. 
However, the similar emission properties of the fluorophores (^emmaX(4.i) = 551nm and 
^emmaX(TMRE) = 588 nm) makes it impossible to distinguish their localisation patterns by 
emission; therefore a different excitation wavelength was used to perform the two 
measurements (XexcmaX(4.i) is 364 nm and texcmax(TMRE) is 555 nm). Using a 405 nm laser 
excitation, emission from 4.1 is observed, Figure 5.40A, whereas on excitation at 543 nm 
only TMRE emission is observed, Figure 5.40B. By superposition of both images obtained 
by confocal microscopy, Figure 5.40C, it is clear that both dyes are being localised in the 
same organelles and thus as TMRE is a selective mitochondrial stain this co-localisation
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experiment provides final proof that demonstrates that the novel rhenium complex, 4.1, is 
also a selective mitochondria fluorescent probe.
Figure 5.40. Complex 4.1 and TMRE co-localization experiment: A exciting at 405 nm, B 
exciting at 543 nm, and C superimposed picture.
Figure 5.41A and B. show a closer view of both dyes in the same cell making it obvious, 
at least by eye, how the two dyes are located in the same areas. Even clearer is the cross 
section shown in Figure 5.41C, where it can be seen that the intensities of both dyes are 
essentially the same along the cell.
! ■
Figure 5.41. Colocalisation of 4.1 and TMRE in MCF-7 close up and cross section.
These results can be also interpreted in a negative way: since the examples seen so far 
showed the same fluorescent pattern in the cell, it can be thought that the experiment was 
flawed and cannot differentiate between the two fluorophores. However, by comparison of 
Figure 5.42A and Figure 5.42B, another snapshot from the cell population, where the 
excitation wavelength used was 405 and 544 nm respectively, a different emission pattern 
is shown, which is confirmed by the superimposition of the two pictures, Figure 5.42C. In 
this case, for a reason that is not known, one cell from the entire population has taken up 
only 4.1 and not TMRE. We do not know why this cell chose to take up only 4.1, but by 
doing so it has validated the experiment, proving that the different excitation technique can 
differentiate between the two agents. Therefore the technique is validated and it can be 
assured that the novel complex [Re(bipy)(CO)3PyCH2Cl]PF6 represents the first example
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of a mitochondrion selective transition metal complex, showing the same localisation as 
TMRE, but with a large Stokes shift and longer lifetime, which indicates a promising 
future for 3MLCT biological imaging agents.
Figure 5.42. Colocalisation of 4.1 and TMRE in MCF-7 showing single uptake in one 
(bottom) cell.
5.8.6 Comparison between the rhenium complexes 4.1 and 2.9.
Having demonstrated that complex 4.1 is a specific mitochondria marker, it was thought 
that complex 2.9 would exhibit the same behaviour due to the similar images obtained 
when it was incubated with human breast cancer cells. However, on closer examination of 
the images, complex 4.1 (Figure 5.43 left picture) stains the cell only in some domains 
specifically (mitochondria) whereas the staining observed by complex 2.9 (Figure 5.44 
right picture) is more spread out through the cytoplasm.
Figure 5.43. Left picture: complex 4.1 incubated with MCF-7. Right picture complex 2.9 
incubated with MCF-7.
As both complexes 2.9 and 4.1 are cationic lipophilic species, they should have similar 
take up and localisation behaviour. Thus, both will be taken up by the cell as they are able 
to enter by passive diffusion due to their lipophilicity, and, being cationic, to concentrate in 
the cell due to the potential gradient. Additionally, they will then be further concentrated in 
the mitochondria which has a greater potential gradient than the remaining cell, and its 
own membrane, therefore attracting cationic-lipophilic species. However, as the species
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4.1 contains a sulfhydryl reactive group (chloromethyl), once inside the mitochondria there 
is the possibility that it can undergo a chemical reaction with the high concentration of 
thiols inside the mitochondria, thus preventing the luminescent species from leaving the 
mitochondria. On the other hand, complex 2.9 does not react with any of the mitochondrial 
components and therefore it can cross the membrane again to leave the mitochondria. 
Thus, while 4.1 will become completely localised in the mitochondria as it is chemically 
bonded there (i.e. becomes membrane impermeable), 2.9 will show a higher concentration 
in mitochondria than in other organelles due to the higher potential gradient, but will be 
distributed throughout lipophilic units of the cell as it remains membrane permeable. 
Although this explanation cannot be considered as a scientific probe, it can be used as an 
initial step for further investigations.
5.8.7 Incubation of complex 3.10 with human breast cancer cells, MCF-7 
adenocarcinoma cells.
Although complex 3.10 was not designed to have any substituents sensitive to a biological 
group and its molecular weight is over 1000 kDa, which implies the necessity of an active 
transport to cross the cell membrane, its ability as a cell imaging probe was tested (Figure 
5.44).
O -Re
OC
CO
\ AgCI
3.10
Figure 5.44. Chemical structure of complex 3.10.
Complex 3.10 was incubated with human breast cancer cells, MCF-7 adenocarcinoma 
cells. Not only was the lipophilic cationic species able to cross the cell membrane, but also 
has affinity for a specific organelle thought to be inside the nuclei, Figure 5.45. This
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preliminary result showed that the dye was taken up by all the cell population getting 
spread throughout the cytoplasm and the nuclei. In addition, a higher dye concentration is 
observed in some domains within the nucleus which could be the nucleolus*1. This initial 
assumption needs to be studied in more detail in order to draw any conclusions. Therefore, 
an extensive study of this fascinating complex will be carried out in future to assay its 
suitability as a chemical sensor and/or cell imaging probe.
Figure 5.45. Species 3.10 incubated with MCF-7 (scale in pm).
5.9 Confocal M icroscopy C onclusions.
Preliminary studies to assess the viability of a variety of differently charged complexes, 
and with diverse lipophilicities, as possible luminescent cell imaging probes were 
performed. The selected complexes (2.9, 4.1, 3.10, 3.16, 3.17, CW, JH  and 
[Re(Phen)(CO)3Cl]) were incubated with different cells (Spironucleous vortens, 
Saccharomyces Cerevisiae-(IFO 0233) yeast cells and human breast cancer cells (MCF-7)- 
adenocarcinoma cells) giving evidence for the possibility of using rhenium metal 
complexes as specific cell imaging agents. A summary of the results is shown in Table 5.3.
h Structure in the nucleus where the ribosomal RNA is transcribed and ribosomal subunits are assembled.
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Spironucleous vortens Yeast cells Adenocarcinoma cells
2.9 L: certain internal 
compartments 
T: more toxic than the 
sulphonated analogues
L: high intensity from certain domains 
close to the cell membrane, possibly 
mitochondria and with lower intensity 
form other organelles in the cytosol, 
possibly endoplasmatic reticulum
4.1 TU: presumably 
only cells in 
budding phase 
L: mitochondria
L: mitochondria
3.10 L: spread throughout the cytoplasm
and the nuclei and with higher 
concentration in probably the 
nucleolus
3.16 L: maybe digestive TU: presumably L: throughout the whole cell, and with
vacuoles occurring only cells in a particularly high concentration in a
during phagocytosis budding phase specific organelle.
T: more toxic than 3.17 L: entire 
cytoplasm
3.17 L: maybe digestive TU: Presumably L: in the outside of the cell, with a
vacuoles occurring only cells in higher concentration near the cell
during phagocytosis budding phase. membrane.
T: less toxic than 3.16 L: entire 
cytoplasm
CW L: internal membranes TU: presumably L: organelles along the cytosol
and constituents within only cells in possibly to endoplasmatic reticulum
organelles at low budding phase including nucleus
concentration* L: certain
T: cell lysis at high organelles, no
concentration** cytosol
JH L: internal membranes TU: presumably
and constituents within only cells in —
organelles at low budding phase
concentration* L: certain
T: cell lysis at high organelles, no
concentration** cytosol
L: localization, T: toxicity, TU: taken up, **40 or *20 ml of 2 mM [Re] with 200 ml of cell suspension. 
Table 53. Summary of cell image results.
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5.10 Cell Culture And Imaging.1
Spironucleous vortens incubation with 2.9,3.16, 3.17, CW, JH, RePhen(CO)3Cl. Live 
cells were harvested by centrifugation, incubated with solutions of each complex in DMSO 
for 2 h (typically 10-40 ml of a 0.5 mM solution of fluorophore incubated with 200 ml of 
cell suspension) before being washed in buffer (PBS, pH 7.2) and mounted in 
methylcellulose to restrict movement. Preparations were viewed using a Leica TCS SP2 
AOBS Confocal Scanning Laser Microscope using a *63 or x 100 objective with excitation 
at 405 nm and detection at 520-570 nm.
Yeast cell incubation with 2.9, 3.16, 3.17, CW, JH, 4.1. Saccharomyces cerevisiae 
IFO 0233 cells were harvested by centrifugation (1000 g, 3 min), washed twice in 
phosphate buffer saline (PBS, pH 7.4) before being resuspended in PBS, incubated with 
the different complexes (final concentration 100 pgml'1) for 30 min. in 0.3 % yeast 
extract, 1 % peptone, 1 % glucose, rinsed in PBS (><3) and mounted on a slide. 
Preparations were viewed as above by confocal microscopy.
Human cell incubation with 2.9, 3.10, 3.16, 3.17, CW, 4.1. Human mammary 
adenocarcinoma cells (MCF-7) , obtained from the European Collection of Cell 
Cultures (Porton Down, Wiltshire, UK) were maintained as adherent cultures in Eagle’s 
Minimum Essential Medium supplemented with 10 % foetal bovine serum, penicillin 
and streptomycin. Cells were detached from the plastic flask using trypsin and EDTA 
and were suspended in an excess volume of growth medium. While suspended in this 
medium, cells were incubated with the luminescent species (final concentration 100 pg. 
ml"1) on ice for 30 min. Cells were then thrice washed in PBS, harvested by 
centrifugation (3 min, 3.190 g) before being mounted on a slide and viewed as above 
by confocal microscopy.
Human cell incubation with TMRE. MCF-7 adenocarcinoma cells were harvested as 
indicated above, resuspended in EMEM culture medium and incubated with TMRE (final 
concentration 20 nM) for 2 h at room temperature before being thrice washed in PBS, 
mounted and viewed as above by confocal microscopy
' Cell culture and imaging experiments carried out by Coralie Millet, postgraduate student in the School of 
Bioscience at Cardiff University under the supervision of Prof. David Lloyd.
214
Chapter 5
5.11 Experimental.*
Pyridine-3-methyleneoxyoctanoate (JHa)
3-Hydroxymethyl pyridine (0.70 ml, 7.2 mmol) was 
dissolved in DCM (25 ml); subsequently octanoyl chloride 
(1.12 ml, 6 mmol) was added dropwise. The reaction 
mixture was then stirred for 3 hours, extracted with 
sodium bicarbonate solution (sat. aq., 3^10 ml) and dried over MgS04. The solvent was 
removed in vacuo to leave JHa (0.90 g, 3.83 mmol, 53.23 %) as a colourless oil.24
Foc-[Re(bipyXCO)3Py-3-CH202C(CH2)6CH3l (JH)
[ReO>ipyXCO)3CH3CN](BF4) (0.080 g, 0.14 
mmol), and JHa (0.075 g, 0.42 mmol) were 
dissolved in tetrahydrofiiran (20 ml) and heated at 
50 °C for 20 hours. The resultant solution was 
subsequently filtered through Celite prior to the 
removal of the solvent in vacuo to afford JH as a 
bright yellow solid. 8H (CDC13): 9.02 (2H, d, J  =
4.7 Hz, C/7(6,6’) bipy); 8.29 (3H, m, C//(2) Py and 
C//(3, 3’) bipy), 7.90 (1H, d, J=  8.0 Hz, CH(6) Py), 7.69 (3H, m, CH(4) Py, CH(5) bipy), 
7.34 (1H, m, CH(5) Py), 4.91 (2H, s, PyCH2), 2.24 (2H, m, COCH2), 1.25 (10 H, br s, 
CH2\  0.81 (m, 3H, CH3); 5C (CDC13): 195.8 173.6, 156.1, 153.2, 151.9, 151.3, 142.1, 
140.0, 136.1, 129.4, 127.5, 126.1, 62.4, 34.3, 32.0, 29.4, 29.2, 25.1, 22.9, 14.4 br; vmax 
(Nujol) 2032, 1917, 1739, (CO) m/z (ESI) 660.2 [M-BF4]+; theoretical isotope pattern
660.2 (58%), 661.2 (19%), 662.2 (100%), 663.2 (32%), 664.2 (6%), observed isotope 
pattern 660.3 (56%), 661.3 (18%), 662.3 (100%), 663.3 (30%), 664.3 (6%); HRMS (ESI) 
[M-BF4]+ calculated 660.1631 observed 660.1628.
J Complexes synthesised and fully characterised by Craig Williams (CW) and Jacob B. Hess (JH), B.Sc. 
Research Projects, Cardiff University, 2006 and 2007 respectively.
r V
10-16
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Pyridinemethylene-3-oxystearate (CWa)
EDCI (2.2 g, 11 mmol) and DMAP (268 mg, 2.2 mmol) 
were dissolved in DCM (15 ml). To this mixture was 
added a solution of myristic acid (1.37 g, 6 mmol) in DCM 
(25 ml) at 0 °C. 15 minutes subsequent to the initial 
mixing, a solution of 3-hydroxymethyl pyridine (0.55 cm3, 6 mmol) in DCM (10 ml) was 
added. The reaction mixture was then left at room temperature for 15 hours with continual 
stirring. Saturated NH4CI (25 ml) was then combined with the reaction mixture and the 
resultant aqueous layer was extracted with diethyl ether (4 x 25 ml) the organic layer was 
dried with MgSC>4 and concentrated in vacuo. The remaining mixture was purified using 
column chromatography (40-60 petroleum ether: ethyl acetate, 1:1) to yield compound 
CWa (1.18 g, 68 %) as a white crystalline solid.25
12-21
F«c-[Re(bipyKC0)3Py-3-CH202C(CH2)i2CH3] (CW)
[Re(bipyXCO)3CH3CN](BF4) (0.161 g, 0.29 
mmol) and CWa (0.092 g, 0.29 mmol) were 
dissolved in THF (20 ml) and heated at 50°C for 
20 hours. The resultant solution was subsequently 
filtered through Celite and the product precipitated 
by the addition of petroleum ether to give CW as a 
bright yellow solid (0.156 g, 64 %), m.p. 123-125 
°C. 6H (CDC13): 9.03 (2H, d, J  = 5.5 Hz, CH(6) 
bipy). 8.65 (2H, d, J  = 8.0 Hz, CH(3) bipy), 8.26 (3H, m, CH(2) Py, CH(4) bipy), 7.89 
(1H, d, J=  7.0 Hz, CH(6) Py), 7.71 (3H, m, CH(4) Py, CH(5) bipy), 7.33 (1H, dd J=  7.5, 
2.0 Hz CH(5) Py), 4.95 (2H, s, PyCH2% 2.24 (2H, t,J=  7.5 Hz, COCH2\  1.22 (20 H, br s 
10 x C//2), 0.82 (3H, t, J  = 3.5 Hz, Ctf3); 8C (CDC13) 174.2, 156.6,. 153.3, 151.8, 151.2, 
142.5, 139.9, 137.3, 129.3, 127.6, 126.4, 52.4, 34.3, 32.3, multiple peaks 30.1-29.4, 25.2, 
23.1,14.5; Vmax (Nujol) 2037,1938 br, m/z (ESI) 746.3 [M-BF4]+ theoretical isotope pattern
744.3 (60%) 746.3 (100%) 747.3 (40 %) 748.3 (10%), observed isotope pattern 744.3 
(60%) 746.3 (100%) 747.3 (40 %) 748.3 (10%); HRMS (ESI) [M-BF4]+ calculated mass 
744.2570 observed 744.2567.
r V
10-22
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